SECURITIES AND EXCHANGE COMMISSION
Washington D.C. 20549
FORM 20-F
[ ] REGISTRATION STATEMENT PURSUANT TO SECTION
12(b) OR 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934
or
[X] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
For the fiscal year ended December 31, 2002
or
[ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from to
Commission file number: No. 0-20892
ATTUNITY LTD
(Exact name of Registrant as specified in its charter
and translation of Registrant's Name into English)
Israel
(Jurisdiction of
incorporation or organization)
Einstein Building, Tirat Carmel, Haifa, 39101, Israel
(Address of principal executive offices)
Securities registered or to be registered pursuant to Section 12(b) of the
Act:
Title of Each Class Name of Each Exchange on Which Registered
------------------- -----------------------------------------
None N/A
Securities registered or to be registered pursuant to Section 12(g) of the
Act:
Ordinary Shares, NIS 0.1 Par Value
(Title of Class)
Securities for which there is a reporting obligation pursuant to Section
15(d) of the Act: None (Title of Class)
Indicate the number of outstanding shares of each of the issuer's classes of
capital or common stock as of the close of the period covered by the annual
report:
Ordinary Shares, par value NIS 0.1 per share
as of December 31, 2002..........................14,767,432
Indicate by check mark whether the registrant (1) has filed all reports required
to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during
the preceding 12 months (or for such shorter period that the registrant was
required to file such reports), and (2) has been subject to such filing
requirements for the past 90 days.
Yes X No __
Indicate by check mark which financial statement item the registrant has elected
to follow:
Item 17 __ Item 18 X
This Report on Form 20-F is incorporated by reference into our Form F-3
Registration Statements File Nos. 333-11972, 333-12450 and 333-14140.
TABLE OF CONTENTS
PART I.........................................................................1
ITEM 1. IDENTITY OF DIRECTORS, SENIOR MANAGEMENT AND ADVISERS...........1
ITEM 2. OFFER STATISTICS AND EXPECTED TIMETABLE.........................1
ITEM 3. KEY INFORMATION.................................................1
A. Selected Financial Data......................................1
B. Capitalization and Indebtedness..............................2
C. Reasons for the Offer and Use of Proceeds....................2
D. Risk Factors.................................................3
ITEM 4. INFORMATION ON THE COMPANY.....................................14
A. History and Development of the Company......................14
B. Business Overview...........................................14
C. Organizational Structure....................................18
D. Property, Plants and Equipment..............................18
ITEM 5. OPERATING AND FINANCIAL REVIEW AND PROSPECTS...................19
A. Operating Results...........................................19
B. Liquidity and Capital Resources.............................29
C. Research and Development, Patents and Licenses..............30
D. Trend Information...........................................31
ITEM 6. DIRECTORS, SENIOR MANAGEMENT AND EMPLOYEES.....................32
A. Directors and Senior Management.............................32
B. Compensation................................................34
C. Board Practices.............................................35
D. Employees...................................................40
E. Share Ownership.............................................41
ITEM 7. MAJOR SHAREHOLDERS AND RELATED PARTY TRANSACTIONS..............44
A. Major Shareholders..........................................44
B. Related Party Transactions..................................45
C. Interests of Experts and Counsel............................46
ITEM 8. FINANCIAL INFORMATION..........................................46
A. Consolidated Statements and Other Financial Information.....46
B. Significant Changes.........................................47
ITEM 9. THE OFFER AND LISTING..........................................47
A. Offer and Listing Details...................................47
B. Plan of Distribution........................................48
C. Markets.....................................................48
D. Selling Shareholders........................................48
E. Dilution....................................................48
F. Expense of the Issue........................................48
ITEM 10. ADDITIONAL INFORMATION.........................................48
A. Share Capital...............................................48
B. Memorandum and Articles of Association......................48
C. Material Contracts..........................................51
D. Exchange Controls...........................................52
E. Taxation....................................................52
F. Dividend and Paying Agents..................................63
G. Statement by Experts........................................63
H. Documents on Display........................................63
I. Subsidiary Information......................................64
ITEM 11. QUANTITATIVE AND QUALITATIVE DISCLOSURE ABOUT MARKET RISKS.....64
ITEM 12. DESCRIPTION OF SECURITIES OTHER THAN EQUITY SECURITIES.........64
-i-
PART II.......................................................................64
ITEM 13. DEFAULTS, DIVIDEND ARREARAGES AND DELINQUENCIES................64
ITEM 14. MATERIAL MODIFICATIONS TO THE RIGHTS OF SECURITY HOLDERS
AND USE OF PROCEEDS............................................64
ITEM 15. CONTROLS AND PROCEDURES........................................65
ITEM 16. RESERVED.......................................................65
PART III......................................................................65
ITEM 17. FINANCIAL STATEMENTS...........................................65
ITEM 18. FINANCIAL STATEMENTS...........................................65
ITEM 19. EXHIBITS.......................................................66
S I G N A T U R E S........................................................67
-ii-
The statements contained in this annual report that are not purely
historical are forward-looking statements. Such forward-looking statements also
include statements in Item 4 - "Information on the Company" and Item 5 -
"Operating and Financial Review and Prospects." These statements involve risks
and uncertainties and actual results could differ materially from such results
discussed in these statements as a result of the risk factors set forth in this
annual report. All forward-looking statements included in this annual report are
based on information available to us on the date hereof, and we assume no
obligation to update any such forward-looking statements.
PART I
ITEM 1. IDENTITY OF DIRECTORS, SENIOR MANAGEMENT AND ADVISERS
-----------------------------------------------------
Not applicable.
ITEM 2. OFFER STATISTICS AND EXPECTED TIMETABLE
---------------------------------------
Not applicable.
ITEM 3. KEY INFORMATION
---------------
A SELECTED FINANCIAL DATA
The following selected consolidated financial data for and as of the five
years ended December 31, 2002 are derived from our audited consolidated
financial statements which have been prepared in accordance with U.S. GAAP. The
selected consolidated financial data as of December 31, 2000, 1999 and 1998 and
for the years ended December 31, 1999 and 1998 have been derived from audited
consolidated financial statements not included in this Annual Report and have
also been prepared in accordance with U.S. GAAP. The selected consolidated
financial data set forth below should be read in conjunction with and are
qualified by reference to "Operating and Financial Review and Prospects" and our
consolidated financial statements included elsewhere in this Annual Report.
1
Income Statement Data:
Year ended December 31,
---------------------------------------------------
1998 1999 2000 2001 2002
---- ---- ---- ---- ----
(U.S. dollars in thousands, except per share data)
Revenues..................................... $14,900 $20,507 $18,671 $16,869 $17,455
Cost of revenues............................. 5,332 7,322 8,345 8,451 6,003
----- ----- ----- ----- -----
Gross profit................................. 9,568 13,185 10,326 8,418 11,452
Research and development costs, net (1)...... 2,272 2,476 3,559 3,982 2,023
Selling and marketing expenses............... 7,012 8,544 11,992 12,120 5,585
General and administrative expenses.......... 1,960 2,533 5,463 3,829 1,509
Impairment of investment and other assets..... -- -- 6,090 2,658 --
Restructuring and other non-recurring charges. -- -- -- 1,326 1,708
In-process research and development write-off -- -- 12,997 -- --
--- --- ------ ----- -----
Operating profit (loss)...................... (1,676) (368) (29,775) (15,497) 627
Financial income, net........................ 252 160 416 48 141
--- --- --- -- ---
Taxes on income (tax benefit)................ -- 188 (200) 402 264
Profit (loss) from continuing operations..... (1,424) (396) (29,159) (15,851) 504
Earnings from discontinued operations of
a segment, net of taxes................ -- -- 82 -- --
Gain (loss) on disposal of segment........... -- -- (2,224) 220 --
--- --- ----- --- ---
Gain (loss) from discontinued operations..... -- -- (2,142) 220 --
Net profit (loss)............................ $(1,424) $ (396) $(31,301) $(15,631) $ 504
======= ====== ======== ======== =======
Basic and diluted net earnings (loss) per
share from continuing operations....... $ (0.17) $(0.05) $ (2.96) $ (1.36) $ 0.03
======= ====== ======== ======== =======
Basic and diluted net earnings (loss) per $ -- $ -- $ (0.22) $ 0.02 $ --
share from discontinued operations .... ======= ====== ======== ======== =======
Basic and diluted net earnings (loss) per
share...................................... $(0.17) $ 0.05) $(3.18) $(1.34) $ 0.03
====== ======= ====== ====== ======
Number of shares used to compute diluted
earnings (loss) per share................ 8,157 8,365 9,844 11,668 14,725
===== ===== ===== ====== ======
- -----------------
(1) Total research and development costs are offset in part by royalty-bearing
grants and the capitalization of certain computer software development costs.
Balance Sheet Data:
December 31,
-------------------------------------------------
(U.S. dollars in thousands)
1998 1999 2000 2001(*) 2002
---- ---- ---- ------- ----
Working capital...................... $ 6,582 $ 7,636 $ 6,983 $ (142) $ 667
Total assets......................... 26,971 27,209 33,506 21,294 21,484
Short-term debt, including current
maturities of long-term debt........ 607 140 260 405 380
Long-term debt, less current maturities 96 93 268 211 55
Shareholders' equity................. 17,735 19,516 23,977 12,325 13,080
- -----------------------
(*) Reclassified
B. CAPITALIZATION AND INDEBTEDNESS
Not applicable.
C. REASONS FOR THE OFFER AND USE OF PROCEEDS
Not applicable.
2
D. RISK FACTORS
Investing in our ordinary shares involves a high degree of risk and
uncertainty. You should carefully consider the risks and uncertainties described
below before investing in our ordinary shares. If any of the following risks
actually occurs, our business, prospects, financial condition and results of
operations could be harmed. In that case, the value of our ordinary shares could
decline, and you could lose all or part of your investment.
Risk Factors Relating to Our Company
We have a history of operating losses.
Although we recorded an operating profit of $0.6 million in the fiscal year
ended December 31, 2002, after incurring operating losses in each of the
preceding four years, we can not assure you that we will be able to continue to
operate profitably in the future.
Our operating results fluctuate significantly.
Our quarterly results have fluctuated significantly in the past and are
likely to fluctuate significantly in the future. Our future operating results
will depend on many factors, including, but not limited to, the following:
o the size and timing of significant orders and their fulfillment;
o demand for our products;
o changes in our pricing policies or those of our competitors;
o the number, timing and significance of product enhancements;
o new product announcements by us and our competitors;
o our ability to successfully market newly acquired products and
technologies;
o our ability to develop, introduce and market new and enhanced products
on a timely basis;
o changes in the level of our operating expenses;
o budgeting cycles of our customers;
o customer order deferrals in anticipation of enhancements or new
products that we or our competitors offer;
o product life cycles;
o software bugs and other product quality problems;
o personnel changes;
o changes in our strategy;
3
o seasonal trends and general domestic and international economic and
political conditions, among others;
o currency exchange rate fluctuations and economic conditions in the
geographic areas where we operate; and
o the assurance of success in marketing new products or technologies.
Due to the foregoing factors, quarterly revenues and operating results are
difficult to forecast, and it is likely that our future operating results will
be adversely affected by these or other factors.
Revenues are also difficult to forecast because our sales cycle, from
initial evaluation to purchase, is lengthy and varies substantially from
customer to customer. We typically ship product orders shortly after receipt
and, consequently, order backlog at the beginning of any quarter has in the past
represented only a small portion of that quarter's revenues. As a result,
license revenues in any quarter depend substantially on orders booked and
shipped in that quarter.
Due to all of the foregoing, we cannot predict revenues for any future
quarter with any significant degree of accuracy. Accordingly, we believe that
period-to-period comparisons of our operating results are not necessarily
meaningful and you should not rely upon them as indications of future
performance. Although we have experienced revenue growth in the past, we may not
be able to sustain this growth rate, and you should not consider such past
growth indicative of future revenue growth, or of future operating results.
We may need to raise additional capital in the future, which may not be
available to us.
Our working capital requirements and the cash flow provided by our
operating activities are likely to vary greatly from quarter to quarter,
depending on the timing of orders and deliveries, and the payment terms offered
to our customers. We anticipate that our existing capital resources will be
adequate to satisfy our working capital and capital expenditure requirements
until December 31, 2003, but we may need to raise additional funds in the next
twelve months for a number of uses, including:
o working capital and operating activities;
o implementing marketing and sales activities for our products and
services;
o maintaining and expanding research and development programs;
o expanding investment in fixed assets; and
o hiring additional qualified personnel.
We may not be able to obtain additional funds on acceptable terms or at
all. If we cannot raise needed funds on acceptable terms, we may be required to
delay, scale back or eliminate some aspects of our operations and we may not be
able to:
o develop new products;
4
o enhance our existing products;
o remain current with evolving industry standards;
o take advantage of future opportunities; or
o respond to competitive pressures or unanticipated requirements.
Any equity or debt financings, if available at all, may cause dilution to
our then-existing shareholders. If additional funds are raised through the
issuance of equity securities, the net tangible book value per share of our
ordinary shares would decrease and the percentage ownership of then current
shareholders would be diluted.
Our operating results vary quarterly and seasonally.
We have often recognized a substantial portion of our revenues in the last
quarter of the year and in the last month, or even weeks or days, of a quarter.
Our expense levels are substantially based on our expectations for future
revenues and are therefore relatively fixed in the short term. If revenue levels
fall below expectations, our quarterly results are likely to be
disproportionately adversely affected because a proportionately smaller amount
of our expenses varies with our revenues.
Our operating results reflect seasonal trends and we expect to continue to
be affected by such trends in the future. We expect to continue to experience
relatively higher sales in the first and second quarters of the year and
relatively lower sales in the third quarter ending September 30, as a result of
reduced sales activity in Europe during the summer months. Due to the foregoing
factors, in some future quarter our operating results may be below the
expectations of public market analysts and investors. In such event, it is
likely that the price of our ordinary shares would be materially adversely
affected.
We may not succeed in penetrating the e-Business integration market.
We may not have the resources, skills and product offerings that will be
required to successfully penetrate the market for e-Business integration
software. To succeed in this market, we will need to:
o develop expertise in marketing and selling business process
integration technology;
o develop and cultivate new sales channels to market our products to
prospective customers;
o hire, train and integrate additional technical and sales personnel;
and
o effectively establish, strengthen and support relationships with
end-users.
Our success in selling legacy integration software is dependent on the growth of
demand for web enablement of legacy data and applications.
Our success in selling legacy integration software is dependent in large
part upon the continued growth of the use of the Internet. Because the use of
the Internet for e-Business
5
and other applications is evolving, we cannot predict with any certainty that
such use will continue to grow in the long term. If the use of the Internet does
not continue to grow, the marketing of our legacy integration software will not
succeed.
We are subject to risks associated with international operations.
We are based in Israel and generate a large percentage of our sales outside
the United States. Our sales in the United States accounted for 48.4%, 45.0% and
40.2 % of our total revenues for the years ended December 31, 2000, 2001 and
2002, respectively. Although we continue to expand our international operations
and commit significant management time and financial resources to developing
direct and indirect international sales and support channels, we cannot be
certain that we will be able to maintain or increase international market demand
for our products. To the extent that we cannot do so in a timely manner, our
business, operating results and financial condition will be adversely affected.
International operations are subject to inherent risks, including the
following:
o the impact of possible recessionary environments in multiple foreign
markets;
o longer receivables collection periods and greater difficulty in accounts
receivable collection;
o unexpected changes in regulatory requirements;
o difficulties and costs of staffing and managing foreign operations;
o reduced protection for intellectual property rights in some countries;
o potentially adverse tax consequences; and
o political and economic instability.
We cannot be certain that we, our distributors or our resellers will be
able to sustain or increase revenues from international operations or that the
foregoing factors will not have a material adverse effect on our future revenues
and, as a result, our business, operating results and financial condition.
We may be adversely affected by fluctuations in currency exchange rates.
While our revenues are generally denominated in United States dollars, the Euro
and British Pound, a significant portion of our expenses are incurred in NIS. If
we were to determine that it was in our best interests to enter into any hedging
transactions in the future, there can be no assurance that we will be able to so
do or that such transactions, if entered into, will materially reduce the effect
of fluctuations in foreign currency exchange rates on our results of operations.
In addition, if for any reason exchange or price controls or other restrictions
on the conversion of foreign currencies into NIS were imposed, our business
could be adversely affected. Although exposure to currency fluctuations to date
has not had a material adverse effect on our business, there can be no assurance
such fluctuations in the future will not have a material adverse effect on
revenues from international sales and, consequently our business, operating
results and financial condition.
6
We are subject to risks relating to proprietary rights and risks of
infringement.
We are dependent upon our proprietary software technology and we rely
primarily on a combination of copyright and trademark laws, trade secrets,
confidentiality procedures and contractual provisions to protect our proprietary
rights. We try to protect our software, documentation and other written
materials under trade secret and copyright laws, which afford only limited
protection. It is possible that others will develop technologies that are
similar or superior to our technology. Despite our efforts to protect our
proprietary rights, unauthorized parties may attempt to copy aspects of our
products or to obtain and use information that we regard as proprietary. It is
difficult to police the unauthorized use of our products, and we expect software
piracy to be a persistent problem, although we are unable to determine the
extent to which piracy of our software products exists. In addition, the laws of
some foreign countries do not protect our proprietary rights as fully as do the
laws of the United States. We cannot be certain that our means of protecting our
proprietary rights in the United States or abroad will be adequate or that our
competition will not independently develop similar technology.
We are not aware that we have infringed any proprietary rights of third
parties. It is possible, however, that third parties will claim that we have
infringed upon their intellectual property rights. We believe that software
product developers will increasingly be subject to infringement claims as the
number of products and competitors in our industry segment grows and the
functionality of products in different industry segments overlaps. It would be
time consuming for us to defend any such claims, with or without merit, and any
such claims could:
o result in costly litigation;
o divert management's attention and resources;
o cause product shipment delays; or
o require us to enter into royalty or licensing agreements. Such royalty
or licensing agreements, if required, may not be available on terms
acceptable to us, if at all.
If there is a successful claim of product infringement against us and we
are not able to license the infringed or similar technology, our business,
operating results and financial condition would be materially adversely
affected.
We rely on maintenance revenues from customers using legacy CorVision(R) and
Mancal 2000 software.
A significant portion of our revenues derives from annual maintenance
payments made by customers who use CorVision(R) and Mancal 2000 which are both
legacy software products. In 2000, 2001 and 2002, these revenues on a
consolidated basis totaled $3.3 million, $3.0 million and $2.6 million
respectively. Some of these customers may replace these legacy products with
more state-of-the-art products from other vendors and, as a result, discontinue
use of these products. This would result in a reduction in our maintenance
revenues and adversely affect our operating results.
7
Our products have a lengthy sales cycle.
Our customers typically use our products to deploy applications that are
critical to their business. As a result, the licensing and implementation of our
products generally involves a significant commitment of attention and resources
by prospective customers. Because of the long approval process that typically
accompanies strategic initiatives or capital expenditures by companies, our
sales process is often delayed, with little or no control over any delays
encountered by us. Our sales cycle can be further extended for sales made
through third party distributors. Delay in the sales cycle of our products could
result in significant fluctuations in our quarterly operating results.
Rapid technological change may adversely affect the market acceptance of our
products and services.
We compete in a market that is characterized by rapid technological change.
The introduction of new technologies could render existing products and services
obsolete and unmarketable and could exert price pressures on our products and
services. Any future success will depend upon our ability to address the
increasingly sophisticated needs of our customers by:
o supporting existing and emerging hardware, software, databases and
networking platforms; and
o developing and introducing new and enhanced applications that keep
pace with such technological developments, emerging new markets and
changing customer requirements.
Our products may contain defects that may be costly to correct, delay market
acceptance of our products and expose us to litigation.
Despite testing by us, errors may be found in our software products. If
defects are discovered, we may not be able to successfully correct them in a
timely manner or at all. Defects and failures in our products could result in a
loss of, or delay in, market acceptance of our products and could damage our
reputation. Although our standard license agreement with our customers contains
provisions designed to limit our exposure to potential product liability claims,
it is possible that these provisions may not be effective or enforceable under
the laws of some jurisdictions, and we could fail to realize revenues and suffer
damage to our reputation as a result of, or in defense of, a substantial claim.
We currently do not carry product liability insurance.
We are dependent on our senior management. Any loss of the services of our
senior management would negatively affect our business.
Our future success depends to a large extent on the continued services of
our senior management and key personnel. Any loss of the services of members of
our senior management or other key personnel would negatively affect our
business.
Our results may be adversely affected by competition.
The market for our software products is fragmented and is intensely
competitive. Competition in the industry is generally based on product
performance, depth of product line,
8
technical support and price. We compete both with international and local
software providers, many of whom have significantly greater financial, technical
and marketing resources than us. We anticipate continued growth and competition
in the software products market and, consequently, the entrance of new
competitors into the market. Our existing and potential competitors may be able
to develop software products and services that are as effective as, or more
effective or easier to use than those offered by us. Such existing and potential
competitors may also enjoy substantial advantages over us in terms of research
and development expertise, manufacturing efficiency, name recognition, sales and
marketing expertise and distribution channels. There can be no assurance that we
will be able to compete successfully against current or future competitors or
that competition will not have a material adverse effect on our future revenues
and, consequently, on our business, operating results and financial condition.
We may be unsuccessful in our appeal of a lower court's decision in the Special
Situation Funds litigation.
In September 2002, an action was filed by Special Situations Fund III L.P.,
Special Situations Cayman Fund, L.P., Special Situations Private Equity Fund,
L.P. and Special Situations Technology Fund, L.P., major investors in the
company, seeking approximately $600,000 in damages under a breach of contract
claim. On March 28, 2003, a jury in New York entered a verdict against us,
awarding the plaintiffs damages in the amount of approximately $603,000, plus
interest and costs, $810,000 as of December 2002. On April 29, 2003, we appealed
the decision to the Supreme Court of New York, Appellate Division, First
Department. On May 13, 2003 we posted a bond in the full amount of the judgment.
There can be no assurance that we will be successful in our appeal.
We may not succeed in implementing our business plans in South East Asia due to
SARS.
The continuing threat of severe acute respiratory syndrome, or SARS, has
caused a downturn in the South East Asian economy. As a result our operations in
Asia might be significantly impacted.
We do not intend to pay cash dividends.
Our policy is to retain earnings for use in our business and, for this
reason, we do not intend to pay cash dividends on the ordinary shares in the
foreseeable future.
Risk Factors Relating to Our Operations in Israel
Conducting business in Israel entails special risks.
We are incorporated under the laws of, and our executive offices and
research and development facilities are located in, the State of Israel.
Although most of our sales are made to customers outside Israel, we are
nonetheless directly affected by the political, economic and military conditions
affecting Israel. Conducting business in Israel entails special risks. Any major
hostilities involving Israel or the interruption or curtailment of trade between
Israel and its present trading partners could have a material adverse effect on
our business, financial condition and results of operations. Since the
establishment of the State of Israel in 1948, a state of hostility has existed,
varying in degree and intensity, between Israel and the Arab countries. While
Israel has entered into peace agreements with both Egypt and Jordan
9
and several other countries have announced their intentions to establish trade
and other relations with Israel, Israel has not entered into any additional
peace agreements with such countries or with Syria or Lebanon. Since September
2000, Israel and the Palestinians have been engaged in violent conflict, which
has included numerous lethal suicide attacks in Israel. In response, the Israeli
Army has taken control of most Palestinian-controlled cities and many towns and
refugee camps. The continued hostilities between the Palestinian community and
Israel and the failure to settle the conflict has had and continues to have a
material adverse effect on the Israeli economy and a material adverse effect on
our business and us. Further expansion of hostilities might require more
widespread military reserve service by some of our employees, which may have a
material adverse effect on our business. Following conclusion of the war in
Iraq, the United States published a "road map" for peace between Israel and the
Palestinians and a summit took place on June 4, 2003 in Jordan between President
Bush, Prime Minister Sharon and the Palestinian Prime Minister Mahmoud Abas
after which the leaders expressed their conviction to end the violence and to
implement the "road map." There can be no assurance that the "road map" will be
implemented or that hostilities between Israel and the Palestinians will cease
or be reduced.
Due to significant economic measures proposed by the Israeli Government,
there have been several strikes and work stoppages during April and May 2003,
which culminated in a three day general strike, including all banks, airports
and ports, in May 2003. These strikes have had an adverse effect on the Israeli
economy and on our ability to carry on our business undisturbed. Following the
passing by the Israeli Parliament of laws to implement the economic measures,
the Israeli trade unions threatened further strikes or work-stoppages, and these
may have a material adverse effect on the Israeli economy and us.
Many of our directors, officers, employees and professional service providers
are obligated to perform annual military reserve duty in Israel. We cannot
assess the potential impact of these obligations on our business.
Our directors, officers and employees who are male adult citizens and
permanent residents of Israel under the age of 48 are, unless exempt, obligated
to perform annual military reserve duty and are subject to being called to
active duty at any time under emergency circumstances. We cannot assess the full
impact of these requirements on our workforce or business if conditions should
change, and we cannot predict the effect on us of any expansion or reduction of
these obligations.
Our financial results may be adversely affected by inflation and currency
fluctuations.
Since we report our financial results in dollars, fluctuations in rates of
exchange between the dollar and non-dollar currencies may have a material
adverse affect on our results of operations. A significant portion of our
expenses are paid in NIS (primarily salaries) and are influenced by the timing
of, and the extent to which, any increase in the rate of inflation in Israel
over the rate of inflation in the United States is not offset by the devaluation
of the NIS in relation to the dollar. We believe that the rate of inflation in
Israel has not had a material adverse effect on our business to date. However,
our dollar costs in Israel will increase if inflation in Israel exceeds the
devaluation of the NIS against the dollar or if the timing of such devaluation
lags behind inflation in Israel. Over time, the NIS has been devalued against
the dollar, generally reflecting inflation rate differentials. Likewise, our
operations could be adversely affected if we are unable to guard against
currency fluctuations in the future. We do not currently engage in any currency
hedging transactions intended to reduce the effect of fluctuations in foreign
currency exchange rates on our results
10
of operations. We cannot guarantee that we will not enter into such transactions
in the future or that such measures will adequately protect us from serious harm
due to the impact of inflation in Israel.
We cannot guarantee continuation of government programs and tax benefits.
We have in the past received certain Israeli government grants and tax
benefits. To remain eligible for these grants and tax benefits, we must continue
to meet certain conditions, including making some specified investments in fixed
assets. If we fail to comply with these conditions in the future, the benefits
we receive could be canceled and we may have to refund payments previously
received under these programs (with interest and linkage differentials) or pay
certain taxes. We cannot guarantee that these programs and tax benefits will be
continued in the future, at their current levels or at all. If these programs
and tax benefits are ended, our business, financial condition and results of
operations could be negatively affected.
We may be adversely affected by tax reform in Israel.
On July 24, 2002, Amendment 132 to the Israeli Tax Ordinance (the
"Amendment") was approved by the Israeli parliament and came into effect on
January 1, 2003. The principal objectives of the amendment were to broaden the
categories of taxable income and to reduce the tax rates imposed on employees
income. The material consequences of the amendment applicable to our company
include, among other things, imposing a tax upon all income of Israeli
residents, individuals and corporations, regardless of the territorial source of
the income and certain modifications in the qualified taxation tracks of
employee stock options.
Service and enforcement of legal process on us and our directors and officers
may be difficult to obtain.
Service of process upon our directors and officers and the Israeli experts
named herein, many of whom reside outside the United States, may be difficult to
obtain within the United States. Furthermore, since a substantial portion of our
assets, almost all of our directors, some of the officers and the Israeli
experts named in this annual report are located outside the United States, any
judgment obtained in the United States against us or these individuals or
entities may not be collectible within the United States. There is doubt as to
the enforceability of civil liabilities under the Securities Act and the
Securities Exchange Act in original actions instituted in Israel. However,
subject to certain time limitations and other conditions, Israeli courts may
enforce final judgments of United States courts for liquidated amounts in civil
matters, including judgments based upon the civil liability provisions of those
Acts.
Risk Factors Relating to Our Ordinary Shares
Our share price has been volatile in the past and may decline in the future.
Our ordinary shares have experienced significant market price and volume
fluctuations in the past and may experience significant market price and volume
fluctuations in the future in response to factors such as the following, some of
which are beyond our control:
11
o quarterly variations in our operating results;
o operating results that vary from the expectations of securities
analysts and investors;
o changes in expectations as to our future financial performance,
including financial estimates by securities analysts and investors;
o announcements of technological innovations or new products by us or
our competitors;
o announcements by us or our competitors of significant contracts,
acquisitions, strategic partnerships, joint ventures or capital
commitments;
o changes in the status of our intellectual property rights;
o announcements by third parties of significant claims or proceedings
against us;
o additions or departures of key personnel;
o future sales of our ordinary shares; and
o stock market price and volume fluctuations.
Domestic and international stock markets often experience extreme price and
volume fluctuations. Market fluctuations, as well as general political and
economic conditions, such as a recession or interest rate or currency rate
fluctuations or political events or hostilities in or surrounding Israel, could
adversely affect the market price of our ordinary shares.
In the past, securities class action litigation has often been brought
against a company following periods of volatility in the market price of its
securities. We may in the future be the target of similar litigation. Securities
litigation could result in substantial costs and divert management's attention
and resources.
We may be delisted from the Nasdaq National Market if we fail to meet listing
maintenance requirements.
Pursuant to the current Nasdaq National Market listing maintenance
requirements, in order to maintain the listing of our ordinary shares, the
minimum bid price of our shares must be $1.00 and the minimum value of our
public free float must be $10.0 million. On February 13, 2003, we were advised
by the staff of the Nasdaq Stock Market that our shares had fallen below
Nasdaq's National Market continued listing standard relating to minimum share
price since the closing bid price for our shares had closed below the minimum of
$1.00 for 30 consecutive trading days. On May 6, 2003, we were notified that we
have regained compliance with Nasdaq's National Market maintenance requirements.
We cannot assure you that we will be able to comply with Nasdaq National
Market listing maintenance requirements in the future. Should we fail to meet
such requirements, our
12
ordinary shares may be delisted from the Nasdaq National Market and transferred
to the either Nasdaq SmallCap Market or to the OTC bulletin board.
Anti-takeover provisions could negatively impact our shareholders.
Some of the provisions of Israeli law could:
o discourage potential acquisition proposals;
o delay or prevent a change in control over us; and
o limit the price that investors might be willing to pay in the future
for our ordinary shares.
Generally, under Israeli corporate law, a merger must be approved by the
board of directors and the shareholders of each of the merging companies. If the
share capital of the non-surviving company consists of more than one class of
shares, the approval of each class is also required. Approval of a merger
requires a majority of shareholders present and voting at a meeting. In certain
cases, court approval is also required. Under the Companies Law, a merger may be
completed only after 70 days have elapsed from the date all the necessary
approvals and the merger proposals have been submitted to the Israeli Companies
Registrar. The Companies Law also provides that an acquisition of shares of a
public company must be made by means of a tender offer if, as a result of such
acquisition, the purchaser would become a 25% or more shareholder of the
company. This rule does not apply if there is already another 25% shareholder of
the company. Similarly, the Companies Law provides that an acquisition of shares
in a public company must be made by means of tender offer if, as a result of the
acquisition, the purchaser would become a 45% shareholder of the company, unless
someone else already holds a majority of the voting power of the company. These
rules do not apply if the acquisition of all the outstanding shares of a company
is made by means of a merger. Regulations promulgated under the Companies Law
provide that, generally, these provisions do not apply to companies whose shares
are listed for trading outside of Israel. The requirements of Israeli corporate
law generally make these forms of acquisition significantly more difficult than
under United States corporate laws.
Other potential means of acquiring a public Israeli company might involve
significant obstacles, such as a requirement for court approval for the
acquisition. In addition, a body of case law has not yet developed with respect
to the Israeli Companies Law. Until this happens, uncertainties will exist
regarding its interpretation.
Finally, Israeli tax law treats some acquisitions, particularly
stock-for-stock swaps between an Israeli company and a foreign company, less
favorably than United States tax law. Israeli tax law may, for instance, subject
a shareholder who exchanges his or her shares in us for shares in a foreign
corporation to immediate taxation.
These provisions of Israeli corporate and tax law and the uncertainties
surrounding such law may have the effect of delaying, preventing or making more
difficult a merger or acquisition involving our company. This could prevent a
change of control in our company and depress the market price of our ordinary
shares that might otherwise rise as a result of such change of control.
13
ITEM 4. INFORMATION ON THE COMPANY
--------------------------
A. HISTORY AND DEVELOPMENT OF THE COMPANY
Historical Background
We were incorporated under the laws of the State of Israel in 1988 as
I.S.G. Software Industries Ltd. for an indefinite term and began operations in
1989 when we acquired the marketing and certain ownership rights to two software
products from a corporation wholly owned by our Chairman, Mr. Arie Gonen. We
changed our name to ISG International Software Group Ltd. in 1992 and we changed
our name to Attunity Ltd in October 2000.
We have subsidiaries in Israel, the United States, the United Kingdom,
France, Australia, Singapore and Hong Kong (PRC). Our executive headquarters are
located at Einstein Building, Tirat Carmel, Haifa, Israel 39101, telephone
number (972)-4-855-9666. Our United States-based subsidiary, Attunity Inc.,
maintains its principal offices at 40 Audubon Road, Wakefield, Massachusetts
01880, telephone number (781) 213-5200. Our address on the internet is
http://www.attunity.com. The information on our website is not incorporated by
reference into this annual report.
During 2001, we implemented a restructuring plan. In accordance with such
plan, we reduced the number of our employees by 30 persons, a 16% reduction from
our September 2001 level of 190 employees, and decreased salaries by 20% on
average.
B. BUSINESS OVERVIEW
We market software products for legacy integration. Our principal product
is Attunity Connect(TM). We also provide consulting, maintenance and other
related services for our products including maintenance services to our legacy
products: CorVision(R) - an application generator, APTuser(R) - a database
retrieval and production report generator, and Mancal 2000 - a logistics and
financial application software package.
Products and Services
o Attunity Connect(TM) - for universal data and application access.
o Attunity BPI(TM) (in development) - for service-oriented process
creation and management across the extended enterprise.
o CorVision(R) - an application generator for enterprise applications.
o APTuser(R)- a production report generator.
o Mancal 2000 - a financial and logistic application software.
Attunity Connect(TM)
Attunity Connect(TM) enables IT departments, software developers, systems
integrators, OEMs and others to transparently access a wide array of data
sources and applications on many major computing platforms and is optimized for
distributed enterprise-wide
14
deployment. Support of TCP/IP and its distributed architecture add the
capability for transparent networking. Attunity Connect(TM) offers both
relational (SQL) and object-based (J2EE CA) data views. Users may employ the
models separately, or in combination, without regard to the underlying data
source or computing platform on which they reside. This is achieved through
standard programming interfaces including ODBC, OLE DB, MS ADO, JDBC, XML and
J2EE CA.
Attunity ConnectTM Features
o Attunity Connect(TM)accesses different data sources transparently
using standard interfaces;
o Attunity Connect(TM) promotes an expanded data model extending SQL to
address heterogeneous databases that span pre-relational, relational,
and post-relational models; and
o Attunity Connect(TM) provides the ability to integrate object-based
data using the Attunity Application Framework, or AAF, through Sun
Microsystems's J2EE Connector Architecture (JCA).
Market requirements addressed
Attunity Connect(TM) addresses today's most demanding enterprise data
access requirements for:
o seamless, native data access to heterogeneous databases:
pre-relational, relational, and post-relational;
o integration of a vast array of data sources through either relational
(SQL) or object-based access (J2EE CA) or a combination of both;
o a total, integrated, industrial-strength solution for handling and
optimizing both data access and connectivity; and
o allowing businesses to integrate their existing legacy systems into
web-based and e-Business applications.
Attunity BPITM
Attunity BPI(TM) provides users with the ability to transform legacy data
and programs into dynamic reusable services. Attunity BPI(TM) includes Attunity
Process Designer and Attunity Process Server. Process Designer is the graphical
user interface that allows users to "draw" their business processes. Process
Server executes the processes. Attunity BPI processes are presented as XML
documents assuring easy transport, independence of platforms and ease of
integration and collaboration. Attunity BPI(TM) enables processes to be
distributed over a TCP/IP, LAN, WAN or Internet network. Attunity BPI(TM)
supports transport protocols including RMI, CORBA, COM/DCOM, HTTP, SMTP and
native sockets. The ability to create, integrate and manage Web-services is
inherent in the architecture of Attunity BPI(TM) through its support of
standards such as SOAP and UDDI. Process security is addressed through the
support for standards including X.509, SSL3, HTTP/S, MIME/S, public keys and
digital certificates.
15
CorVision(R)
CorVision(R) is an application generator tool that runs on Digital VAX
computers under the Open VMS operating system and allows developers to use
either terminals or a Client/Server Windows application connected to VAX
computers.
APTuser(R)
APTuser(R) is a production report generator able to access data residing in
different databases and file managers such as Oracle, Ingres, Informix, Sybase,
Rdb, Adabas, RMS and C-ISAM. APTuser(R) is able to generate combined reports,
which access all of these files and databases concurrently. APTuser(R) is
available for OpenVMS, HP/UNIX, IBM AIX, Data General Aviion and SUN Solaris
operating systems.
Mancal 2000
Mancal 2000 is a comprehensive financial and logistics software application
package developed to address the accounting and material management requirements
of large organizations.
Customer Support Services
We provide the following direct support services to our customers:
o Hot-line support,
o Training, and
o Professional services.
Hot-line Support. We provide technical advice and information on the use of
our products. Our hot-line support is also responsible for publishing technical
bulletins and distributing new versions of software and program "patches." We
have hot-line operations in the United States, Israel, France, the United
Kingdom, Hong Kong and Australia.
Training. We provide classroom and on-site training in the use of our
products. The course curriculum includes product use education, software
development methodologies and system management. Our customers receive
documentation that includes user manuals, reference manuals, tutorials,
installation guides and release notes.
Professional Services. We provide consulting services to enable customers
to use our products efficiently and effectively.
Sales and Marketing
Distribution Channels. Our products and services are sold through both
direct and indirect channels, including distributors and value-added resellers,
or VARs. We maintain direct sales operations in Israel, the United States,
France, the United Kingdom, Australia and Hong Kong. We do business in Japan,
Korea, Taiwan and Singapore through independent direct software sales agents.
Our field force is comprised of 13 persons in North America, 16 persons in
Europe, the Middle East and Africa, and 10 persons in Asia Pacific. We have
16
indirect sales operations for Attunity Connect(TM) including hardware vendors
and resellers, database and other data source vendors.
We have non-exclusive distribution and reseller agreements for Attunity
Connect(TM) with Oracle, HP and others.
Customers
Our products are sold to large corporations and governmental and public
institutions with in-house IT staffs. The following table provides a breakdown
by geographical area of our revenues, including maintenance revenues, during the
last three fiscal years:
2000 2001 2002
---- ---- ----
(in thousands)
Israel............................... $3,231 $2,761 $2,576
United States........................ 9,037 7,589 7,025
Europe............................... 5,001 4,012 4,950
Asia................................. 889 1,212 1,064
South America........................ - 1,066 1,500
Other................................ 513 229 340
--- --- ---
Total............................. $18,671 $16,869 $17,455
======= ======= =======
Competition and Pricing
The markets in which we compete are intensely competitive. Competition is
generally based on product performance, depth of product line, technical support
and price. We compete both with international and local software product
providers, many of whom have significantly greater financial, technical and
marketing resources than us. We anticipate continued growth and competition and,
consequently, the entrance of new competitors into the market. Our existing and
potential competitors may be able to develop software products and services that
are as effective as, or more effective or easier to use, than those offered by
us. Such existing and potential competitors may also enjoy substantial
advantages over us in terms of research and development expertise, manufacturing
efficiency, name recognition, sales and marketing expertise and distribution
channels. We believe that the prices for our products compare favorably with
those of competing products.
Intellectual Property Rights and Software Protection
We do not hold any patents and rely upon a combination of security devices,
copyrights, trademarks, trade secret laws and contractual restrictions to
protect our rights in our products. Our policy has been to pursue copyright
protection for our software and related documentation and trademark registration
of our product names. In addition, our employees and independent contractors are
generally required to sign non-disclosure agreements.
We have obtained trademark registrations for CorVision(R), CorVision
Workbench, and Builder, and have applied for trademark registration for
Attunity, Attunity Connect(TM) and Attunity BPI(TM) in the United States. The
use and registration rights of our trademarks do not ensure that we have
superior rights over other third parties that may have registered or used
identical related marks on related goods or services. We believe that copyright
protection, which generally applies whether or not a license agreement exists,
is sufficient to protect our
17
rights in our products. Our policy is for our customers to sign non-transferable
software licenses providing contractual protection against unauthorized use of
the software.
Preventing the unauthorized use of software is difficult, and unauthorized
software use is a persistent problem in the software industry. However, we
believe that, because of the rapid pace of technological change in the software
industry, the legal protections for our products are less significant factors in
our success than the knowledge, ability and experience of our employees, the
frequency of product enhancements and the timeliness and quality of support
services provided by us.
C. ORGANIZATIONAL STRUCTURE
Our wholly owned subsidiaries act as marketing and customer service
organizations in the countries where they are incorporated and for neighboring
countries. The following table sets forth the legal name, location and country
of incorporation and percentage ownership of each of our subsidiaries:
Country of Ownership
Subsidiary Name Incorporation Percentage
----------------------------------- ------------- ----------
Attunity Inc....................... United States 100%
Attunity (UK) Limited.............. United Kingdom 100%
Attunity France.................... France 100%
Attunity Australia................. Australia 100%
Attunity Hong Kong Limited......... Hong-Kong (PRC) 100%
Attunity Singapore PTE Ltd......... Singapore 100%
Bridges for Islands, Ltd........... Israel 100%
Attunity Israel (1992) Ltd......... Israel 100%
Attunity Software Services Ltd..... Israel 98.8%
D. PROPERTY, PLANTS AND EQUIPMENT
Our executive offices and research and development facilities are located
at Einstein Building, Tirat Carmel, Haifa, Israel 39101, where we occupy 9,800
square feet. The premises are occupied under a lease which terminates on
December 31, 2003. We have an option to extend the lease period for two
consecutive periods of two years each. Our Herzliya marketing and sales offices
constituting approximately 5,700 square feet, is occupied under a lease which
expires on October 30, 2005. Our subsidiary Attunity Software Services Ltd.,
(formerly known as Meyad), or Attunity Software, operates out of a 5,200
square-feet facility in Moshav Ya'ad (Galilee). The lease for the facility used
by Attunity Software expires on December 31, 2003 and Attunity Software has an
option to extend the lease period for an additional period of two years. Our
annual rental cost for all of our facilities in Israel was approximately
$280,000 in 2002.
In April 2002 we leased approximately 6,137 square feet of office space at
40 Audubon Road, Wakefield, MA 01880 at an annual rental fee of $97,885. The
lease expires in June 2005. Our offices were previously located in a 28,783
square foot facility in Burlington, Massachusetts. We are currently attempting
to negotiate the termination of the lease for the Burlington site which expires
in August 2005 and has an annual rental of approximately $859,000.
18
The aggregate annual rent for our sales and service offices in Hong Kong;
Shanghai, the People's Republic of China; Sydney, Australia; Reading, England
and Paris, France was approximately $268,000 in 2002.
ITEM 5. OPERATING AND FINANCIAL REVIEW AND PROSPECTS
--------------------------------------------
A. OPERATING RESULTS
The following discussion and analysis should be read in conjunction with
our Financial Statements and notes thereto included elsewhere in this Report.
We maintain our books and records in Israeli currency in compliance with
statutory requirements and in United States dollars, or dollars. Approximately
85% (49% in dollars) of our revenues in 2002 and approximately 84% (51% in
dollars) of our revenues in 2001 were derived outside of Israel and received in
currencies other than the New Israeli Shekel, or NIS. In addition, a substantial
portion of our costs is incurred in dollars. In view of the foregoing, our
management considers the dollar to be the currency of the primary economic
environment in which we operate and therefore, our functional operating and
reporting currency. Transactions denominated in dollars are presented at their
original amounts. Transactions and balances in other currencies are remeasured
into dollars in accordance with the principles set forth in Statement No. 52 of
the Financial Accounting Standards Board, "Foreign Currency Translation." The
functional currency of each of our non-U.S. foreign subsidiaries and our Israeli
subsidiaries has been determined to be their respective local currency, and
therefore, other than with respect to our subsidiaries in the United States, our
assets and liabilities are translated at year-end exchange rates and income
statement items are translated at average exchange rates prevailing during the
year. Such translation adjustments are recorded as a separate component of
shareholders' equity, accumulated other comprehensive income (loss).
Recent Accounting Pronouncements
In November 2002, the Financial Accounting Standard Board, or FASB issued
FASB Interpretation No. 45, "Guarantor's Accounting and Disclosure Requirements
for Guarantees, Including Indirect Guarantees of Indebtedness of Others, an
interpretation of FASB Statements No. 5, 57, and 107 and Rescission of FASB
Interpretation No. 34" ("FIN No. 45"). FIN No. 45 elaborates on the disclosures
to be made by a guarantor in its interim and annual financial statements about
its obligations under certain guarantees that it has issued. It also clarifies
that a guarantor is required to recognize, at the inception of a guarantee, a
liability for the fair value of the obligation undertaken in issuing the
guarantee. FIN No. 45 does not prescribe a specific approach for subsequently
measuring the guarantor's recognized liability over the term of the related
guarantee. It also incorporates, without change, the guidance in FASB
Interpretation No. 34, "Disclosure of Indirect Guarantees of Indebtedness of
Others," which is being superseded. The disclosure provisions of FIN No. 45 are
effective for financial statements of interim or annual periods that ended after
December 15, 2002, and the provisions for initial recognition and measurement
are effective on a prospective basis for guarantees that are issued or modified
after December 31, 2002, irrespective of a guarantor's year-end. We do not
expect the adoption of FIN No. 45 to have a material impact on our results of
operations or financial position.
19
Critical Accounting Policies
The preparation of financial statements requires us to make estimates and
assumptions that affect the reported amounts of assets and liabilities and the
disclosure of contingent liabilities at the date of the financial statements and
the reported amounts of revenues and expenses during the reporting period. On an
on-going basis, we evaluate our estimates and judgments, including, but not
limited to those related to revenue recognition, bad debts and intangible
assets. We base our estimates and judgments on historical experience and on
various other factors that are believed to be reasonable under the
circumstances, the results of which form the basis for making judgments about
the carrying values of assets and liabilities that are not readily apparent from
other sources. Under different assumptions or conditions, actual results may
differ from these estimates.
The following critical accounting policies, among others described in note
2 to our financial statements, are the basis for our more significant judgments
and estimates used in the preparation of our consolidated financial statements.
Revenue recognition. We generate revenues from licensing the rights to use
our software products directly to end-users and indirectly through sub-license
fees from distributors. We also generate revenues from sales of professional
services, including consulting, implementation, project and training and
maintenance. Revenues from software license agreements are recognized upon
delivery of the software when collection is probable; all license payments are
due within one year; the license fee is otherwise fixed or determinable; no
significant obligations with regard to implementation remain; and persuasive
evidence of an arrangement exists.
Bad debt allowance. An allowance for doubtful accounts is determined with
respect to those specific amounts that our management has determined to be
doubtful accounts.
Intangible assets. Goodwill that resulted from transactions before June
2001 is amortized using the straight-line method over the estimated useful life,
which is 7 to 10 years until December 31, 2001. SFAS No.142 requires goodwill to
be tested for impairment on adoption and at least annually thereafter or between
annual tests in certain circumstances, and written down when impaired, rather
than being amortized as previous accounting standards required. Goodwill is
tested for impairment by comparing the fair value of our company reporting unit
with its carrying value. Fair value was determined using discounted cash flows,
market multiples and comparative analysis. Significant estimates used in the
methodologies include estimates of future cash flows and estimates of market
multiples for the reportable unit.
Research and Development Expenses. Research and development costs, are
charged to income as incurred before technological feasibility is established.
Based on our product development process, technological feasibility is
established upon completion of a detailed program design. Costs that are
incurred between completion of a detailed program design and the point at which
the product is ready for general release are capitalized according to the
principles set forth in SFAS Statement No. 86 "Accounting for the Costs of
Computer Software to be Sold, Leased or Otherwise Marketed." Capitalized
software costs are amortized on a product by product basis commencing with
general product release by the amount computed using the straight-line method
over the estimated useful life of the product (five years), and are included in
costs of revenues. At each balance sheet date, we assesses
20
the recoverability of this intangible asset by comparing the unamortized
capitalized software costs to the net realizable value on a product by product
basis.
Contingencies. We are, from time to time, subject to proceedings and other
claims related to employees, an alleged lease agreement and other matters. We
are required to assess the likelihood of any outcomes to these matters as well
as potential ranges of probable losses. A determination of the amount of
reserves required, if any, for these contingencies is made after careful
analysis of each individual issue. The required reserves may change in the
future due to new developments in each matter or changes in approach such as a
change in settlement strategy in dealing with these matters.
Deferred Taxes. We record a valuation allowance to reduce our deferred tax
assets to an amount that is more likely than not to be realized. While we have
considered future taxable income and ongoing prudent and feasible tax planning
strategies in assessing the need for the valuation allowance, in the event we
were to determine that we would be able to realize our deferred tax assets in
the future in excess of our net recorded amount, an adjustment to the deferred
tax asset would increase income in the period such determination was made.
Likewise, should we determine that we would not be able to realize all or part
of our net deferred tax asset in the future, an adjustment to the deferred tax
asset would be charged to income in the period such determination was made.
Exit Disposal Activities. We were early adapters of Statement of Financial
Accounting Standard No. 146, "Accounting for Costs Associated with Exit Disposal
Activities" ("SFAS No. 146"), which addresses significant issues regarding the
recognition, measurement, and reporting of costs associated with exit and
disposal activities, including restructuring activities. SFAS No. 146 requires
that costs associated with exit or disposal activities be recognized when they
are incurred rather than at the date of a commitment to an exit or disposal
plan. We recognized a one-time charge of $290,000 related to the costs that will
continue to be incurred under the Burlington, Massachusetts lease agreement for
its remaining term, without economic benefit to our company. The one-time charge
was measured at its fair value at the date we ceased to use the facility, based
on the future remaining lease payments, reduced by estimated sublease rentals
that could be reasonably obtained for those facilities.
Results of Operations
The following discussion of our results of operations for the years ended
December 31, 2000, 2001 and 2002, including the following table, which presents
selected financial information as a percentage of total revenues, is based upon
our statements of operations contained in our financial statements for those
periods, and the related notes, included in this annual report:
2000 2001 2002
---- ---- ----
Revenues:
Software licenses.................... 42% 40% 40%
Maintenance.......................... 24 27 34
Services............................. 34 33 26
-- -- --
Total revenues......................100 100 100
Cost of revenues:
Software licenses.................... 11 15 11
21
Maintenance.......................... 5 6 4
Services............................. 29 29 19
-- -- --
Total cost of revenues.......... 45 50 34
Gross profit............................ 55 50 66
Research and development, net........ 19 24 12
Selling and marketing................ 64 72 32
General and administrative........... 29 22 9
Impairment of investment............. 33 16 -
Restructuring and other non - 8 10
recurring charges..................
In process research and
development
write-off....................... 69 - -
-- --- --
Operating profit (loss)................ (159) (92) 3
Financial income, net.................. 2 0 1
Taxes on income (tax benefit)....... 1 2 1
------- ------- -----
Profit (loss) from continuing
operations, net of taxes.............. (156) (94) 3
Earnings from discontinued
operations of a segment, net of
taxes............................. - 1 -
Gain (loss) on disposal of segment..... (12) 1 -
------ ------ -----
Gain (loss) from discontinued
operations........................... (12) - -
------ ------ -----
Net profit (loss)...................... (168)% (93)% 3%
====== ===== ======
Year Ended December 31, 2002 Compared with Year Ended December 31, 2001
Revenues. Our revenues are derived primarily from software licenses,
maintenance and services, including service center income, project development,
maintenance and support. Total revenues increased 3.5% to $17.5 million in 2002
from $16.8 million in 2001. This increase is mainly attributable to a 9%
increase in revenues from software licenses, which increased to $6.9 million in
2002 from $6.3 million in 2001.
Cost of Revenues. Cost of revenues consists primarily of (i) production
costs including media, packaging, freight and documentation, (ii) amortization
of capitalized software development costs, (iii) certain royalties and licenses
payable to third parties and to the Office of the Chief Scientist of the
Ministry of Industry and Trade, or the Chief Scientist, and (iv) support costs.
Our cost of revenues decreased 29.4% to $6.0 million in 2002 from $8.5 million
in 2001 primarily due to the decrease in amortization of capitalized software,
production costs and salary expenses.
Gross Profit. Our gross profit increased 36.9% to $11.5 million in 2002
from $8.4 million in 2001, as a direct result of increased revenues and
decreased cost of revenues in 2002.
Research and Development, Net. Research and development expenses consist
primarily of salaries of employees engaged in on-going research and development
activities and other related costs. Total research and development costs
decreased by 37.9% to $3.6 million in 2002 from $5.8 million in 2001. The
decrease is principally attributable to a decrease in headcount and in salaries.
We capitalized approximately $1.6 million of software developments costs in 2002
and $1.8 million in 2001. We did not receive any royalty-bearing grants from the
Chief Scientist in either 2002 or 2001. As a result of the foregoing,
22
net research and development costs decreased by 49.2% to $2.0 million in 2002
from $4.0 million in 2001.
Selling and Marketing, Net. Selling and marketing expenses consist
primarily of costs relating to promotion, advertising, trade shows and
exhibitions, compensation, sales support, travel and related expenses. Selling
and marketing expenses decreased by 54% to $5.6 million in 2002 from $12.1
million in 2001 due to a substantial decrease in marketing investments and a
reduction in headcount.
General and Administrative. General and administrative expenses consist
primarily of compensation costs for administration, finance and general
management personnel and office maintenance and administrative costs. General
and administrative expenses decreased by 60.5% to $1.5 million in 2002 from $3.8
million in 2001. The decrease is principally attributable to the decrease in
headcount and decreased lease and salary expenses.
Impairment of Investment and Other Assets. We recorded a $2.7 million asset
impairment charge with respect to our capitalized software costs and workforce
in 2001.
Restructuring and Other Non-Recurring Charges. We recorded non-recurring
charges of $0.8 million and $0.3 million relating to legal disputes with the
Special Situations Funds and with the lessor of our offices in Burlington and
$0.6 million relating to severance payments and other expenses in 2002, compared
with restructuring charges of $1.3 million relating to severance payments,
write-off of leasehold improvements and other related expenses in 2001.
Operating Income (Loss). Based on the foregoing, we recorded an operating
income of $0.6 million in 2002 compared to an operating loss of $15.5 million in
2001.
Financial Income ,Net. Our financial income was offset in part by (i)
interest expense and (ii) currency transaction adjustments between the dollar
exchange rate and the NIS. In 2002, we had net financial income of $141,000 as
compared to financial income of $48,000 in 2001. This increase in financial
income is attributable to foreign currency adjustments.
Taxes on Income (Tax Benefit). The income taxes for 2002 were $264,000
compared with an income tax provision of $402,000 in 2001.
Gain on Disposal of Segment. We recorded a $201,000 gain in 2001 with
respect to provisions related to the disposal of Medatech in our financial
statements for 2000.
Net Income (Loss). As a result of the foregoing, we had net income of 0.5
million in 2002 compared to a net loss of $15.6 million in 2001.
Year Ended December 31, 2001 Compared with Year Ended December 31, 2000
Revenues. Total revenues decreased 9.7% to $16.8 million in 2001 from $18.7
million in 2000. This decrease is mainly attributable to a 14.3% decrease in
revenues from software services, which declined to $5.5 million in 2001 from
$6.4 million in 2000.
Gross Profit. Our gross profit decreased 18.5% to $8.4 million in 2001 from
$10.3 million in 2000, as a direct result of decreased revenues in 2001.
23
Cost of Revenues. Our cost of revenues increased 1.3% to $8.5 million in
2001 from $8.3 million in 2000.
Research and Development, Net. Total research and development costs
increased by 3.6% to $5.8 million in 2001 from $5.6 million in 2000. The
increase is principally attributable to intensive research and development
activity in the first half of 2001 relating to Attunity BPITM. This increase was
partly offset by a 20% reduction in salaries and headcount reduction of 16% that
was in effect by the end of the year. We capitalized approximately $1.8 million
of software developments costs in 2001 and $2.0 million in 2000. We did not
receive any royalty-bearing grants from the Chief Scientist in both 2001 and
2000. As a result of the foregoing, net research and development costs increased
by 11.1% to $4.0 million in 2001 from $3.6 million in 2000.
Selling and Marketing, Net. Selling and marketing expenses increased by
1.0% to $12.1 million in 2001 from $12.0 million in 2000 due to the increase in
investments in marketing and sales force.
General and Administrative. General and administrative expenses decreased
by 29.9% to $3.8 million in 2001 from $5.5 million in 2000. The decrease is
principally attributable to the reduction of expenses especially in U.S. and
includes the worldwide 20% reduction in salaries and 16% headcount reduction.
Impairment of Investment and Other Assets. We recorded a $2.7 million asset
impairment charge with respect to our capitalized software costs and workforce
in 2001 and a $6.1 million asset impairment charge with respect to our
investment in VisOpt in 2000.
In Process Research and Development Write-off. In 2000, based on an
appraisal performed by a specialist, we recorded a $13.0 million non-recurring
charge with respect to the write-off of in process research and development
costs acquired from Bridges for Islands Ltd. for which technological feasibility
had not yet been established and for which no alternative future use existed.
Operating Loss. Based on the foregoing, we suffered an operating loss of
$15.5 million in 2001 compared to an operating loss of $29.8 million in 2000.
Restructuring. We recorded restructuring charges of $1.3 million relating
to severance payments, write-off of leasehold improvements and other related
expenses in 2001.
Financial Income, Net. Our financial income was offset in part by (i)
interest expense and (ii) currency transaction adjustments between the dollar
exchange rate and (a) the NIS and (b) the NIS adjusted for inflation imposed on
our assets and liabilities in Israel. In 2001, we recorded net financial income
of $48,000 as compared to financial income of $416,000 in 2000. This decrease in
financial income is attributable to the declining interest bearing deposits and
to the decrease in interest rate.
Taxes on Income (Tax Benefit). Our income taxes for 2001 were $402,000
compared with an income tax provision of $200,000 in 2000.
Loss from Continuing Operations. As a result of the foregoing, we had a
loss from continuing operations of $15.9 million in 2001 compared to a loss of
$29.2 million in 2000.
24
Earnings from Discontinued Operations of a Segment, Net of Taxes. We
recorded earnings of $82,000, net of taxes of $74,000, with respect to the
discontinued operations of Medatech in our financial statements for 2000.
Gain (Loss) on Disposal of Segment. We recorded a $220,000 gain in 2001
with respect to the disposal of Medatech in our financial statements compared to
a loss of $2.2 million in 2000.
Gain (Loss) from Discontinued Operations. As a result of the foregoing, we
recorded a $220,000 gain and a $2.1 million loss with respect to the provisions
related to discontinued operations of Medatech in our financial statements for
2001 and 2000, respectively.
Net Loss. As a result of the foregoing, we had a net loss of $15.6 million
in 2001 compared to a net loss of $31.3 million in 2000.
Political Conditions
Since the establishment of the State of Israel in 1948, a number of armed
conflicts have taken place between Israel and its Arab neighbors, and the
continued state of hostility, varying in degree and intensity, has led to
security and economic problems for Israel. Since September 2000, there has been
significant increase in violence, primarily in the West Bank and Gaza Strip, and
more recently there has been a marked deterioration in the relations between
Israel and the Palestinian Authority and Israel has experienced many terrorist
incidents within its borders. As a result, peace negotiations between Israel and
representatives of the Palestinian Authority have been sporadic and have failed
to result in peace.
Several countries continue to restrict business with Israel and with
companies having operations in Israel. Although we are precluded from marketing
our products to these countries, we believe that in the past these restrictions
have not had a material adverse effect on us. In addition, as a result of the
hostilities between Israel and the Palestinian Authority, most Arab countries
with which Israel had commercial and trading agreements have publicly announced
the halt of these agreements. Also, as a result of the Israeli military
activities in the West Bank during April 2002, several European countries are
considering participating in a boycott of Israeli firms. We do not believe that
these measures will have a material adverse affect on us. However, restrictive
laws, policies or practices directed towards Israel or Israeli businesses could
have an adverse impact on our business.
In addition, some of our employees in Israel are subject to being called
upon to perform military service in Israel, and their absence may have an
adverse effect upon our operations. Generally, unless exempt, male adult
citizens and permanent residents of Israel under the age of 54 are obligated to
perform up to 37 days of military reserve duty annually and all such residents
are subject to being called to active duty at any time under emergency
circumstances. In addition, due to the current hostilities between the State of
Israel and the Palestinian Authority, the Ministry of Defense from time to time
issues emergency orders to recruit a large number of reserve soldiers. While we
have operated effectively under these requirements since we began operations, we
cannot assess the full impact of these requirements on our workforce or business
if conditions should change, and we cannot predict the effect on us of any
expansion or reduction of these obligations.
25
To date, no executive officer or key employee was recruited for military
service for any significant time period. Any further expansion of the
hostilities between Israel and the Palestinian Authority into a full-scale
conflict might require more significant military reserve service by some of our
employees, which may have a material adverse effect on our business.
Economic Conditions
Israel's economy has been subject to numerous destabilizing factors,
including a period of rampant inflation in the early to mid-1980s, low foreign
exchange reserves, fluctuations in world commodity prices, military conflicts
and civil unrest. The Israeli Government has intervened in various sectors of
the economy by utilizing fiscal and monetary policies, import duties, foreign
currency restrictions and controls of wages, prices and foreign currency
exchange rates. The Israeli Government has periodically changed its policies in
all these areas.
As a result of political instability, the increased level of hostilities
with the Palestinian Authority and the world-wide economic crisis in the hi-tech
and communication industries, during 2001, 2002, and the first five months of
2003 the Israeli rate of economic growth has deteriorated. The NIS was devalued
against the dollar and the Euro during 2001 and 2002 but this devaluation has
been reversed to a certain extent in recent months. Due to significant economic
measures, including significant budgetary cuts and changes with respect to
employee pension plans, proposed by the Israeli Government, there have been
several strikes and work stoppages during April and May 2003, which culminated
in a three-day general strike, including all banks, airports and ports, in May
2003. These strikes had an adverse effect on the Israeli economy and on our
ability to carry on our business undisturbed. Following the enactment by the
Israeli Parliament of laws to implement the economic measures, the Israeli trade
unions threatened further strikes or work-stoppages, which may have a material
adverse effect on the Israeli economy and our company.
However, the impact on the Israeli economy of these and other measures that
may eventually be adopted is uncertain. In addition, certain credit agencies
have stated that they are reviewing Israel's credit rating. Should such agencies
lower Israel's credit rating, the ability of the Israeli government to generate
foreign financial and economical assistance may be adversely affected. We cannot
assure you that the Israeli government will be successful in its attempts to
stabilize the Israeli economy or to maintain Israel's current credit rating.
Economic decline as well as price and exchange rate instability may have a
material adverse effect on us.
Trade Agreements
Israel is a member of the United Nations, the International Monetary Fund,
the International Bank for Reconstruction and Development and the International
Finance Corporation. Israel is a signatory to the General Agreement on Tariffs
and Trade, which provides for reciprocal lowering of trade barriers among its
members. In addition, Israel has been granted preferences under the Generalized
System of Preferences from the U.S., Australia, Canada and Japan. These
preferences allow Israel to export products covered by such programs either
duty-free or at reduced tariffs.
Israel and the European Union Community concluded a Free Trade Agreement in
July 1975 which confers certain advantages on Israeli exports to most European
countries and obligates Israel to lower its tariffs on imports from these
countries over a number of years. In
26
1985, Israel and the U.S. entered into an agreement to establish a free trade
area. The free trade area has eliminated all tariff and specified non-tariff
barriers on most trade between the two countries. On January 1, 1993, an
agreement between Israel and the European Free Trade Association, known as EFTA,
which includes Austria, Finland, Iceland, Liechtenstein, Norway, Sweden and
Switzerland, established a free-trade zone between Israel and the EFTA nations.
In November 1995, Israel entered into a new agreement with the European Union,
which includes redefinement of rules of origin and other improvements, including
providing for Israel to become a member of the research and technology programs
of the European Union. In recent years, Israel has established commercial and
trade relations with a number of other nations, including China, India, Russia,
Turkey and other nations in Eastern Europe and Asia.
Effective Corporate Tax Rate
Israeli companies are generally subject to income tax at the corporate rate
of 36% of taxable income. We have been granted the status of an "Approved
Enterprise" under the Law for the Encouragement of Capital Investments, 1959
(the "Investment Law") with respect to our production facilities. An enlargement
project of ours was granted "Approved Enterprise" status in December 1998. In
accordance with the provisions of the Investment Law, we have elected to enjoy
"alternative benefits," wherein a company waives the receipt of grants in return
for a tax exemption. Income derived from an "Approved Enterprise" is tax-exempt
for a period of two years, commencing with the year it first earns taxable
income, and is subject to corporate tax at the rate of 10% to 25% for additional
periods of five to eight years based on the percentage of foreign investments in
our company. The Investment Law has been extended to December 31, 2003, and no
assurance can be given that it will be extended further. A failure to extend the
Investment Law will result in a significant increase in our corporate tax rate.
Our subsidiary, Attunity Software Services Ltd., or ASS granted "Approved
Enterprise" status for two separate investment programs from 1991 and 1993
whereby it has elected to receive Government grants and to enjoy the benefit of
a reduced tax rate of 25% during a period of seven years commencing with the
year it first earns taxable income. The period of tax benefits, detailed above,
is subject to limits of the earlier of twelve years from the commencement of
production, or fourteen years from the date of approval. In 1993, ASS received
approval for an expansion of the aforementioned programs whereby it elected to
enjoy "alternative benefits" - waiver of grants in return for tax exemption -
and, accordingly, its income from the "Approved Enterprise" will be tax-exempt
for a period of ten years commencing with the year it first earns taxable
income. As of December 31, 2002, ASS has not received final approvals for such
programs.
Since we currently have no taxable income, the benefits have not yet
commenced for all programs. Should we or ASS derive income from sources other
than the "Approved Enterprise" during the periods of benefits, such income shall
be taxable at the regular corporate tax rate of 36%. Our taxes outside Israel
are dependent on our operations in each jurisdiction as well as relevant laws
and treaties. Under Israeli tax law, the results of our foreign consolidated
subsidiaries, which have generally been unprofitable, cannot be consolidated for
tax purposes with the results of operations of the parent company.
Impact of Currency Fluctuations and of Inflation
Since the majority of our sales are denominated and paid in dollars, we
believe that
27
inflation and fluctuations in the dollar exchange rate have no material effect
on our sales. Inflation and dollar exchange rate fluctuations, however, have
some influence on our expenses and, as a result, on our net income. The dollar
cost of our operations in Israel is influenced by the extent to which any
increase in the rate of inflation in Israel is not offset (or is offset on a
lagging basis) by a devaluation of the NIS in relation to the dollar.
The dollar cost of our operations in Israel is influenced by the extent to
which any increase in the rate of inflation in Israel is (or is not) offset, or
is offset on a lagging basis, by the devaluation of the NIS in relation to the
dollar. Unless offset by a devaluation of the NIS, inflation in Israel will have
a negative effect on our profitability as we incur expenses, principally
salaries and related personnel expenses, in NIS. For several years prior to
1997, the rate of inflation in Israel exceeded the rate of devaluation of the
NIS against the dollar and companies experienced increases in the dollar cost of
their operations in Israel. This trend was reversed during 1997 and 1998. In
1999 and 2000, the rate of inflation exceeded the rate of devaluation of the NIS
against the U.S. dollar. In 2001 and 2002, the devaluation rate again exceeded
the inflation rate in Israel. We cannot assure you that we will not be
materially and adversely affected in the future if inflation in Israel exceeds
the devaluation of the NIS against the dollar or if the timing of such
devaluation lags behind inflation in Israel.
The following table sets forth, for the periods indicated, information with
respect to the rate of inflation in Israel, the rate of devaluation of the NIS
against the dollar, and the rate of inflation in Israel adjusted for such
devaluation:
Israeli
Israeli inflation
Year ended Israeli Israeli devaluation adjusted for
December 31, price index inflation rate % rate % devaluation %
------------ ----------- ---------------- ----------- -------------
1998 402.6 8.6 17.6 (7.7)
1999 408.0 1.3 (0.2) 1.5
2000 408.0 0 (2.7) 2.8
2001 413.8 1.4 9.3 (7.8)
2002 440.65 6.4 7.3 (0.7)
A devaluation of the NIS in relation to the dollar has the effect of
reducing the dollar amount of any of our expenses or liabilities which are
payable in NIS (unless such expenses or payables are linked to the dollar). Such
a devaluation also has the effect of decreasing the dollar value of any asset
which consists of NIS or receivables payable in NIS (unless such receivables are
linked to the dollar). Conversely, any increase in the value of the NIS in
relation to the dollar has the effect of increasing the dollar value of any
unlinked NIS assets and the dollar amounts of any unlinked NIS liabilities and
expenses.
Because exchange rates between the NIS and the dollar fluctuate
continuously (albeit with a historically declining trend in the value of the
NIS), exchange rate fluctuations and especially larger periodic devaluations
will have an impact on our profitability and period-to-period comparisons of our
results. The effects of foreign currency re-measurements are reported in our
consolidated financial statements in shareholders equity as other comprehensive
income.
Since most of our sales are quoted in dollars and in other foreign
currencies, and a significant portion of our expenses are incurred in NIS, our
results are adversely affected by a change in the rate of inflation in Israel
when such change is not offset (or is offset on a
28
lagging basis) by a corresponding devaluation of the NIS against the dollar and
other foreign currencies.
B. LIQUIDITY AND CAPITAL RESOURCES
Historically, we have financed our operations through cash generated by
operations, funds generated by our public offering in 1992 (approximately $12
million), private equity investments (approximately $24.8 million), exercise of
stock options and warrants (approximately $9.5 million) as well as from research
and development and marketing grants, primarily from the Government of Israel.
In March 2000, we raised net proceeds of approximately $13 million in a private
placement of our securities. In October 2001, we raised additional proceeds of
approximately $5 million in a private placement of our securities. On a limited
basis we have also financed our operations through short-term loans and
borrowings under available credit facilities.
As of December 31, 2002, we had $2.8 million in cash and cash equivalents
and working capital of $6.1 million as compared to $3.1 million in cash and cash
equivalents and working capital of $5.9 million at December 31, 2001. As of
December 31, 2002, we had a bank line of credit of approximately $0.6 million of
which approximately $0.2 million was used.
As of December 31, 2002 we had $16,000 in long-term loans from United
Mizrachi Bank Ltd. These loans bear interest ranging between 5% to 7.8%.
Principal and interest are linked to the Israeli Consumer Price Index.
Net cash provided by operating activities was $1.7 million in 2002 and $5.0
million was used in operating activities in 2001. The amount provided from
operating activities in 2002 was primarily attributable to our improved
operating results.
Net cash used in investing activities was $1.8 million in 2002 and $2.3
million in 2001, which funds were used primarily for research and development
activities.
Net cash used in financing activities was $0.3 million in 2002 and $4.5
million was provided by financing activities in 2001. The funds used in 2002
were used primarily for the repayment of long-term debts, while in 2001 we
received 5 million before expenses in a private placement of our securities.
Our principal commitments consist of obligations outstanding under
operating leases. Our capital expenditures were approximately $199,000 in 2002
and $400,000 in 2001. In 2002, the majority of our capital expenditures were for
computer and electronic equipment, software and office furniture and equipment.
We currently do not have significant capital spending or purchase commitments.
We anticipate that our existing capital resources will be adequate to
satisfy our working capital and capital expenditure requirements until December
31, 2003, but we may need to raise additional funds in the next twelve months in
order to provide the necessary capital for our working capital and capital
expenditure requirements in the next twelve months.
29
C. RESEARCH AND DEVELOPMENT, PATENTS AND LICENSES
The software industry is characterized by rapid product change resulting
from new technological developments, performance improvements and lower hardware
costs and is highly competitive with respect to timely product innovation. We,
through our research and development and support personnel, work closely with
our customers and prospective customers to determine their requirements, to
design enhancements and new releases to meet their needs and to adapt our
products to new platforms, operating systems and databases. Research and
development activities for all products principally take place in our research
and development facilities in Israel. As of December 31, 2002, we employed 34
persons in research and development.
We seek external resources for co-financing our development projects,
mainly from the Office of the Chief Scientist of the Israeli Ministry of
Industry and Trade. The Chief Scientist participated in financing Attunity
Connect(TM), APTuser(R) and the Hungarian version of Mancal 2000. Under the
Israeli Law for the Encouragement of Industrial Research and Development, or the
Research Law, research and development programs approved by the research
committee of the Chief Scientist are eligible for grants of up to 50% of project
expenditures if they meet certain criteria, in return for the payment of
royalties from the sale of the product developed in accordance with the program.
The terms of these grants prohibit the manufacture outside of Israel or the
transfer of the technology developed pursuant to the terms of these grants to
any person or entity without the prior consent of the Chief Scientist. The
Research Law also provides that know-how from the research and development which
is used to produce the product may not be transferred to third parties without
the approval of the Chief Scientist. There can be no assurance that such
consent, if requested, will be granted.
We have committed substantial financial resources to our research and
development efforts. During 2000, 2001 and 2002, our research and development
expenditures were $5.6 million, $5.8 million and $3.6 million, respectively. We
did not receive any reimbursement from the Chief Scientist during the last three
years. We capitalized computer software development costs of $2.0 million $1.8
million and $1.6 million in 2000, 2001 and 2002, respectively. We believe that
our investment in product development activities will be consistent with our
expenditures in 2002.
Under the research and development approval letters of the Chief Scientist
and pursuant to the Research Law, we are required to pay royalties as follows:
3% of revenues during the first three years, 4% of revenues during the following
three years, and 5% of revenues in the seventh year and thereafter, with the
total royalties not to exceed 100% of the dollar value of the Chief Scientist
grant (or in some cases up to 300%). Following the full payment of such
royalties, there is no further liability for payment. For participation received
with respect to approvals granted after December 31, 1998, interest at the
12-month LIBOR rate as published on the first business day of each calendar year
will be added to the royalty payments. Our royalties expenses to the Chief
Scientist during the years 2000, 2001 and 2002 were $220,000, $156,000 and
$232,000 respectively.
The Research Law further requires that products developed with government
grants be manufactured in Israel, unless a special approval has been granted.
However, in the event that any portion of the manufacturing is not conducted in
Israel, if approval is received from the Chief Scientist, we would be required
to pay royalties that are adjusted in proportion to manufacturing outside of
Israel as follows: when the manufacturing is performed outside of
30
Israel by us or an affiliate company, the royalties are to be paid as described
above with the addition of 1%, and when the manufacturing outside of Israel is
not performed by us or an affiliate, the royalties paid shall be equal to the
ratio of the amount of grant received from the Chief Scientist divided by the
amount of grant received from the Chief Scientist and the investment(s) made by
us in the project. The payback will also be adjusted to 120%, 150% or 300% of
the grant if the portion of manufacturing that is performed outside of Israel is
up to 50%, between 50% and 90%, or more than 90%, respectively. The technology
developed pursuant to the terms of these grants may not be transferred to third
parties without the prior approval of the Research Committee. Such approval is
not required for the export of any products resulting from such research or
development. Approval of the transfer of technology may be granted only if the
recipient abides by all the provisions of the Research Law and regulations
promulgated thereunder, including the restrictions on the transfer of know-how
and the obligation to pay royalties in an amount that may be increased.
The funds generally available for grants by the Chief Scientist were
reduced for 2003, and the Israeli authorities have indicated that the government
may further reduce grants from the Chief Scientist in the future. Even if these
grants are maintained, we cannot assure you that we will receive Chief Scientist
grants in the future.
D. TREND INFORMATION
We expect that our results will continue to be impacted by the continued
decline in sales of our legacy products and by increased marketing expenditures
while we attempt to gain market acceptance for our e-Business integration
products. As a result of a less predictable business environment and the decline
in worldwide software sales, we are unable to provide any guidance as to sales
and profitability trends.
As a result of unfavorable decision against us in our litigation with the
various Special Situation Funds we recorded a charge of 0.8 million in the year
ended December 31, 2002. We have appealed the verdict and expect the resolution
of this litigation by year end 2003.
Cautionary Statement Regarding Forward-Looking Statements
This Annual Report on Form 20-F contains various "forward-looking
statements" within the meaning of Section 27A of the Securities Act of 1933, as
amended, and Section 21E of the Securities Exchange Act of 1934, as amended.
Such forward-looking statements reflect our current view with respect to future
events and financial results. Forward-looking statements usually include the
verbs "anticipates," "believes," "estimates," "expects," "intends," "plans,"
"projects," "understands" and other verbs suggesting uncertainty. We remind
shareholders that forward-looking statements are merely predictions and
therefore inherently subject to uncertainties and other factors and involve
known and unknown risks that could cause our actual results, performance, levels
of activity, or achievements, or industry results, to be materially different
from any future results, performance, levels of activity, or achievements of us
and our subsidiaries expressed or implied by such forward-looking statements.
These uncertainties and other factors that could cause or contribute to such
differences include, among other things, (i) the market's acceptance of Attunity
Connect(TM) and Attunity BPI(TM), (ii) the final outcome of our litigation with
the Special Situations Funds, (iii) rapid technological changes in the industry,
(iv) increasing competition and (v) general and economic business conditions.
31
We have attempted to identify additional significant uncertainties and
other factors affecting forward-looking statements in a Risk Factors section
which appears in "Item 3 - Key Information."
ITEM 6. DIRECTORS, SENIOR MANAGEMENT AND EMPLOYEES
------------------------------------------
A. DIRECTORS AND SENIOR MANAGEMENT
The following table lists our executive officers and directors.
Name Age Position with the Company
- ---- --- -------------------------
Arie Gonen.................... 57 Chairman of the Board and
Acting Chief Executive Officer
Ofer Segev.................... 44 Chief Financial and Operating Officer
Shlomo Baumgarten............. 54 Vice President-Finance and Secretary
Dan Falk...................... 58 Director*
Roni Ferber................... 60 Outside Director*
Robert J. Majteles............ 38 Director
Anat Segal.................... 36 Outside Director*
*Member of Audit Committee
Messrs. Gonen, Falk, and Majteles will serve as directors until our 2002
annual general meeting of shareholders and until their successors are elected.
Mr. Roni Ferber was designated an outside director by our board of directors in
May 2001. According to regulations promulgated under the Israeli Companies Law,
the board of directors of companies like us whose shares are traded outside
Israel is permitted to designate a director who was appointed prior to February
1, 2000 and who would otherwise qualify as an outside director, as an outside
director. Mr. Roni Ferber will serve in such office pursuant to the provisions
of the Israeli Companies Law for a three-year term until our 2004 annual general
meeting of shareholders. Thereafter, his office may be renewed for only one
additional three-year term. Ms. Anat Segal was elected as an outside director in
December 2002. Ms. Anat Segal will serve in such office pursuant to the
provisions of the Israeli Companies Law for a three-year term until our 2005
annual general meeting of shareholders. Thereafter, her office may be renewed
for only one additional three-year term.
Our articles of association provide for a Board of Directors of not fewer
than three nor more than eleven members. The Board is currently composed of five
directors. Officers serve at the pleasure of the Board of Directors, subject to
the terms of any agreement between an officer and our company.
Arie Gonen has served as our Chairman and a director since December 1988.
He served as our Chief Executive Officer from December 1988 until January 2001
and assumed that position once again in August 2002. Prior thereto from 1976, he
served as President of Milan Software Industries (1976) Ltd., an Israeli
software company, or Milan. Mr. Gonen received a B.Sc. in Electrical Engineering
and a M.Sc. in Computer Sciences from the Technion Israel Institute of
Technology.
Ofer Segev has been our Chief Financial and Operating Officer since June
2003. From January 2002 until June 2003 he served as the Chief Executive Officer
of Teleknowledge Group Ltd., a private company in the billing and customer care
field. From
32
May 2001, he was the Chief Financial Officer of Teleknowledge. Prior to that and
from May 2000 until April 2001, Mr. Segev was the Chief Financial Officer of
Tundo Corp., a company in the VoIP field. Prior to that Mr. Segev was a partner
at Kost Forer & Gabbay, a member of Ernst & Young Global, where he led the high
technology service group. Mr. Segev holds a B.A. degree in Economics and
Accounting from Bar Ilan University in Israel and has studied at the Kellogg
Graduate School of Management at Northwestern University.
Shlomo Baumgarten has been our Vice President-Finance Since October 1992.
From October 1992 until June 2003, Mr. Baumgarten served as our Chief Financial
Officer, and previously he served as our Comptroller since our incorporation in
October 1988. Mr. Baumgarten served as a director of our company from our
inception until November 2000. Prior thereto and from 1983, he was the
Comptroller of Milan. Mr. Baumgarten holds a B.A. degree in Economics and
Auditing from Haifa University.
Dan Falk was appointed as a director in April 2002, and was designated as
an outside director by our board of directors in May 2002. From 1999 until 2000
he served as the President and Chief Operating Officer and then Chief Executive
Officer of Sapiens International Corporation N.V., a publicly traded company
that provides cost-effective business software solutions. From 1995 until 1999
Mr. Falk was Executive Vice President and Chief Financial Officer of Orbotech, a
maker of automated optical inspection and computer aided manufacturing systems.
Mr. Falk serves as the chairman of the board of directors of Atara Technology
Ventures and is a member of the boards of directors of Nice System Ltd, Orad
Ltd, Netafim Ltd, Visionix Ltd., Ramdor Ltd., Medcon Ltd. and Advanced Vision
Technology Ltd. He has an M.B.A. degree from the Hebrew University School of
Business. Roni Ferber was appointed to the Board of Directors in October 1995
and was designated as an outside director by our Board of Directors in May 2001.
Since 1992, Mr. Ferber has been self-employed as a business consultant. From
1967 until December 1992, Mr. Ferber was General Manager and President of Nikuv
Computers Ltd., a publicly-traded software company located in Israel. Mr. Ferber
serves as a director of Comtech Ltd., a computer software company, traded on the
Tel Aviv Stock Exchange, and Dmatek Ltd, a manufacturer and distributor of
electronic tagging systems, traded on the London Stock Exchange. He has a B.A in
Economics from the Hebrew University in Jerusalem, and an M.A. in Semitic
Languages from the Tel Aviv University.
Robert J. Majteles was appointed as a director June 2002. Mr. Majteles is
the founder and the managing partner of Treehouse Capital, LLC, an investment
firm, since August 2002. Treehouse Capital is a joint venture between Mr.
Majteles and Special Situations Funds. From January 2000 through April 2001 he
was the Chief Executive Officer of Citadon, Inc., a leading provider of
collaboration software to the construction and engineering industries. Prior
thereto and from April 1997 Mr. Majteles was the Chief Executive Officer of
ULTRADATA Corporation, a publicly-traded developer of software for financial
institutions. From January 1991 until June 1996, he held several management
positions which included Vice President Sales, Chief Operating Officer,
President and Chief Executive Officer in CAMAX Systems Inc., a mechanical
engineering software firm. From January 1990 until January 1991 Mr. Majteles was
a merchant banker with Investment Advisers, Inc., a fund management firm based
in Minnesota. Prior thereto and from July 1989 he was a mergers and acquisitions
attorney at Skadden, Arps, Slate, Meagher & Flom, a New York-based law firm. Mr.
Majteles also serves as a board member of Superconductor
33
Technologies Inc. and Artisoft, Inc., public companies traded on the Nasdaq
Stock Market. Mr. Majteles holds a J.D. degree from Stanford University Law
School and a B.A. degree from Columbia University.
Special Situations Fund III, L.P., Special Situations Cayman Fund, L.P.,
Special Situations Private Equity Fund, L.P. and Special Situations Fund, L.P.
have entered into an agreement with Mr. Majteles and Treehouse Capital, LLC
pursuant to which Treehouse, through Mr. Majteles, provides certain management
and financial advisory services for the funds on request. Pursuant to this
agreement, the funds pay Treehouse a retainer of $10,000 per month. If Mr.
Majteles's services are requested by the funds with respect to a particular
portfolio investment, Treehouse is entitled to 10% of the funds' net gain (as
defined) or net loss (as defined) on the investment during the term of the
agreement, offset by certain fees that may be paid by the portfolio company to
Treehouse or Mr. Majteles directly and, except in certain cases, the amount of
the retainer paid to Treehouse. Under the agreement, Mr. Majteles is required to
act independently of the funds in discharging his fiduciary duties to
shareholders of any company for which he serves as a member of the Board of
Directors and also is obligated not to disclose to the funds or use for his own
benefit any confidential information he obtains in connection with his service
for a particular portfolio company. Mr. Majteles does not have or share voting
or dispositive power over any securities held by the funds. Mr. Majteles has
agreed to serve as our director pursuant to this agreement.
Anat Segal was appointed as an outside director in December 2002. Since
January 2000 Ms. Segal has acted as an independent advisor providing investment
banking services and financial and strategic consulting to high-tech companies.
Ms. Segal is also member of the management team of Xenia Ventures, a high tech
incubator based in Kiryat Gat, Israel. Prior to that and since 1998, she has
served as the Managing Director and Head of Corporate Finance of Tamir Fishman &
Co., which was then an Israeli strategic affiliate of Hambrecht and Quist. From
1996 until 1998 she served as a Vice President of Investment Banking, Robertson
Stephens & Co/Evergreen. From 1990 until 1996 Ms. Segal held senior positions
with Bank Hapoalim Group and Poalim Capital Markets. She also serves as a board
member of AVT, a public company traded in Frankfurt, Germany. Ms. Segal holds a
B.A. degree in Economics and Management, an M.B.A. degree and an L.L.B. degree
from Tel Aviv University.
Paul T. MacKay who served as our Chief Executive Officer, President and
director beginning in January 2001, resigned from all of his positions with our
company in August 2002. Stephen J. Kohn who served as a director since October
1992 resigned in September 2002.
B. COMPENSATION
The following table sets forth all compensation we paid with respect to all
of our directors and executive officers as a group for the year ended December
31, 2002:
Salaries, fees,
commissions and Pension, retirement
bonuses and similar benefits
------- --------------------
All directors and executive officers
as a group, consisting of 8 persons..... $455,348 $45,955
34
Non-employee directors received an annual fee of $9,000 and an attendance
fee of $300 per meeting attended.
As of December 31, 2002, our directors and executive officers as a group,
consisting of 8 persons, held options to purchase an aggregate of 256,499
ordinary shares, at an exercise price of $0.82-$10.125 per share, with vesting
over three-year terms. Of such options, 5,000 options expire in 2003 and the
rest expire between 2005 and 2008. All options were issued under our 1994 1998
and 2001 Employee Stock Option Plans. See "E. Share Ownership - Stock Option
Plans."
C. BOARD PRACTICES
Election of Directors
Pursuant to our articles of association, all of our directors (except the
outside directors as detailed below) are elected at our annual general meeting
of shareholders by a vote of the holders of a majority of the voting power
represented and voting at such meeting. All the members of our Board of
Directors (except the outside directors as detailed below) may be reelected upon
completion of their term of office. All our directors currently in office,
except Roni Ferber, an outside director, were elected by our shareholders at our
annual meeting of shareholders of December 2002.
Independent and Outside Directors
The Israeli Companies Law requires Israeli companies with shares that have
been offered to the public in or outside of Israel to appoint at least two
outside directors. No person may be appointed as an outside director if the
person or the person's relative, partner, employer or any entity under the
person's control has or had, on or within the two years preceding the date of
the person's appointment to serve as outside director, any affiliation with the
company or any entity controlling, controlled by or under common control with
the company. The term affiliation includes:
o an employment relationship;
o a business or professional relationship maintained on a regular basis;
o control; and
o service as an officer holder.
No person may serve as an outside director if the person's position or
other activities create, or may create, a conflict of interest with the person's
responsibilities as an outside director or may otherwise interfere with the
person's ability to serve as an outside director. If, at the time outside
directors are to be appointed, all current members of the Board of Directors are
of the same gender, then at least one outside director must be of the other
gender.
Outside directors are elected by shareholders. The shareholders voting in
favor of their election must include at least one-third of the shares of the
non-controlling shareholders of the company who are present at the meeting. This
minority approval requirement need not be met if the total shareholdings of
those non-controlling shareholders who vote against their
35
election represent 1% or less of all of the voting rights in the company.
Outside directors serve for a three-year term, which may be renewed for only one
additional three-year term. Outside directors can be removed from office only by
the same special percentage of shareholders as can elect them, or by a court,
and then only if the outside directors cease to meet the statutory
qualifications with respect to their appointment or if they violate their duty
of loyalty to the company.
Any committee of the board of directors must include at least one outside
director and the audit committee must include all of the outside directors. An
outside director is entitled to compensation as provided in regulations adopted
under the Companies Law and is otherwise prohibited from receiving any other
compensation, directly or indirectly, in connection with such service.
In addition, the Nasdaq National Market requires us to have at least three
independent directors on our board of directors and to establish an audit
committee. Messrs. Dan Falk and Roni Ferber and Ms. Segal qualify as independent
directors under the Nasdaq Market requirements.
Approval of Related Party Transactions Under Israeli Law
The Companies Law codifies the fiduciary duties that "office holders,"
including directors and executive officers, owe to a company. An office holder's
fiduciary duties consist of a duty of care and a duty of loyalty. The duty of
care requires an office holder to act at a level of care that a reasonable
office holder in the same position would employ under the same circumstances.
The duty of loyalty includes avoiding any conflict of interest between the
office holder's position in the company and his personal affairs, avoiding any
competition with the company, avoiding exploiting any business opportunity of
the company in order to receive personal gain for the office holder or others,
and disclosing to the company any information or documents relating to the
company's affairs which the office holder has received due to his position as an
office holder. Each person listed as a director or executive officer in the
table under " -- Directors and Senior Management" above is an office holder.
Under the Companies Law, all arrangements as to compensation of office holders
who are not directors require approval of our board of directors, and the
compensation of office holders who are directors must be approved by our audit
committee, board of directors and shareholders.
The Companies Law requires that an office holder promptly disclose any
personal interest that he or she may have and all related material information
known to him or her, in connection with any existing or proposed transaction by
us. In addition, if the transaction is an extraordinary transaction, that is, a
transaction other than in the ordinary course of business, other than on market
terms, or likely to have a material impact on the company's profitability,
assets or liabilities, the office holder must also disclose any personal
interest held by the office holder's spouse, siblings, parents, grandparents,
descendants, spouse's descendants and the spouses of any of the foregoing, or by
any corporation in which the office holder or a relative is a 5% or greater
shareholder, director or general manager or in which he or she has the right to
appoint at least one director or the general manager. Some transactions, actions
and arrangements involving an office holder (or a third party in which an office
holder has an interest) must be approved by the board of directors or as
otherwise provided for in a company's articles of association, as not being
adverse to the company's interest. In some cases, such a transaction must be
approved by the audit committee and by the board of directors itself (with
further shareholder approval required in the case of
36
extraordinary transactions). An office holder who has a personal interest in a
matter, which is considered at a meeting of the board of directors or the audit
committee, may not be present during the board of directors or audit committee
discussions and may not vote on this matter, unless the majority of the members
of the board or the audit committee have a personal interest, as the case may
be.
The Companies Law also provides that an extraordinary transaction between a
public company and a controlling shareholder, or transactions in which a
controlling shareholder of the company has a personal interest but which are
between a public company and another entity or the terms of compensation of a
controlling shareholder, require the approval of the board of directors and of
the shareholders. The shareholder approval for any such extraordinary
transaction must include at least one-third of the shareholders who have no
personal interest in the transaction and are present at the meeting. The
transaction can be approved by shareholders without this one-third approval, if
the total shareholdings of those shareholders who have no personal interest and
voted against the transaction do not represent more than one percent of the
voting rights in the company.
However, under the Companies Regulations (Relief From Related Party
Transactions), 5760-2000, promulgated under the Companies Law and amended in
January 2002, certain transactions between a company and its controlling
shareholder(s) do not require shareholder approval.
In addition, pursuant to the recent amendment to these regulations,
directors' compensation and employment arrangements do not require the approval
of the shareholders if both the audit committee and the board of directors agree
that such arrangements are for the benefit of the company. If the director or
the office holder is a controlling shareholder of the company, then the
employment and compensation arrangements of such director or office holder do
not require the approval of the shareholders provided that certain criteria are
met.
The above exemptions will not apply if one or more shareholders, holding at
least 1% of the issued and outstanding share capital of the company or of the
company's voting rights, objects to the grant of such relief, provided that such
objection is submitted to the company in writing not later than seven (7) days
from the date of the filing of a report regarding the adoption of such
resolution by the company pursuant to the requirements of the Israeli Securities
Law. If such objection is duly and timely submitted, then the compensation
arrangement of the directors will require shareholders' approval as detailed
above.
The Companies Law provides that an acquisition of shares in a public
company must be made by means of a tender offer if as a result of the
acquisition the purchaser would become a 25% shareholder of the company. This
rule does not apply if there is already another 25% shareholder of the company.
Similarly, the Companies Law provides that an acquisition of shares in a public
company must be made by means of a tender offer if as a result of the
acquisition the purchaser would become a 45% shareholder of the company, unless
there is a 50% shareholder of the company. Regulations under the Companies Law
provide that the Companies Law's tender offer rules do not apply to a company
whose shares are publicly traded outside of Israel, if pursuant to the
applicable foreign securities laws and stock exchange rules there is a
restriction on the acquisition of any level of control of the company, or if the
acquisition of any level of control of the company requires the purchaser to
make a tender offer to the public shareholders.
37
Indemnification of Directors and Officers
The Companies Law provides that an Israeli company cannot exculpate an
office holder from liability with respect to a breach of his duty of loyalty,
but may exculpate in advance an office holder from his liability to the company,
in whole or in part, with respect to a breach of his duty of care. Our articles
of association provide that, subject to any restrictions imposed by corporate
law, we may enter into a contract for the insurance of the liability of any of
our office holders with respect to:
o a breach of his duty of care to us or to another person;
o breach of his duty of loyalty to us, provided that the office holder
acted in good faith and had reasonable cause to assume that his act
would not prejudice our interests; or
o a financial liability imposed upon him in favor of another person in
respect of an act performed by him in his capacity as an office
holder.
In addition, we may indemnify an office holder against:
o a financial liability imposed on him in favor of another person by any
judgment, including a settlement or an arbitrator's award approved by
a court in respect of an act performed in his capacity as an office
holder; and
o reasonable litigation expenses, including attorneys' fees, expended by
such office holder or charged to him by a court, in proceedings we
institute against him or instituted on our behalf or by another
person, or in a criminal charge from which he was acquitted, all in
respect of an act performed in his capacity as an office holder.
These provisions are specifically limited in their scope by the Companies
Law, which provides that a company may not indemnify an office holder, nor enter
into an insurance contract which would provide coverage for any monetary
liability incurred as a result of certain improper actions.
Pursuant to the Companies Law, indemnification of, and procurement of
insurance coverage for, our office holders must be approved by our audit
committee and our board of directors and, in specified circumstances, by our
shareholders.
We have undertaken to indemnify our office holders to the fullest extent
permitted by law. We currently maintain directors and officers liability
insurance with a per claim and aggregate coverage limit of $10 million including
legal costs incurred in Israel.
Employment Agreements
Mr. Gonen has acted as our Chief Executive Officer and Chairman of the
Board from October 31, 1988 until November 22, 2001 and has served as our active
Chairman since November 2000. Upon the resignation of our former Chief Executive
Officer on August 22, 2002, Mr. Gonen assumed the position of Chief Executive
Officer, and has agreed to serve in this capacity until a new Chief Executive
Officer is appointed. In 2003 our company signed a
38
new employment agreement with Mr. Gonen. Under the terms of the new agreement,
effective as of September 1, 2002, Mr. Gonen has agreed to devote his full
working time and best efforts to our business and affairs, and to the
performance of his duties under the agreement as long as he is employed by us
and has agreed to act as a consultant for a period of three years after
termination of his employment. During his employment period, Mr. Gonen will
receive a monthly gross salary of NIS 90,000 linked to the Israeli Consumer
Price Index (approximately $20,450). Mr. Gonen's salary will be reduced by 20%
as long as the 20% pay reduction for all our employees remains in force. In
addition, during his employment with our company, Mr. Gonen will be entitled to
the use of a company car, full reimbursement for his home telephone expenses,
refund for all-reasonable entertainment and living expenses both in Israel and
abroad, managers insurance, bonuses of $288,000 in 2003 and $108,000 in 2004 and
additional yearly bonuses at the discretion of our Board of Directors of up to
$100,000 commencing in 2003, and options to purchase 400,000 of our ordinary
shares at a price of $1.75 per share, vesting over three equal annual
installments starting September 1, 2002. The agreement also contains
non-competition and confidentiality provisions. Following termination of his
employment by us, Mr. Gonen will be entitled to a severance payment that is
calculated at two times his last Gross Salary multiplied by the number of years
since October 1, 1987, less the amount accumulated in the severance component of
his manager's insurance maintained by us for him which will be transferred to
his name. The agreement provides that following termination of his employment,
we will retain Mr. Gonen as a consultant for a fixed monthly consulting fee of
$13,500 plus VAT during a three-year consulting period for up to 54 hours per
month and not more than 1,800 hours during the entire consulting period and
annual bonuses until 2007 which will not exceed the lower of (i) 5% of our
yearly net profit excluding impairment of intangible assets and (ii) up to
$100,000 per year.
On January 1, 2001, we entered into an employment agreement with Mr.
Baumgarten our VP Finance and Secretary. Under the terms of this agreement, Mr.
Baumgarten received the salary of $6,483 per month in 2002, payable in NIS. We
agreed to evaluate Mr. Baumgarten's performance once a year. Mr. Baumgarten is
entitled to a yearly bonus at the sole discretion of our Chief Executive Officer
and Board of Directors.
Audit Committee
Our audit committee currently composed of Ms. Anat Segal and Messrs. Dan
Falk and Roni Ferber. It is currently contemplated that the audit committee meet
at least four times each year. The responsibilities of the audit committee
include identifying irregularities in the management of our business and
approving related-party transactions as required by law. The audit committee is
authorized generally to investigate any matter within the scope of its
responsibilities and has the power to obtain from the internal auditing unit,
our independent auditors or any other officer or employee any information that
is relevant to such investigations.
The Audit Committee assists the Board of Directors in monitoring (i) the
integrity of the financial statements of the company, (ii) the compliance by the
company with legal and regulatory requirements and (iii) the independence and
performance of our external auditors. Management is responsible for the
preparation and integrity of our financial statements.
The Audit Committee reviewed our audited financial statements for the year
ended December 31, 2002 and members of the Committee met with both management
and our external auditors to discuss those financial statements. Management and
the external auditors
39
have represented to the Audit Committee that the financial statements were
prepared in accordance with the generally accepted accounting principles.
Members of the Audit Committee have received from and discussed with the
external auditors their written disclosure and letter regarding their
independence from our company as required by Independence Standards Board
Standard No. 1. Members of the Audit Committee also discussed with the external
auditors the matters required to be discussed by Statement on Auditing Standards
No. 61. Based upon these reviews and discussions, the Audit Committee has
recommended to the Board of Directors that the audited financial statements be
included in our Annual Report on Form 20-F for the year ended December 31, 2002.
The Israeli Companies Law provides that public companies must appoint an
audit committee. The responsibilities of the audit committee also include
approving related-party transactions as required by law. Under the Israeli
Companies Law, an audit committee must consist of at least three members, and
include all of the company's outside directors. However, the chairman of the
board of directors, any director employed by the company or providing services
to the company on a regular basis, any controlling shareholder and any relative
of a controlling shareholder may not be a member of the audit committee. An
audit committee may not approve an action or a transaction with a controlling
shareholder, or with an office holder, unless at the time of approval two
outside directors are serving as members of the audit committee and at least one
of the outside directors was present at the meeting in which an approval was
granted.
Internal Audit
The Companies Law requires the board of directors of a public company to
appoint an internal auditor nominated by the audit committee. A person who does
not satisfy the Companies Law's independence requirements may not be appointed
as an internal auditor. The role of the internal auditor is to examine, among
other things, the compliance of a company's conduct with applicable law and
orderly business practice. Our internal auditor complies with the requirements
of the Companies Law.
D. EMPLOYEES
On December 31, 2002, we employed 158 persons, comprised of 34 persons in
research and development, 11 persons in product and customer support, 54 persons
in software services, 38 persons in marketing and sales and 21 persons in
general administration and management. As of December 31, 2002, we had 118
employees in Europe, the Middle East and Africa, 26 employees in the United
States and 14 employees located in other countries.
Certain provisions of the collective bargaining agreements between the
Histadrut (General Federation of Labor in Israel) and the Coordination Bureau of
Economic Organizations (including the Industrialists' Association) are
applicable to our employees by order of the Israeli Ministry of Labor. These
provisions concern mainly the length of the workday, minimum daily wages for
professional workers, contributions to a pension fund, insurance for
work-related accidents, procedures for dismissing employees, determination of
severance pay and other conditions of employment. We generally provide our
employees with benefits and working conditions beyond the required minimums.
Pursuant to Israeli law, we are legally required to pay severance benefits
upon the retirement or death of an employee or the termination of employment of
an employee without
40
due cause. Israeli employers and employees are required to pay predetermined
amounts to the National Insurance Institute, which is similar to the United
States Social Security Administration. In 2002 payments to the National
Insurance Institute amounted to approximately 13.9% of wages, of which
approximately two-thirds was contributed by employees with the balance
contributed by the employer.
Our U.S. subsidiary maintains a 401(k) Savings and Profit Sharing Plan. The
401(k) Plan covers employees who have completed one year of service and have
attained the age of 21. Employees who participate in the 401(k) Plan may elect
to defer, in the form of before-tax contributions to the 401(k) Plan, an amount
up to 12% of his or her compensation for each year. A participant's before-tax
contributions cannot exceed $10,500 per year, adjusted for cost-of-living
increases. Contributions to the 401(k) Plan made on behalf of a participant are
invested in the manner directed by the participant. Before-tax contributions are
fully vested and nonforfeitable at all times. Our subsidiary does not contribute
to the 401(k) Plan.
E. SHARE OWNERSHIP
Beneficial Ownership of Executive Officers and Directors
The following table sets forth certain information as of June 13, 2003
regarding the beneficial ownership of our ordinary shares by each of our
directors and executive officers:
Number of Ordinary Percentage of
Shares Outstanding
Beneficially Owned(1) Ordinary Shares (7)
--------------------- -------------------
Arie Gonen ..................... 1,250,000 8.46%
Ofer Segev...................... -- --
Shlomo Baumgarten............... 124,667 (3,4) 0.84%
Dan Falk........................ -- --
Roni Ferber..................... 21,667 (3,5) *
Robert J. Majteles.............. -- --
Anat Segal...................... -- --
- ---------------
* Less than 1%.
(1) Beneficial ownership is determined in accordance with the rules of the
Securities and Exchange Commission (the Commission) and generally
includes voting or investment power with respect to securities.
Ordinary shares relating to options currently exercisable or
exercisable within 60 days of June 13, 2003 are deemed outstanding for
computing the percentage of the person holding such securities but are
not deemed outstanding for computing the percentage of any other
person. Except as indicated by footnote, and subject to community
property laws where applicable, the persons named in the table above
have sole voting and investment power with respect to all shares shown
as beneficially owned by them.
(2) The percentages shown are based on 14,767,432 ordinary shares issued
and outstanding as of June 13, 2003.
41
(3) These ordinary shares are subject to currently exercisable options.
(4) Includes 124,667 ordinary shares subject to currently exercisable
options granted under our stock option plan, at exercise prices
between $1.05 - $10.125 per share. Such options expire between
December 2003 and December 2008.
(5) Includes 18,333 ordinary shares subject to currently exercisable
options granted under our stock option plan, at exercise prices
between $1.08-$7.75 per share. Such options expire between December
2005 and December 2008.
Stock Option Plans
Under our 1994 and 1998 Stock Option Plans, incentive stock options or
ISOs, as defined in Section 422 of the United States Internal Revenue Code of
1986, as amended, may be granted to our officers and employees or to employee of
any of our subsidiaries, and options which do not qualify as ISOs or
non-qualified options, may be granted to our employees, officers and directors
or to employees of any of our subsidiaries. An aggregate of 2,500,000 ordinary
shares are reserved for issuance under the plans. Ordinary shares underlying any
options which are canceled or not exercised become available for future grants.
The plans will terminate in 2004 and 2008, unless previously terminated by the
Board of Directors.
The plans are currently administered by our Board of Directors, which in
the future may delegate such administration to a committee of directors. The
Board or such committee has the authority to determine the persons to whom
options will be granted, the number of ordinary shares to be covered by each
option, the time or times at which options will be granted or exercised, and the
other terms and provisions of the options. The exercise price of an ISO granted
under the plans may not be less than 100% (110% in the case of a 10%
shareholder) and the exercise price of a non-qualified option may not be less
than 75% of the fair market value (as defined in the plan) of our ordinary
shares on the date of the grant.
It is intended that each option granted under the plans will be exercisable
in installments during the option term and shall not be transferable by the
optionee other than by will or by the laws of descent and distribution. Options
granted under the plans will terminate at such time (not to exceed ten years
from the date of grant) and under such circumstances as the Board or Option
Committee determines, generally not later than three months after a termination
of employment, or one year in the event of termination by reason of the
optionee's death or disability.
No options were granted under the 1994 Plan in 2002, and 225,000 ordinary
shares remained available for future grant under the 1994 Plan at December 31,
2002.
Options for 61,894 ordinary shares having exercise prices ranging from
$0.024 to $1.8 per share were granted under the 1998 Plan in 2002 and at
December 31, 2002 options for 421,980 ordinary shares were available for future
grant under such plan.
Of the total 1,533,163 outstanding options under the 1994 and 1998 Plans,
172,916 options will expire in 2003, 54,800 options will expire in 2004, 267,596
options will expire in 2005 and the remaining 1,037,851 options will expire
thereafter.
42
A total of 187,272 ordinary shares were issued in 2002 upon exercise of
options previously granted under the Plans, and no options were exercised by our
officers and directors in 2002.
2001 Stock Option Plan
Our 2001 Employee Stock Option Plan, or the 2001 Plan, authorizes the grant
of options to purchase up to 1,000,000 ordinary shares. Employees, officers,
directors and consultants of our company and its subsidiaries are eligible to
participate in the 2001 Plan. Awards under the 2001 Plan may be granted in the
forms of incentive stock options as provided in Section 422 of the U.S. Internal
Revenue Code of 1986, as amended, non-qualified stock options, options granted
pursuant to Section 102 of the Israeli Tax Ordinance and options granted
pursuant to Section 3.9 of the Israeli Tax Ordinance. The 2001 Plan has a term
of ten (10) years and will terminate in 2011. No award of options may be made
after such date.
The plan is currently administered by our Board of Directors, which in the
future may delegate such administration to a committee of directors. Subject to
the provisions of the 2001 Plan and applicable law, the Board or the Committee
has the authority, to determine, among other things, to whom options may be
granted, the number of ordinary shares to which an option may relate, the
exercise price for each share, the vesting period of the option, and the terms,
conditions and restrictions thereof; to construe and interpret the Plans, to
prescribe, amend and rescind rules and regulations relating to such Plans; and
to make all other determinations deemed necessary or advisable for the
administration of the Plans.
The Board or such committee has the authority to determine the persons to
whom options will be granted, the number of ordinary shares to be covered by
each option, the time or times at which options will be granted or exercised,
and the other terms and provisions of the options. The exercise price of an ISO
granted under the plans may not be less than 100% (110% in the case of a 10%
shareholder) and the exercise price of a non-qualified option may not be less
than 100% of the fair market value (as defined in the plan) of our ordinary
shares on the date of the grant.
As of June 1, 2003, options to purchase 71,000 ordinary shares had been
granted under the 2001 Plan, at exercise prices of $0.82 - $1.15 per share.
In 2002, 440,000 new options were approved for grant to our officers and
directors, of which 40,000 options were actually granted.
The 71,000 outstanding options under the 2001 Plan will expire after 2005.
As of June 1, 2003, our executive officers and directors as a group,
consisting of 8 persons, held options to purchase 256,499 ordinary shares, at an
average exercise price of $3.30 per share.
We intend to amend our stock option plans to conform to the recent tax
reform in Israel for the benefit of our Israeli employees and officers. This
amendment will require approval of both our Board of Directors and shareholders.
43
ITEM 7. MAJOR SHAREHOLDERS AND RELATED PARTY TRANSACTIONS
-------------------------------------------------
A. MAJOR SHAREHOLDERS
The following table sets forth certain information as of June 23, 2003
regarding the beneficial ownership by all shareholders known to us to own
beneficially more than 5% of our ordinary shares:
Number of Ordinary Percentage of
Shares Outstanding
Beneficially Owned (1) Ordinary Shares (2)
---------------------- -------------------
Arie Gonen..................................... 1,250,000 8.5 %
Dov Biran...................................... 863,720 (3)(12) 6.1
Special Situations Fund III, L.P.*............. 3,538,200 (4)(5)(12) 21.2
Special Situations Private Equity Fund, L.P.* 1,830,100 (6)(7)(12) 11.7
Special Situations Technology Fund, L.P.*...... 912,900 (8)(9)(12) 6.0
Special Situations Cayman Fund, L. P.*......... 761,900 (10)(11)(12) 5.0
Total.......................................... 9,186,820 (13) 50.2 %
- -------------
(1) Beneficial ownership is determined in accordance with the rules of the
Securities and Exchange Commission and generally includes voting or
investment power with respect to securities. Ordinary shares relating to
options currently exercisable or exercisable within 60 days of June 23,
2003 are deemed outstanding for computing the percentage of the person
holding such securities but are not deemed outstanding for computing the
percentage of any other person. Except as indicated by footnote, and
subject to community property laws where applicable, the persons named in
the table above have sole voting and investment power with respect to all
shares shown as beneficially owned by them.
(2) The percentages shown are based on 14,767,432 shares issued and outstanding
as of June 23, 2003.
(3) Includes 230,000 ordinary shares subject to the agreement dated June 20,
2001 between us and the former shareholders of Bridges for Islands.
(4) Includes 1,326,825 ordinary shares currently issuable upon exercise of
Series A Warrants exercisable at $1.75 per share.
(5) Includes 442,275 ordinary shares currently issuable upon exercise of Series
B Warrants exercisable at $2.25 per share.
(6) Includes 692,250 ordinary shares currently issuable upon exercise of Series
A Warrants exercisable at $1.75 per share.
(7) Includes 230,750 ordinary shares currently issuable upon exercise of Series
B Warrants exercisable at $2.25 per share.
(8) Includes 346,125 ordinary shares currently issuable upon exercise of Series
A Warrants exercisable at $1.75 per share.
(9) Includes 115,375 ordinary shares currently issuable upon exercise of Series
B Warrants
44
exercisable at $2.25 per share.
(10) Includes 288,450 ordinary shares currently issuable upon exercise of Series
A Warrants exercisable at $1.75 per share.
(11) Includes 96,150 ordinary shares currently issuable upon exercise of Series
B Warrants exercisable at $2.25 per share.
(12) Based on the Form 4 filed by Special Situations Fund III, L.P., Special
Situations Private Equity Fund, L.P., Special Situations Technology Fund,
L.P. and Special Situations Cayman Fund L.P. with the Securities and
Exchange Commission on May 7, 2003.
(13) See footnotes 3-12.
* MGP Advisors Limited is the general partner of Special Situations Fund III,
L.P. AWM Investment Company, Inc. is the general partner of MGP Advisors Limited
and the general partner of and investment adviser to Special Situations Cayman
Fund, L.P. SST Advisers, L.L.C. is the general partner of and investment adviser
to Special Situations Technology Fund, L.P. MG Advisers, L.L.C. is the general
partner of and investment adviser to Special Situations Private Equity Fund,
L.P. Austin W. Marxe and David M. Greenhouse are the principal owners of MGP
Advisers Limited, AWM Investment Company, Inc., SST Advisers, L.L.C. and MG
Advisers, L.L.C. and are principally responsible for the selection, acquisition
and disposition of the portfolio securities by each investment adviser on behalf
of its fund.
At June 23, 2003, there were 65 holders of record holders of our ordinary
shares, of which 44 record holders holding approximately 67.684% of our ordinary
shares had registered addresses in the United States. On October 30, 2002 we had
approximately 1,266 beneficial holders of our ordinary shares, we do not believe
this number has materially changed.
B. RELATED PARTY TRANSACTIONS
In February 2000, we acquired Bridges for Islands Ltd., an Israeli
corporation which was then developing Attunity BPITM, a business process
integration solution, in consideration of $18 million, of which $4 million was
paid in cash and the remaining balance by the issuance of 875,000 ordinary
shares and options of our company. We entered into a share price protection
guarantee with the shareholders of Bridges for Islands, based on an issuance
price of $16 per share, for a one-year period. In June 2001 we entered into an
agreement with Bridges for Islands Ltd., Dr. Dov Biran, at that time our chief
technology officer and a director, Dr. Dov Biran Holdings Ltd., a company
controlled by Dr. Dov Biran, and Poalim Capital Markets and Investments Ltd.,
which provided that, instead of the price protection, we would issue or
transfer, or cause third parties to transfer, an additional 350,000 ordinary
shares to the former shareholders of Bridges for Islands. The shareholders of
Medatech Information Technology Ltd., and VisOpt B.V. transferred 300,000 of
these 350,000 ordinary shares to the former shareholders of Bridges for Islands
and we issued 50,000 ordinary shares to these persons. On November 28, 2001, we
filed an F-3 Registration Statement with respect to these shares with the SEC.
As additional consideration to the former shareholders of Bridges for Islands,
we agreed that in the event of a merger, consolidation or other business
combination in which we are not the surviving entity, or in an acquisition of
all or substantially all of our outstanding share capital or assets, that they
will receive $11,962,400 for their 1,097,650 ordinary shares. We agreed to
provide these shareholders with either cash
45
or additional ordinary shares of our company in order to insure that they will
receive $11,962,400 for their 1,097,650 ordinary shares.
C. INTERESTS OF EXPERTS AND COUNSEL
Not applicable.
ITEM 8. FINANCIAL INFORMATION
---------------------
A. CONSOLIDATED STATEMENTS AND OTHER FINANCIAL INFORMATION
See the consolidated financial statements, including the notes thereto, and
the exhibits listed in Item 19 hereof and incorporated herein by this reference.
Legal Proceedings
In September 2002 an action was filed by Special Situations Fund III L.P.,
Special Situations Cayman Fund, L.P., Special Situations Private Equity Fund,
L.P. and Special Situations Technology Fund, L.P., major investors in the
company, seeking approximately $600,000 in damages under a breach of contract
claim. On March 28, 2003, a jury in New York entered a verdict against us,
awarding the plaintiffs damages in the amount of approximately $603,000, plus
interest and costs, $810,000 as of December 2002. On April 29, 2003 we appealed
the decision to the Supreme Court of New York, Appellate Division, First
Department. On May 13, 2003 we posted a bond in the full amount of the judgment.
There can be no assurance that we will be successful in our appeal.
Dividend Distribution
We have never paid and do not intend to pay cash dividends on our ordinary
shares in the foreseeable future. Our earnings and other cash resources will be
used to continue the development and expansion of our business. Any future
dividend policy will be determined by our Board of Directors and will be based
upon conditions then existing, including our results of operations, financial
condition, current and anticipated cash needs, contractual restrictions and
other conditions. Under Israeli law, the declaration of any final dividends also
requires shareholder approval, which may reduce but not increase such dividends
from the amount recommended by the Board of Directors.
46
B. SIGNIFICANT CHANGES
Since the date of the annual consolidated financial statements included in
this annual report, no significant change has occurred.
ITEM 9. THE OFFER AND LISTING
---------------------
A. OFFER AND LISTING DETAILS
Annual Stock Information
The following table sets forth, for each of the years indicated, the
range of high ask and low bid prices of our ordinary shares on the Nasdaq
National Market:
High Low
---- ---
1998................................. $15.375 $6.125
1999................................. 16.375 6.75
2000................................. 37.50 3.3125
2001................................. 5.50 0.75
2002................................. 2.12 0.50
Quarterly Stock Information
The following table sets forth, for each of the full financial quarters in
the years indicated, the range of high ask and low bid prices of our ordinary
shares on the Nasdaq National Market:
High Low
---- ---
2001
- ----
First Quarter......................... $5.50 $1.125
Second Quarter........................ 2.60 0.825
Third Quarter......................... 2.80 0.96
Fourth Quarter........................ 2.15 1.05
2002
- ----
First Quarter......................... $1.55 $0.72
Second Quarter........................ 1.94 0.90
Third Quarter......................... 2.12 0.90
Fourth Quarter........................ 1.34 0.50
Monthly Stock Information
The following table sets forth, for each month in the last six months of
2002, the range of high ask and low bid prices of our ordinary shares on the
Nasdaq National Market:
47
High Low
---- ---
July................................. $2.12 $1.06
August............................... 1.45 0.90
September............................ 1.40 0.91
October.............................. 1.34 0.50
November............................. 1.29 0.92
December............................. 1.21 0.65
B. PLAN OF DISTRIBUTION
Not applicable.
C. MARKETS
Our ordinary shares have traded on the Nasdaq National Market since our
initial public offering on December 17, 1992. On October 27, 2000, our name was
changed to Attunity Ltd and our Nasdaq symbol changed to ATTU.
D. SELLING SHAREHOLDERS
Not applicable.
E. DILUTION
Not applicable.
F. EXPENSE OF THE ISSUE
Not applicable.
ITEM 10. ADDITIONAL INFORMATION
-----------------------
A. SHARE CAPITAL
Not applicable.
B. MEMORANDUM AND ARTICLES OF ASSOCIATION
Purposes and Objects of the Company
We are a public company registered under the Israel Companies Law as
Attunity Ltd, registration number 52-003801-9. Our objects and purposes, as
provided by Article 5A of our articles of association, are to carry on any
lawful activity.
The Powers of the Directors
Under the provisions of the Israel Companies Law and our articles of
association, a director cannot participate in a meeting nor vote on a proposal,
arrangement or contract in which he or she is personally interested. In
addition, our directors cannot vote compensation to themselves or any members of
their body without the approval of our audit committee and our shareholders at a
general meeting. See "Item 6B. Directors, Senior Management and Employees -
Compensation."
48
The authority of our directors to enter into borrowing arrangements on our
behalf is not limited, except in the same manner as any other transaction by us.
Under our articles of association, retirement of directors from office is
not subject to any age limitation and our directors are not required to own
shares in our company in order to qualify to serve as directors.
Rights Attached to Shares
Our authorized share capital consists of 30,000,000 ordinary shares of a
nominal value of NIS 0.1 each. All outstanding ordinary shares are validly
issued, fully paid and non-assessable.
Ordinary shares. The rights attached to the ordinary shares are as follows:
Dividend rights. Subject to any preferential, deferred, qualified or other
rights, privileges or conditions attached to any special class of shares with
regard to dividends, the profits of the company available for dividend and
resolved to be distributed shall be applied in payment of dividends upon the
shares of the company in proportion to the amount paid up or credited as paid up
per the nominal value thereon respectively. Unless not otherwise specified in
the conditions of issuance of the shares, all dividends with respect to shares
which were not fully paid up within a certain period, for which dividends were
paid, shall be paid proportionally to the amounts paid or credited as paid on
the nominal value of the shares during any portion of the abovementioned period.
The board of directors may declare interim dividends and propose the final
dividend with respect to any fiscal year only out of profits legally available
for distribution, in accordance with the provisions of the Israeli Companies
Law. See "Item 8A. Financial Information - Consolidated and Other Financial
Information - Dividend Distribution." If after one year a dividend has been
declared and it is still unclaimed, the board of directors is entitled to invest
or utilize the unclaimed amount of dividend in any manner to our benefit until
it is claimed. We are not obligated to pay interest or linkage differentials on
an unclaimed dividend.
Voting rights. Holders of ordinary shares have one vote for each ordinary
share held on all matters submitted to a vote of shareholders. Such voting
rights may be affected by the grant of any special voting rights to the holders
of a class of shares with preferential rights that may be authorized in the
future.
The quorum required at any meeting of shareholders consists of at least two
shareholders present in person or represented by proxy who hold or represent, in
the aggregate, at least one-third (33%) of the voting rights in the company. A
meeting adjourned for lack of a quorum generally is adjourned to the same day in
the following week at the same time and place or any time and place as the
directors designate in a notice to the shareholders. At the reconvened meeting,
the required quorum consists of any two members present in person or by proxy.
Under our articles of association, all resolutions require approval of no
less than a majority of the voting rights represented at the meeting in person
or by proxy and voting thereon.
Pursuant to our articles of association, our directors (except outside
directors) are elected at our annual general meeting of shareholders by a vote
of the holders of a majority of
49
the voting power represented and voting at such meeting. See "Item 6A.
Directors, Senior Management and Employees - Election of Directors."
Rights to share in profits. Our shareholders have the right to share in our
profits distributed as a dividend and any other permitted distribution. See
"Item 10B. Rights Attached to Shares - Dividend Rights."
Rights to share in surplus in the event of liquidation. In the event of our
liquidation, after satisfaction of liabilities to creditors, our assets will be
distributed to the holders of ordinary shares in proportion to the nominal value
of their holdings. This right may be affected by the grant of preferential
dividend or distribution rights to the holders of a class of shares with
preferential rights that may be authorized in the future.
Liability to capital calls by the company. Under our memorandum of
association and the Companies Law, the liability of our shareholders is limited
to the unpaid amount of the par value of the shares held by them.
Limitations on any existing or prospective major shareholder. See "Item 6A.
Directors and Senior Management - Approval of Related Party Transactions Under
Israeli Law."
Changing Rights Attached to Shares
The rights attached to any class of shares (unless otherwise provided by
the terms of issuance of the shares of that class) may be varied with the
consent in writing of the holders of all the issued shares of that class, or
with the sanction of a vote at a meeting of the shareholders passed at a
separate meeting of the holders of the shares of the class by a majority of the
voting rights of such class represented at the meeting in person or by proxy and
voting thereon.
Unless otherwise provided by the conditions of issuance, the enlargement of
an existing class of shares, or the issuance of additional shares thereof, shall
not be deemed to modify or abrogate the rights attached to the previously issued
shares of such class or of any other class.
Annual and Extraordinary Meetings
The Board of Directors must convene an annual meeting of shareholders at
least once every calendar year, within fifteen months of the last annual
meeting. Unless a longer period for notice is prescribed by the Companies Law,
at least ten (10) days and not more than sixty (60) days notice of any general
meeting of shareholders shall be given. An extraordinary meeting may be convened
by the board of directors, as it decides or upon a demand of any two directors
or 25% of the directors, whichever is lower, or of one or more shareholders
holding in the aggregate at least 5% of the shares and 1% of the voting rights,
or one or more shareholders holding in the aggregate at least 5% of the voting
rights in the company. An extraordinary meeting must be held not more than
thirty-five days from the publication date of the announcement of the meeting.
See "Item 10B. Rights Attached to Shares-Voting Rights."
50
Limitations on the Rights to Own Securities in Our Company
Neither our memorandum of association or our articles of association nor
the laws of the State of Israel restrict in any way the ownership or voting of
shares by non-residents, except with respect to subjects of countries which are
in a state of war with Israel.
Provisions Restricting Change in Control of Our Company
The Companies Law requires that mergers between Israeli companies be
approved by the board of directors and general meeting of shareholders of both
parties to the transaction. The approval of the board of directors of both
companies is subject to such boards' confirmations that there is no reasonable
doubt that after the merger the surviving company will be able to fulfill its
obligations towards its creditors. Each company must notify its creditors about
the contemplated merger. The approval of a merger by the general meetings of
shareholders of the companies is also subject to additional approval
requirements as specified in the Companies Law and regulations promulgated
thereunder. See also "Item 6A. Directors, Senior Management and Employees -
Directors and Senior Management - Approval of Related Party Transactions Under
Israeli Law."
Disclosure of Shareholders Ownership
The Israeli Securities Law and regulations promulgated thereunder do not
require a company whose shares are publicly traded solely on a stock exchange
outside of Israel, as in the case of our company, to disclose its share
ownership.
Changes in Our Capital
Changes in our capital are subject to the approval of the shareholders by a
majority of the votes of shareholders present by person or by proxy and voting
in the shareholders meeting.
C. MATERIAL CONTRACTS
In February 2000, we acquired Bridges for Islands Ltd., an Israeli
corporation which was then developing Attunity BPITM, a business process
integration solution, in consideration of $18 million, of which we paid $4
million in cash and the balance by the issuance of 875,000 our ordinary shares
and options. As part of the agreement, we provided the shareholders of Bridges
for Islands with a share price protection guarantee, based on an issuance price
of $16 per share, for a one-year period. This agreement was amended in June 2001
to provide that, instead of the price protection, we would issue, or transfer,
or cause third parties to transfer, an additional 350,000 ordinary shares to the
former shareholders of Bridges for Islands. The shareholders of Medatech
Information Technology Ltd., and VisOpt B.V. transferred 300,000 of these
350,000 ordinary shares to the former shareholders of Bridges for Islands and we
issued an additional 50,000 ordinary shares. On November 28, 2001, we filed an
F-3 Registration Statement with respect to these shares with the SEC. As
additional consideration to the former shareholders of Bridges for Islands, we
agreed that in the event of a merger, consolidation or other business
combination in which we are not the surviving entity, or in an acquisition of
all or substantially all of our outstanding share capital or assets that they
will receive $11,962,400 for their 1,097,650 ordinary shares. We agreed to
provide these shareholders with either cash or additional ordinary shares of our
company in order to insure that they will receive $11,962,400 for their 1,097,
650 ordinary shares.
51
D. EXCHANGE CONTROLS
Israeli law and regulations do not impose any material foreign exchange
restrictions on non-Israeli holders of our ordinary shares. In May 1998, a new
"general permit" was issued under the Israeli Currency Control Law, 1978, which
removed most of the restrictions that previously existed under such law, and
enabled Israeli citizens to freely invest outside of Israel and freely convert
Israeli currency into non-Israeli currencies.
Non-residents of Israel who purchase our ordinary shares will be able to
convert dividends, if any, thereon, and any amounts payable upon our
dissolution, liquidation or winding up, as well as the proceeds of any sale in
Israel of our ordinary shares to an Israeli resident, into freely repatriable
dollars, at the exchange rate prevailing at the time of conversion, provided
that the Israeli income tax has been withheld (or paid) with respect to such
amounts or an exemption has been obtained.
E. TAXATION
The following is a summary of the current tax structure applicable to
companies in Israel, with special reference to its effect on us and our
shareholders. To the extent that the discussion is based on new tax legislation
that has not been subject to judicial or administrative interpretation, we
cannot assure you that the tax authorities will accept the views expressed in
the discussion in question. The discussion is not intended, and should not be
taken, as legal or professional tax advice and is not exhaustive of all possible
tax considerations.
Recent Tax Reform
On January 1, 2003, the Law for Amendment of the Income Tax Ordinance
(Amendment No.132), 5762-2002, known as the Tax Reform, came into effect,
following its enactment by the Israeli Parliament on July 24, 2002. On December
17, 2002, the Israeli Parliament approved a number of amendments to the tax
reform, which came into effect on January 1, 2003.
The tax reform, aimed at broadening the categories of taxable income and
reducing the tax rates imposed on employment income, introduced the following,
among other things:
o Reduction of the tax rate levied on capital gains (other than gains
deriving from the sale of listed securities) derived after January 1,
2003, to a general rate of 25% for both individuals and corporations.
Regarding assets acquired prior to January 1, 2003, the reduced tax
rate will apply to a proportionate part of the gain, in accordance
with the holding periods of the asset, before or after January 1,
2003, on a linear basis;
o Imposition of Israeli tax on all income of Israeli residents,
individuals and corporations, regardless of the territorial source of
income, including income derived from passive sources such as
interest, dividends and royalties;
o Introduction of controlled foreign corporation (CFC) rules into the
Israeli tax structure. Generally, under such rules, an Israeli
resident who holds, directly of indirectly, 10% or more of the rights
in a foreign corporation whose shares are not publicly traded, in
which more than 50% of the rights are held directly or indirectly by
52
Israeli residents, and a majority of whose income in a tax year is
considered passive income, will be liable for tax on the portion of
such income attributed to his holdings in such corporation, as if such
income were distributed to him as a dividend; and
o Imposition of capital gains tax on capital gains realized by
individuals as of January 1, 2003, from the sale of shares of publicly
traded companies (such gain was previously exempt from capital gains
tax in Israel). For information with respect to the applicability of
Israeli capital gains taxes on the sale of ordinary shares. See,
"Capital Gains Tax " below.
o Introduction of a new regime for the taxation of shares and options
issued to employees and officers (including directors). See, "Stock
Option Plans" in Item 6E. above.
General Corporate Tax Structure
Israeli companies are subject to "Company Tax" at the rate of 36% of
taxable income. However, the effective tax rate payable by a company that
derives income from an approved enterprise (as further discussed below) may be
considerably less. Subject to relevant tax treaties, dividends or interest
received by an Israeli corporation from foreign subsidiaries are generally
subject to tax regardless of its status as an Approved Enterprise.
Tax Benefits Under the Law for the Encouragement of Capital Investments, 1959
The Law for the Encouragement of Capital Investments, 1959, as amended,
commonly referred to as the Investment Law, provides that a proposed capital
investment in eligible facilities may, upon application to the Investment Center
of the Ministry of Industry and Trade of the State of Israel, be designated as
an approved enterprise. Each certificate of approval for an approved enterprise
relates to a specific investment program delineated both by its financial scope,
including its capital sources, and by its physical characteristics, e.g., the
equipment to be purchased and utilized pursuant to the program. An approved
enterprise is entitled to benefits including Israeli Government cash grants and
tax benefits in specified development areas. The tax benefits derived from any
such certificate of approval relate only to taxable income attributable to the
specific approved enterprise. If a company has more than one approval or only a
portion of its capital investments is approved, its effective tax rate is the
result of a weighted average of the applicable rates.
Taxable income of a company derived from an approved enterprise is subject
to Company Tax at the maximum rate of 25% (rather than 36%) for the benefit
period. This period is ordinarily seven years (or ten years if the company
qualifies as a foreign investors' company as described below) commencing with
the year in which the approved enterprise first generates taxable income, and is
limited to twelve years from commencement of production or fourteen years from
the date of approval, whichever is earlier. The Investment Law also provides
that a company that has an approved enterprise within Israel will be eligible
for a reduced tax rate for the remainder of the benefit period and is entitled
to claim accelerated depreciation on buildings, machinery and equipment used by
the approved enterprise.
A company owning an approved enterprise may elect to forego entitlement to
the grants otherwise available under the Investment Law and in lieu thereof
participate in an alternative package of benefits. Under the alternative package
of benefits, a company's
53
undistributed income derived from an approved enterprise will be exempt from
company tax for a period of between two and ten years from the first year of
taxable income, depending on the geographic location of the approved enterprise
within Israel, and such company will be eligible for a reduced tax rate for the
remainder, if any, of the otherwise applicable benefits period.
A company that has an approved enterprise program is eligible for further
tax benefits if it qualifies as a foreign investors' company. A foreign
investors' company is essentially a company more than 25% of whose share capital
and combined share and loan capital is owned by non-Israeli residents. A company
which qualifies as a foreign investors' company and has an approved enterprise
program is eligible for tax benefits for a ten year benefit period. Income
derived from the approved enterprise program will be exempt from tax for a
period of two years and will be subject to a reduced tax rate for an additional
eight years, provided that the company qualifies as a foreign investors' company
as follows:
The Company Tax
For a company with foreign investment of.... rate is
-------------------------------------------- -------
over 25% but less than 49%.................. 25%
49% or more but less than 74%............... 20%
74% or more but less than 90%............... 15%
90% or more................................. 10%
In addition, the dividend recipient is taxed at the reduced rate applicable
to dividends from approved enterprises (15%), if the dividend is distributed
during the tax benefit period or within twelve years thereafter. The company
must withhold this tax at source, regardless of whether the dividend is
converted into foreign currency.
Subject to applicable provisions concerning income under the alternative
package of benefits, all dividends are considered to be attributable to the
entire enterprise and their effective tax rate is the result of a weighted
average of the various applicable tax rates. We currently intend to reinvest any
income derived from our approved enterprise programs and not to distribute such
income as a dividend.
The Investment Center bases its decision as to whether or not to approve an
application on the criteria set forth in the Investment Law and regulations, the
then prevailing policy of the Investment Center and the specific objectives and
financial criteria of the applicant. Accordingly, we cannot assure you that any
of our applications, if made, will be approved in the future.
Our production facilities and those of our subsidiary ASS have been granted
"Approved Enterprise" status under the Investment Law.
In June 2000, we filed an application for a fourth investment program which
has not been approved, and the other three investment programs, which were
approved in February 1993, November 1993 and February 1998, will expire in
February 2005, October 2009 and February 2010, respectively. As of December 31,
2002, the investments under the June 2000 investment program remain in progress
and have not been completed.
According to the provisions of the Investment Law, we have elected to enjoy
"alternative benefits" - waiver of grants in return for tax exemption - and,
accordingly, income derived from the "Approved Enterprise" will be tax-exempt
for a period of two years commencing with the year we first earn taxable income,
and will be taxed at 10% to 25%,
54
based upon the percentage of our foreign investment in, for an additional period
of five-eight years. The period of tax benefits, detailed above, is subject to
limits of the earlier of twelve years from the commencement of production, or
fourteen years from the date of approval.
ASS has been granted status as an "Approved Enterprise" for two separate
investment programs from 1991 and 1993 whereby it has elected to receive
government grants and to enjoy the benefit of a reduced tax rate of 25% during a
period of seven years commencing with the year it first earns taxable income.
The period of tax benefits, detailed above, is subject to limits of the earlier
of twelve years from the commencement of production, or fourteen years from the
date of approval. In 1993, ASS received approval for an expansion of the
aforementioned programs whereby it has elected to enjoy "alternative benefits" -
and, accordingly, its income from the "Approved Enterprise" will be tax-exempt
for a period of ten years commencing with the year it first earns taxable
income. As of December 31, 2002, ASS has not received final approvals for such
programs.
If these retained tax-exempt profits are distributed in a manner other than
in our complete liquidation they would be taxed at the corporate tax rate
applicable to such profits as if the Company had not elected the alternative
system of benefits, currently between 15%-20% for an "Approved Enterprise." As
of December 31, 2002, our accumulated deficit does not include tax-exempt
profits earned by our and ASS's "Approved Enterprises."
Since we currently have no taxable income, the benefits have not yet
commenced for all programs. Should we or ASS derive income from sources other
than the "Approved Enterprise" during the periods of benefits, such income shall
be taxable at the regular corporate tax rate of 36%.
The tax benefits discussed above are conditioned upon fulfillment of the
requirements stipulated by the aforementioned law and the regulations
promulgated thereunder, as well as the criteria set forth in the certificates of
approval. In the event that we fail to comply with these conditions, the tax
benefits could be canceled, in whole or in part, and we would be required to
refund the amount of the canceled benefits, plus interest and certain inflation
adjustments. We believe that we have been in full compliance with the
aforementioned conditions through December 31, 2002.
The Investment Law has been extended until December 31, 2003 and there is
no assurance that it will be further extended. Failure to extend the law will
result in a significant increase in our effective corporate tax rate.
Tax Benefits Under the Law for the Encouragement of Industry (Taxes), 1969
According to the Law for the Encouragement of Industry (Taxes), 1969, or
the Industry Encouragement Law, an Industrial Company is a company resident in
Israel, at least 90% of the income of which, in a given tax year, determined in
Israeli currency (exclusive of income from some government loans, capital gains,
interest and dividends), is derived from an Industrial Enterprise owned by it.
An "Industrial Enterprise" is defined as an enterprise whose major activity in a
given tax year is industrial production activity.
Under the Industry Encouragement Law, Industrial Companies are entitled to
the following preferred corporate tax benefits:
55
o amortization of purchases of know-how and patents over an eight-year
period for tax purposes;
o the right to elect, under specified conditions, to file a consolidated
tax return with additional related Israeli Industrial Companies; and
o accelerated depreciation rates on equipment and buildings.
Eligibility for benefits under the Industry Encouragement Law is not
subject to receipt of prior approval from any governmental authority.
We cannot assure you that we will continue to qualify as an Industrial
Company or that the benefits described above will be available to us in the
future.
Taxation Under Inflationary Conditions
The Income Tax Law (Inflationary Adjustments), 1985, generally referred to
as the Inflationary Adjustments Law, represents an attempt to overcome the
problems presented to a traditional tax system by an economy undergoing rapid
inflation. The Inflationary Adjustments Law is highly complex. Its features
which may be material to us can be summarized as follows:
There is a special tax adjustment for the preservation of equity whereby
some corporate assets are classified broadly into fixed assets and non-fixed
assets. Where a company's equity, as defined in such law, exceeds the
depreciated cost of fixed assets, a deduction from taxable income that takes
into account the effect of the applicable annual rate of inflation on such
excess is allowed up to a ceiling of 70% of taxable income in any single tax
year, with the unused portion permitted to be carried forward on a linked basis.
If the depreciated cost of fixed assets exceeds a company's equity, then such
excess multiplied by the applicable annual rate of inflation is added to taxable
income.
o Subject to specific limitations, depreciation deductions on fixed
assets and losses carried forward are adjusted for inflation based on
the increase in the consumer price index.
o Capital gains on specific traded securities are normally exempt from
tax for individuals and are taxable for companies. However, dealers in
securities are subject to the regular tax rules applicable to business
income in Israel.
Capital Gains Tax
Israeli law imposes a capital gains tax on the sale of capital assets. The
law distinguishes between real gain and inflationary surplus. The inflationary
surplus is a portion of the total capital gain that is equivalent to the
increase of the relevant asset's purchase price which is attributable to the
increase in the Israeli consumer price index between the date of purchase and
the date of sale. The real gain is the excess of the total capital gain over the
inflationary surplus.
Prior to the tax reform, sales of our ordinary shares by individuals were
generally exempt from Israeli capital gains tax for so long as they were quoted
on Nasdaq or listed on a
56
stock exchange in a country appearing in a list approved by the Controller of
Foreign Currency and we qualified as an Industrial Company or an Industrial
Holding Company.
Pursuant to the tax reform, generally, capital gains tax is imposed at a
rate of 15% on real gains derived on or after January 1, 2003, from the sale of
shares in companies (i) publicly traded on the Tel Aviv Stock Exchange ("TASE")
or; (ii) (subject to a necessary determination by the Israeli Minister of
Finance) Israeli companies publicly traded on a recognized stock exchange
outside of Israel (such as Nasdaq).
This tax rate does not apply to: (i) dealers in securities; (ii)
shareholders that report in accordance with certain provisions of the
Inflationary Adjustment Law; or (iii) shareholders who acquired their shares
prior to an initial public offering (that are subject to a different tax
arrangement).
The tax basis of shares acquired prior to January 1, 2003 will be
determined in accordance with the average closing share price in the three
trading days preceding January 1, 2003. However, a request may be made to the
tax authorities to consider the actual adjusted cost of the shares as the tax
basis if it is higher than such average price.
Non-Israeli residents are exempt from Israeli capital gains tax on any
gains derived from the sale of shares publicly traded on the TASE, and are
exempt from Israeli capital gains tax on any gains derived from the sale of
shares of Israeli companies publicly traded on a recognized stock exchange
outside of Israel (including Nasdaq), provided however that such capital gains
are not derived from a permanent establishment of such shareholders in Israel
and provided that such shareholders did not acquire their shares prior to an
initial public offering.
However, non-Israeli corporations will not be entitled to such exemption if
an Israeli resident (i) has a controlling interest of 25% or more in such
non-Israeli corporation, or (ii) is the beneficiary or is entitled to 25% or
more of the revenues or profits of such non-Israeli corporation, whether
directly or indirectly.
In any event, the provisions of the tax reform shall not effect the
exemption from capital gains tax for gains accrued before January 1, 2003, as
described above.
In certain instances where our shareholders may be liable to Israeli tax on
the sale of their ordinary shares, the payment of the consideration may be
subject to the withholding of Israeli tax at the source.
Pursuant to the Convention between the Government of the United States of
America and the Government of Israel with respect to Taxes on Income, as
amended, the sale, exchange or disposition of ordinary shares by a person who
qualifies as a resident of the United States within the meaning of the U.S.-
Israel Tax Treaty and who is entitled to claim the benefits afforded to such
person by the U.S.-Israel Tax Treaty generally will not be subject to the
Israeli capital gains tax unless such Treaty U.S. Resident holds, directly or
indirectly, shares representing 10% or more of our voting power during any part
of the 12-month period preceding such sale, exchange or disposition, subject to
particular conditions. A sale, exchange or disposition of ordinary shares by a
Treaty U.S. Resident who holds, directly or indirectly, shares representing 10%
or more of our voting power at any time during such preceding 12-month period
would be subject to such Israeli tax, to the extent applicable; however, under
the U.S.-Israel Tax Treaty, such Treaty U.S. Resident would be permitted to
57
claim a credit for such taxes against the U.S. federal income tax imposed with
respect to such sale, exchange or disposition, subject to the limitations in
U.S. laws applicable to foreign tax credits. The U.S.-Israel Tax Treaty does not
relate to U.S. state or local taxes.
Taxation of Non-Residents
Non-residents of Israel are subject to income tax on income accrued or
derived from sources in Israel. Such sources of income include passive income
such as dividends, royalties and interest, as well as non-passive income from
services rendered in Israel. On distributions of dividends other than bonus
shares or stock dividends, income tax at the rate of 25% (12.5% for dividends
not generated by an approved enterprise if the non-resident is a U.S.
corporation and holds over 10% of our voting power, and 15% for dividends
generated by an approved enterprise) is withheld at source, unless a different
rate is provided in a treaty between Israel and the shareholder's country of
residence. Under the U.S.-Israel Tax Treaty, the maximum tax on dividends paid
to a holder of ordinary shares who is a Treaty U.S. Resident will be 25%.
However, under the Investment Law, dividends generated by an approved enterprise
are taxed at the rate of 15%.
Under an amendment to the Inflationary Adjustments Law, non-Israeli
entities might be subject to Israeli taxes on the sale of traded securities in
an Israeli company, subject to the provisions of any applicable double taxation
treaty.
Tax Benefits and Government Support for Research and Development
Israeli tax law allows, under specific conditions, a tax deduction in the
year incurred for expenditures, including capital expenditures, relating to
scientific research and development projects, if the expenditures are approved
by the relevant Israeli Government ministry, determined by the field of
research, and the research and development is for the promotion of the company
and is carried out by or on behalf of the company seeking such deduction.
Expenditures not so approved are deductible over a three-year period. However,
expenditures from proceeds made available to us through government grants are
not deductible according to Israeli law.
United States Federal Income Tax Consequences
The following is a summary of certain material U.S. federal income tax
consequences that apply to U.S. Holders who hold ordinary shares as capital
assets. This summary is based on the United States Internal Revenue Code of
1986, as amended (the "Code"), Treasury regulations promulgated thereunder,
judicial and administrative interpretations thereof, and the U.S.-Israel Tax
Treaty, all as in effect on the date hereof and all of which are subject to
change either prospectively or retroactively. This summary does not address all
tax considerations that may be relevant with respect to an investment in
ordinary shares. This summary does not account for the specific circumstances of
any particular investor, such as:
o broker-dealers;
o financial institutions;
o certain insurance companies;
o investors liable for alternative minimum tax;
58
o tax-exempt organizations;
o non-resident aliens of the U.S. or taxpayers whose functional currency
is not the U.S. dollar;
o persons who hold the ordinary shares through partnerships or other
pass-through entities;
o investors that actually or constructively own 10 percent or more of
our voting shares; and
o investors holding ordinary shares as part of a straddle or a hedging
or conversion transaction.
This summary does not address the effect of any U.S. federal taxation other
than U.S. federal income taxation. In addition, this summary does not include
any discussion of state, local or foreign taxation.
You are urged to consult your tax advisors regarding the foreign and United
States federal, state and local tax considerations of an investment in ordinary
shares.
For purposes of this summary, a U.S. Holder is:
o an individual who is a citizen or, for U.S. federal income tax
purposes, a resident of the United States;
o a partnership, corporation or other entity created or organized in or
under the laws of the United States or any political subdivision
thereof;
o an estate whose income is subject to U.S. federal income tax
regardless of its source; or
o a trust that (a) is subject to the primary supervision of a court
within the United States and the control of one or more U.S. persons
or (b) has a valid election in effect under applicable U.S. Treasury
regulations to be treated as a U.S. person.
Taxation of Dividends
The gross amount of any distributions received with respect to ordinary
shares, including the amount of any Israeli taxes withheld therefrom, will
constitute dividends for U.S. federal income tax purposes, to the extent of our
current and accumulated earnings and profits as determined for U.S. federal
income tax principles. You will be required to include this amount of dividends
in gross income as ordinary income (see "-New Tax Law Applicable to Dividends
and Long-Term Capital Gain," below). Distributions in excess of our earnings and
profits will be treated as a non-taxable return of capital to the extent of your
tax basis in the ordinary shares and any amount in excess of your tax basis,
will be treated as gain from the sale of ordinary shares. See "Disposition of
Ordinary Shares" below for the discussion on the taxation of capital gains.
Dividends will not qualify for the dividends-received deduction generally
available to corporations under Section 243 of the Code.
59
Dividends that we pay in NIS, including the amount of any Israeli taxes
withheld therefrom, will be included in your income in a U.S. dollar amount
calculated by reference to the exchange rate in effect on the day such dividends
are received. A U.S. Holder who receives payment in NIS and converts NIS into
U.S. dollars at an exchange rate other than the rate in effect on such day may
have a foreign currency exchange gain or loss that would be treated as ordinary
income or loss. U.S. Holders should consult their own tax advisors concerning
the U.S. tax consequences of acquiring, holding and disposing of NIS.
Any Israeli withholding tax imposed on such dividends will be a foreign
income tax eligible for credit against a U.S. Holder's U.S. federal income tax
liability, subject to certain limitations set out in the Code (or,
alternatively, for deduction against income in determining such tax liability).
The limitations set out in the Code include computational rules under which
foreign tax credits allowable with respect to specific classes of income cannot
exceed the U.S. federal income taxes otherwise payable with respect to each such
class of income (see "-New Tax Law Applicable to Dividends and Long-Term Capital
Gain," below). Dividends generally will be treated as foreign-source passive
income or financial services income for United States foreign tax credit
purposes. Foreign income taxes exceeding the credit limitation for the year of
payment or accrual may be carried back for two taxable years and forward for
five taxable years in order to reduce U.S. federal income taxes, subject to the
credit limitation applicable in each of such years. Other restrictions on the
foreign tax credit include a prohibition on the use of the credit to reduce
liability for the U.S. individual and corporation alternative minimum taxes by
more than 90%. A U.S. Holder will be denied a foreign tax credit with respect to
Israeli income tax withheld from dividends received on the ordinary shares to
the extent such U.S. Holder has not held the ordinary shares for at least 16
days of the 30-day period beginning on the date which is 15 days before the
ex-dividend date or to the extent such U.S. Holder is under an obligation to
make related payments with respect to substantially similar or related property.
Any days during which a U.S. Holder has substantially diminished its risk of
loss on the ordinary shares are not counted toward meeting the 16-day holding
period required by the statute. The rules relating to the determination of the
foreign tax credit are complex, and you should consult with your personal tax
advisors to determine whether and to what extent you would be entitled to this
credit.
Disposition of Ordinary Shares
If you sell or otherwise dispose of ordinary shares, you will recognize
gain or loss for U.S. federal income tax purposes in an amount equal to the
difference between the amount realized on the sale or other disposition and the
adjusted tax basis in ordinary shares. Subject to the discussion below under the
heading "Passive Foreign Investment Companies," such gain or loss generally will
be capital gain or loss and will be long-term capital gain or loss if you have
held the ordinary shares for more than one year at the time of the sale or other
disposition. In general, any gain that you recognize on the sale or other
disposition of ordinary shares will be U.S.-source for purposes of the foreign
tax credit limitation; losses will generally be allocated against U.S. source
income. Deduction of capital losses is subject to certain limitations under the
Code.
In the case of a cash basis U.S. Holder who receives NIS in connection with
the sale or disposition of ordinary shares, the amount realized will be based on
the U.S. dollar value of the NIS received with respect to the ordinary shares as
determined on the settlement date of such exchange. A U.S. Holder who receives
payment in NIS and converts NIS into United States dollars at a conversion rate
other than the rate in effect on the settlement date may have a foreign currency
exchange gain or loss that would be treated as ordinary income or loss.
60
An accrual basis U.S. Holder may elect the same treatment required of cash
basis taxpayers with respect to a sale or disposition of ordinary shares,
provided that the election is applied consistently from year to year. Such
election may not be changed without the consent of the Internal Revenue Service
(the "IRS"). In the event that an accrual basis U.S. Holder does not elect to be
treated as a cash basis taxpayer (pursuant to the Treasury regulations
applicable to foreign currency transactions), such U.S. Holder may have a
foreign currency gain or loss for U.S. federal income tax purposes because of
differences between the U.S. dollar value of the currency received prevailing on
the trade date and the settlement date. Any such currency gain or loss would be
treated as ordinary income or loss and would be in addition to gain or loss, if
any, recognized by such U.S. Holder on the sale or disposition of such ordinary
shares.
New Tax Law Applicable to Dividends and Long-Term Capital Gain
Under recently enacted tax legislation, dividends received by individual
U.S. Holders from certain foreign corporations, and long-term capital gain
realized by individual U.S. Holders, generally are subject to a reduced maximum
tax rate of 15 percent through December 31, 2008. Dividends received with
respect to ordinary shares should qualify for the 15% percent rate. The reduced
rate on capital gains applies to sales and exchanges on or after May 6, 2003 and
the reduced rates on dividend income to dividends received after December 31,
2002. The rate reduction does not apply to dividends received in respect of
certain short-term or hedged positions in the common stock or in certain other
situations. The legislation contains special rules for computing the foreign tax
credit limitation of a taxpayer who receives dividends subject to the rate
reduction. U.S. Holders should consult their own tax advisors regarding the
implications of these rules in light of their particular circumstances.
Passive Foreign Investment Companies
For U.S. federal income tax purposes, we will be considered a passive
foreign investment company ("PFIC") for any taxable year in which either (i) 75%
or more of our gross income is passive income, or (ii) at least 50% of the
average value of all of our assets for the taxable year produce or are held for
the production of passive income. For this purpose, passive income includes
dividends, interest, royalties, rents, annuities and the excess of gains over
losses from the disposition of assets which produce passive income. If we were
determined to be a PFIC for U.S. federal income tax purposes, highly complex
rules would apply to U.S. Holders owning ordinary shares. Accordingly, you are
urged to consult your tax advisors regarding the application of such rules.
Based on our current and projected income, assets and activities, we
believe that we are not currently a PFIC nor do we expect to become a PFIC in
the foreseeable future. However, because the determination of whether we are a
PFIC is based upon the composition of our income and assets from time to time,
there can be no assurances that we will not become a PFIC for any future taxable
year.
If we are treated as a PFIC for any taxable year, then, unless you elect
either to treat your investment in ordinary shares as an investment in a
"qualified electing fund" (a "QEF election") or to "mark-to-market" your
ordinary shares, as described below:
61
o you would be required to allocate income recognized upon receiving
certain dividends or gain recognized upon the disposition of ordinary
shares ratably over the holding period for such ordinary shares;
o the amount allocated to each year during which we are considered a
PFIC other than the year of the dividend payment or disposition would
be subject to tax at the highest individual or corporate tax rate, as
the case may be, and an interest charge would be imposed with respect
to the resulting tax liability allocated to each such year;
o gain recognized upon the disposition of ordinary shares would be
taxable as ordinary income; and
o you would be required to make an annual return on IRS Form 8621
regarding distributions received with respect to ordinary shares and
any gain realized on your ordinary shares.
If you make either a timely QEF election or a timely mark-to-market
election in respect of your ordinary shares, you would not be subject to the
rules described above. If you make a timely QEF election, you would be required
to include in your income for each taxable year your pro rata share of our
ordinary earnings as ordinary income and your pro rata share of our net capital
gain as long-term capital gain, whether or not such amounts are actually
distributed to you. You would not be eligible to make a QEF election unless we
comply with certain applicable information reporting requirements.
Alternatively, if you elect to "mark-to-market" your ordinary shares, you
will generally include in income any excess of the fair market value of the
ordinary shares at the close of each tax year over your adjusted basis in the
ordinary shares. If the fair market value of the ordinary shares had depreciated
below your adjusted basis at the close of the tax year, you may generally deduct
the excess of the adjusted basis of the ordinary shares over its fair market
value at that time. However, such deductions generally would be limited to the
net mark-to-market gains, if any, that you included in income with respect to
such ordinary shares in prior years. Income recognized and deductions allowed
under the mark-to-market provisions, as well as any gain or loss on the
disposition of ordinary shares with respect to which the mark-to-market election
is made, is treated as ordinary income or loss.
Backup Withholding and Information Reporting
Payments in respect of ordinary shares may be subject to information
reporting to the U.S. Internal Revenue Service and to U.S. backup withholding
tax at a rate equal to the fourth lowest income tax rate applicable to
individuals which, under current law, is 28%, Backup withholding will not apply,
however, if you (i) are a corporation or come within certain exempt categories,
and demonstrate the fact when so required, or (ii) furnish a correct taxpayer
identification number and make any other required certification.
Backup withholding is not an additional tax. Amounts withheld under the
backup withholding rules may be credited against a U.S. Holder's U.S. tax
liability, and a U.S. Holder may obtain a refund of any excess amounts withheld
under the backup withholding rules by filing the appropriate claim for refund
with the IRS.
62
Any U.S. holder who holds 10% or more in vote or value of our ordinary
shares will be subject to certain additional United States information reporting
requirements.
U.S. Gift and Estate Tax
An individual U.S. Holder of ordinary shares will be subject to U.S. gift
and estate taxes with respect to ordinary shares in the same manner and to the
same extent as with respect to other types of personal property.
F. DIVIDEND AND PAYING AGENTS
Not applicable.
G. STATEMENT BY EXPERTS
Not applicable.
H. DOCUMENTS ON DISPLAY
We are subject to the reporting requirements of the United States
Securities Exchange Act of 1934, as amended, as applicable to "foreign private
issuers" as defined in Rule 3b-4 under the Exchange Act, and in accordance
therewith, we file annual and interim reports and other information with the
Securities and Exchange Commission.
As a foreign private issuer, we are exempt from certain provisions of the
Exchange Act. Accordingly, our proxy solicitations are not subject to the
disclosure and procedural requirements of Regulation 14A under the Exchange Act,
transactions in our equity securities by our officers and directors are exempt
from reporting and the "short-swing" profit recovery provisions contained in
Section 16 of the Exchange Act. In addition, we are not required under the
Exchange Act to file periodic reports and financial statements as frequently or
as promptly as United States companies whose securities are registered under the
Exchange Act. However, we distribute annually to our shareholders an annual
report containing financial statements that have been examined and reported on,
with an opinion expressed by, an independent public accounting firm, and we file
reports with the Securities and Exchange Commission on Form 6-K containing
unaudited financial information for the first three quarters of each fiscal
year.
This annual report and the exhibits thereto and any other document we file
pursuant to the Exchange Act may be inspected without charge and copied at
prescribed rates at the following Securities and Exchange Commission public
reference rooms: 450 Fifth Street, N.W., Judiciary Plaza, Room 1024, Washington,
D.C. 20549; and on the Securities and Exchange Commission Internet site
(http://www.sec.gov) and on our website www.attunity.com. You may obtain
information on the operation of the Securities and Exchange Commission's public
reference room in Washington, D.C. by calling the Securities and Exchange
Commission at 1-800-SEC-0330 or by visiting the Securities and Exchange
Commission's website at http://www.sec.gov. The Exchange Act file number for our
Securities and Exchange Commission filings is 0-20892.
The documents concerning our company which are referred to in this annual
report may also be inspected at our offices located at Einstein Building, Tirat
Carmel, Haifa, 39101, Israel.
63
I. SUBSIDIARY INFORMATION
Not applicable.
ITEM 11. QUANTITATIVE AND QUALITATIVE DISCLOSURE ABOUT MARKET RISKS
----------------------------------------------------------
We are exposed to a variety of risks, including changes in interest rates
affecting primarily the interest received on short term deposits, and foreign
currency fluctuations. We do not use derivative financial instruments.
Interest Rate Risk
Our exposure to market risk for changes in interest rates relates primarily
to our cash and cash equivalents. Our cash and cash equivalents are held in U.S.
dollars and bear annual interest of 1.04% which is based upon the London Inter
Bank Offered Rate (LIBOR). We place our cash and cash equivalents with major
financial banks. For purposes of specific risk analysis, we use sensitivity
analysis to determine the impact that market risk exposure may have on the
financial income derived from our cash and cash equivalents. The potential loss
to us over one year that would result from a hypothetical change of 10% in the
LIBOR rate would be approximately $20,000.
Foreign Currency Exchange Risk
We have operations in several countries in connection with the sale of our
products. A substantial portion of our sales and expenditures are denominated in
U.S. dollars. We have mitigated, and expect to continue to mitigate a portion of
our foreign currency exposure through salaries (which in 2002 represented 54% of
our total expenses, impairment of assets and discontinued operations), marketing
and support operations in which all costs are local currency based. As a result,
our results of operations and cash flows can be affected by fluctuations in
foreign currency exchange rates (primarily the Euro).
ITEM 12. DESCRIPTION OF SECURITIES OTHER THAN EQUITY SECURITIES
------------------------------------------------------
Not applicable.
PART II
ITEM 13. DEFAULTS, DIVIDEND ARREARAGES AND DELINQUENCIES
-----------------------------------------------
None.
ITEM 14. MATERIAL MODIFICATIONS TO THE RIGHTS OF SECURITY
HOLDERS AND USE OF PROCEEDS
-------------------------------------------------
Not applicable.
64
ITEM 15. CONTROLS AND PROCEDURES
-----------------------
Within the 90 days prior to the date of the filing of this annual report,
we carried out an evaluation, under the supervision and with the participation
of our senior management, including Chief Executive Officer Arie Gonen and Chief
Financial Officer Shlomo Baumgarten, of the effectiveness of the design and
operation of our disclosure controls and procedures pursuant to Rule 13(a)-14(c)
of the Securities Exchange Act of 1934. Disclosure controls and procedures are
designed to ensure that the material financial and non-financial information
required to be disclosed in this Form 20-F filed with the SEC is recorded,
processed, summarized and reported timely. In designing and evaluating the
disclosure controls and procedures, management recognized that any controls and
procedures, no matter how well designed and operated, can provide only
reasonable, rather than absolute, assurance of achieving the desired control
objectives, and management necessarily was required to apply its judgment in
evaluating the cost-benefit relationship of possible controls and procedures.
Based upon that evaluation, our management, including the Chief Executive
Officer and Chief Financial Officer, concluded that our disclosure controls and
procedures are effective in timely alerting them to material information
relating to us required to be included in the our periodic SEC filings.
There have been no significant changes in our internal controls or other
factors which could significantly affect internal controls subsequent to the
date of the evaluation. Therefore, no corrective actions were taken.
ITEM 16. Reserved.
PART III
ITEM 17. FINANCIAL STATEMENTS
--------------------
The Company has elected to furnish financial statements and related
information specified in Item 18.
ITEM 18. FINANCIAL STATEMENTS
--------------------
Consolidated Financial Statements.
Index to Financial Statements...............................................F-1
Report of Independent Auditors......................................F-2
Consolidated Balance Sheets.........................................F-3
Consolidated Statements of Operations...............................F-5
Statements of Changes in Shareholders' Equity.......................F-6
Consolidated Statements of Cash Flows...............................F-7
Notes to Consolidated Financial Statements..........................F-9
65
ITEM 19. EXHIBITS
--------
Index to Exhibits
Exhibit Description
------- -----------
3.1 Memorandum of Association of the Registrant (1)
3.2 Articles of Association of the Registrant, as Amended (2)
4.1 Specimen of Ordinary Share Certificate (3)
10.1 Share Purchase Agreement among the Registrant, VisOpt B.V., Moyo B.V.
and Natram B.V. dated as of July 21, 2000 (4)
10.2 Share Purchase Agreement between the Registrant and Bridges for Islands
Ltd. dated March 27, 2000 (5)
10.3 Share Purchase Agreement among the Registrant, MedaTech Information
Technology Ltd., Natram Management Ltd., Moyo Management Ltd. and Alon
Harel, dated as of July 14, 2000 (6)
10.4 Annulment Agreement among the Registrant, VisOpt B.V., Moyo B.V. and
Natram B.V. dated as of May 28, 2001 (2)
10.5 Annulment Agreement among the Registrant, MedaTech Information
Technology Ltd., Natram Management Ltd., Moyo Management Ltd. and Alon
Harel, dated as of May 28, 2001 (2)
10.6 Amendment to Share Purchase Agreement among the Registrant, Bridges for
Islands Ltd., Dov Biran, Dr. Dov Biran Holdings Ltd. and Poalim Capital
Markets and Investments Ltd., dated as of June 20, 2001 (2)
10.7 1992 Employee Stock Option Plan
10.8 1994 Employee Stock Option Plan
10.9 1998 Employee Stock Option Plan
10.10 Employment and Services Agreement among the Registrant and Mr. Gonen
21 List of Subsidiaries of the Registrant
23.1 Consent of Kost, Forer & Gabbay, Certified Public Accountants (Israel)
99.1 Certification by Chief Executive Officer Pursuant to Section 302 of the
Sarbanes-Oxley Act of 2002.
99.2 Certification by Chief Financial Officer Pursuant to Section 302 of the
Sarbanes-Oxley Act of 2002.
99.3 Certification by Chief Executive Officer Pursuant to 18
U.S.C. Section 1350, As Adopted Pursuant to Section 906 of
the Sarbanes-Oxley Act of 2002.
99.4 Certification by Chief Financial Officer Pursuant to 18
U.S.C. Section 1350, As Adopted Pursuant to Section 906 of
the Sarbanes-Oxley Act of 2002.
- ----------------
(1) Filed as Exhibit 3.1 to the Registrant's Registration Statement on Form
F-1, registration number 33-54020, and incorporated herein by reference.
(2) Filed as an exhibit to the registrant's annual report on Form 20-F for
the year ended December 31, 2000.
(3) Filed as Exhibit 4.1 to the Registrant's Registration Statement on Form
F-1 registration number 33-54020, and incorporated herein by reference.
(4) Filed as Exhibit 10.4 to the Registrant's Registration Statement on Form
F-3 registration number 333-12450, and incorporated herein by reference.
(5) Filed as Exhibit 10.5 to the Registrant's Registration Statement on Form
F-3 registration number 333-11972, and incorporated herein by reference.
(6) Filed as Exhibit 10.5 to the Registrant's Registration Statement on Form
F-3 registration number 333-12450, and incorporated herein by reference.
66
ATTUNITY LTD. AND ITS SUBSIDIARIES
CONSOLIDATED FINANCIAL STATEMENTS
AS OF DECEMBER 31, 2002
IN U.S. DOLLARS
INDEX
Page
----
Report of Independent Auditors F-2
Consolidated Balance Sheets F-3 - F-4
Consolidated Statements of Operations F-5
Statements of Changes in Shareholders' Equity F-6
Consolidated Statements of Cash Flows F-7 - F-8
Notes to Consolidated Financial Statements F-9 - F-38
- - - - - - - -
F-1
ERNST & YOUNG
REPORT OF INDEPENDENT AUDITORS
To the Shareholders of
ATTUNITY LTD.
We have audited the accompanying consolidated balance sheets of Attunity
Ltd. ("the Company") and its subsidiaries as of December 31, 2002 and 2001, and
the related consolidated statements of operations, changes in shareholders'
equity and cash flows for each of the three years in the period ended December
31, 2002. These financial statements are the responsibility of the Company's
management. Our responsibility is to express an opinion on these financial
statements based on our audits.
We conducted our audits in accordance with auditing standards generally
accepted in the United States. Those standards require that we plan and perform
the audit to obtain reasonable assurance about whether the financial statements
are free of material misstatement. An audit includes examining, on a test basis,
evidence supporting the amounts and disclosures in the financial statements. An
audit also includes assessing the accounting principles used and significant
estimates made by management, as well as evaluating the overall financial
statement presentation. We believe that our audits provide a reasonable basis
for our opinion.
In our opinion, the consolidated financial statements referred to above
present fairly, in all material respects, the consolidated financial position of
the Company and its subsidiaries as of December 31, 2002 and 2001, and the
consolidated results of their operations and cash flows for each of the three
years in the period ended December 31, 2002, in conformity with accounting
principles generally accepted in United States.
As discussed in Note 2i to the consolidated financial statements, the
Company adopted Statement of Financial Accounting Standard No. 142 in 2002.
/s/Kost Forer & Gabbay
KOST FORER & GABBAY
Tel-Aviv, Israel A Member of Ernst & Young Global
March 3, 2003
Except for Note 19 for which
the date is March 31, 2003
F-2
ATTUNITY LTD. AND ITS SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS
- --------------------------------------------------------------------------------
U.S. dollars in thousands
December 31,
------------------------------
2002 2001
------------- -------------
ASSETS
CURRENT ASSETS:
Cash and cash equivalents $ 2,693 $ 3,045
Short-term bank deposits 88 -
Marketable securities - 21
Trade receivables (net of allowance for doubtful accounts of
$33 and $63 at December 31, 2002 and 2001, respectively) 3,377 2,800
Other accounts receivable and prepaid expenses (Note 3) 1,233 1,082
------ -------
Total current assets 7,391 6,948
----- ------ -------
SEVERANCE PAY FUND 1,189 1,207
------ -------
PROPERTY AND EQUIPMENT, NET (Note 4) 1,145 1,670
------ -------
SOFTWARE DEVELOPMENT COSTS, NET (Note 5) 6,075 6,070
------ -------
GOODWILL (Note 6) 5,684 5,399
------ -------
Total assets $21,484 $21,294
----- ======= =======
The accompanying notes are an integral part of the consolidated financial
statements.
F-3
ATTUNITY LTD. AND ITS SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS
- --------------------------------------------------------------------------------
U.S. dollars in thousands, except for share data
December 31,
-----------------------------
2002 2001
------------- -------------
LIABILITIES AND SHAREHOLDERS' EQUITY
CURRENT LIABILITIES:
Short-term bank credit (Note 7) $ 175 $ 174
Current maturities of long-term debt (Note 9) 205 231
Trade payables 645 1,320
Deferred revenues 1,986 2,221
Employees and payroll accruals 1,055 1,200
Accrued expenses and other liabilities (Note 8) 2,658 1,156
Accrued expenses related to restructuring (Note 1c) - 788
------- --------
Total current liabilities 6,724 7,090
----- -------- --------
LONG-TERM LIABILITIES:
Long-term debts (Note 9) 55 211
Accrued severance pay 1,625 1,668
-------- --------
Total long-term liabilities 1,680 1,879
----- -------- --------
COMMITMENTS AND CONTINGENT LIABILITIES (Note 11)
SHAREHOLDERS' EQUITY (Note 12):
Share capital - Authorized: 30,000,000 Ordinary shares of NIS
0.1 par value as of December 31, 2002 and 2001; Issued and
outstanding: 14,767,432 and 14,580,160 shares as of December
31, 2002 and 2001, respectively 525 520
Additional paid-in capital 86,504 86,557
Treasury shares at cost - (31)
Accumulated other comprehensive loss (608) (876)
Accumulated deficit (73,341) (73,845)
-------- --------
Total shareholders' equity 13,080 12,325
----- -------- --------
Total liabilities and shareholders' equity $ 21,484 $ 21,294
----- ======== ========
The accompanying notes are an integral part of the consolidated financial
statements.
F-4
ATTUNITY LTD. AND ITS SUBSIDIARIES
CONSOLIDATED STATEMENTS OF OPERATIONS
- --------------------------------------------------------------------------------
U.S. dollars in thousands, except per share data
Year ended December 31,
-----------------------------------------
2002 2001 2000
------------ ------------ -----------
Revenues (Note 17):
Software licenses $ 6,931 $ 6,355 $ 7,583
Maintenance and support 6,057 4,978 4,626
Services 4,467 5,536 6,462
-------- --------- ---------
17,455 16,869 18,671
-------- --------- ---------
Cost of revenues:
Software licenses 1,863 2,547 2,113
Maintenance and support 764 1,042 858
Services 3,376 4,862 5,374
-------- --------- ---------
6,003 8,451 8,345
-------- --------- ---------
Gross profit 11,452 8,418 10,326
-------- --------- ---------
Operating expenses:
Research and development, net (Note 18a) 2,023 3,982 3,559
Selling and marketing 5,585 12,120 11,992
General and administrative 1,509 3,829 5,463
Restructuring and other non-recurring charges (Note 18b) 1,708 1,326 -
Impairment of investment and other assets (Note 14) - 2,658 6,090
In-process research and development write-off - - 12,997
-------- --------- ----------
Total operating expenses 10,825 23,915 40,101
----- -------- --------- ---------
Operating income (loss) 627 (15,497) (29,775)
Financial income, net (Note 18b) 141 48 416
Taxes on income (tax benefit) (Note 13) 264 402 (200)
-------- --------- ---------
Income (loss) from continued operations 504 (15,851) (29,159)
-------- --------- ---------
Discontinued operations (Note 15):
Earnings from discontinued operations of a segment of
a business, net of income tax provision of $ 74 - - 82
Gain (loss) on disposal of segment - 220 (2,224)
-------- --------- ---------
Gain (loss) from discontinued operations, net of income
tax - 220 (2,142)
-------- --------- ---------
Net income (loss) $ 504 $ (15,631) $ (31,301)
======== ========= =========
Basic and diluted net earnings (loss) per share from
continued operations $ 0.03 $ (1.36) $ (2.96)
======== ========= =========
Basic and diluted net earnings (loss) per share from
discontinued operations $ - $ 0.02 $ (0.22)
======== ========= =========
Basic and diluted net earnings (loss) per share $ 0.03 $ (1.34) $ (3.18)
======== ========= =========
The accompanying notes are an integral part of the consolidated financial
statements.
F-5
ATTUNITY LTD. AND ITS SUBSIDIARIES
STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY
- --------------------------------------------------------------------------------
U.S. dollars in thousands, except share data
Accumulated
Additional Treasury other Total Total
Share paid-in shares at comprehensive Accumulated comprehensive shareholders'
capital capital cost loss deficit income (loss) equity
-------- ---------- --------- ------------- ----------- ------------- ------------
Balance as of January 1, 2000 $379 $46,742 $ - $(692) $(26,913) $ 19,516
Issuance of shares ,net 21 12,911 - - - 12,932
Issuance of shares, upon acquisition
of Medatech 1 1,299 - - - 1,300
Issuance of shares, upon investment in
Visopt 6 6,494 - - - 6,500
Issuance of shares and options upon
acquisition of BFI 19 13,982 - - - 14,001
Exercise of employees stock options 5 1,044 - - - 1,049
Other comprehensive loss:
Foreign currency translation adjustments - - - (20) - $ (20) (20)
Net loss - - - - (31,301) (31,301) (31,301)
---- ------- ----- ----- -------- -------- --------
Total comprehensive loss $(31,321)
========
Balance as of December 31, 2000 431 82,472 - (712) (58,214) 23,977
Issuance of shares and options, net 89 4,577 - - - 4,666
Purchase of treasury shares as result of
Medatech and Visopt annulment agreement (7) - (485) - - (492)
Issuance of shares and options upon price
protection related to the acquisition
of BFI 7 (492) 485 - - -
Exercise of employees stock options *)- - - - - *) -
Write-off of loan granted to a senior
employee - (31) - - (31)
Other comprehensive loss:
Foreign currency translation adjustments - - - (164) - $ (164) (164)
Net loss - - - - (15,631) (15,631) (15,631)
---- ------- ----- ----- -------- -------- --------
Total comprehensive loss $(15,795)
========
Balance as of December 31, 2001 520 86,557 (31) (876) (73,845) 12,325
Exercise of employees stock options 5 - - - - 5
Issuance expenses related to issuance of
shares in 2001 - (103) - - - (103)
Compensation in respect of warrants granted
to a consultant - 50 - - - 50
Release of treasury stock resulted from
write-off of a loan granted to a senior
employee - - 31 - - 31
Other comprehensive income:
Foreign currency translation adjustments - - - 268 - $ 268 268
Net income - - - - 504 504 504
---- ------- ----- ----- -------- -------- --------
Total comprehensive income $ 772
========
Balance as of December 31, 2002 $525 $86,504 $ - $(608) $(73,341) $ 13,080
==== ======= ===== ===== ======== ========
*) Represents an amount lower than $ 1.
The accompanying notes are an integral part of the consolidated financial
statements.
F-6
ATTUNITY LTD. AND ITS SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CASH FLOWS
- --------------------------------------------------------------------------------
U.S. dollars in thousands
Year ended December 31,
-----------------------------------------
2002 2001 2000
------------ ------------ -----------
Cash flows from operating activities:
-------------------------------------
Net income (loss) $ 504 $(15,631) $(31,301)
Adjustments required to reconcile net income (loss)
to net cash provided by (used in) operating
activities:
Depreciation and amortization 679 1,782 1,612
Impairment of property and equipment - 389 -
Amortization of capitalized software development
costs 1,590 2,378 2,064
Loss (gain) from discontinued operations - (220) 2,142
Impairment of investment and other assets - 2,658 6,090
Decrease (increase) in trading marketable
securities, net 24 866 (113)
Decrease (increase) in trade receivables (552) 3,115 1,034
Decrease (increase) in other accounts receivable and
prepaid expenses (101) 321 (77)
Increase (decrease) in trade payables (691) (864) 825
Increase (decrease) in deferred revenues (291) (331) 329
Increase (decrease) in accrued expenses, employees
and other liabilities 479 358 (296)
Increase (decrease) in accrued severance pay, net (18) 117 123
In-process research and development write-off - - 12,997
Write-off of loan granted to employee - 90 -
Compensation in respect of warrants granted to a
consultant 50 - -
Others (9) (3) -
-- -- --
Net cash provided by (used in) operating activities 1,664 (4,975) (4,571)
----- ------ ------
Cash flows from investing activities:
-------------------------------------
Proceeds from restricted marketable securities - 205 -
Investment in restricted marketable securities - (205) -
Capitalization of software development costs (1,595) (2,000) (1,995)
Purchase of property and equipment (199) (400) (1,449)
Proceeds from sale of property and equipment 46 63 119
Loan granted to a senior employee - - (121)
Investment in short-term bank deposits (88) - -
Payment for acquisition of Bridges for
Islands, net of cash acquired (1) - - (4,364)
-- -- ------
Net cash used in investing activities (1,836) (2,337) (7,810)
------ ------ ------
Cash flows from financing activities:
-------------------------------------
Proceeds from exercise of options 5 *) - 1,049
Proceeds from issuance of shares and options, net - 4,666 12,932
Issuance expenses related to issuance of shares in
2001 (103) - -
Short-term bank credit, net 2 108 43
Proceeds from long-term debt 86 33 140
Principal payment of long-term debt (259) (292) (163)
Proceeds from release of treasury stocks 31 - -
-- -- --
Net cash provided by (used in) financing activities (238) 4,515 14,001
---- ----- ------
Effect of exchange rate changes on cash and cash
equivalents 58 (46) (4)
-- --- --
Increase (decrease) in cash and cash equivalents (352) (2,843) 1,616
Cash and cash equivalents at the beginning of the year 3,045 5,888 4,272
----- ----- -----
Cash and cash equivalents at the end of the year $ 2,693 $ 3,045 $ 5,888
======= ======== ========
*) Represents an amount lower than $ 1.
The accompanying notes are an integral part of the consolidated financial
statements.
F-7
ATTUNITY LTD. AND ITS SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CASH FLOWS
- --------------------------------------------------------------------------------
U.S. dollars in thousands
Year ended December 31,
-----------------------------------------
2002 2001 2000
----------- ------------ ------------
(1) Cash and cash equivalents from the
acquisition of Bridges for Islands
(see also Note 1b):
-------------------
Net fair value of the assets acquired and
liabilities assumed at the
acquisition date was as follows:
Working capital deficiency, excluding cash and
cash equivalents $ (139)
Property and equipment 73
Long-term liabilities (48)
In process research and development 12,997
Goodwill 4,758
Assembled workforce 724
---
18,365
Less - issuance of Ordinary shares and options 14,001
------
$ 4,364
=======
Supplemental disclosure of cash flow activities:
Cash paid during the year for:
Interest $ 60 $ 209 $ 54
======== ======== =======
Income taxes $ 12 $ 402 $ 33
======== ======== =======
Supplemental disclosure of non-cash
investing and financing activities:
Capital lease obligation incurred upon the
acquisition of property and equipment $ - $ 259 $ 242
======== ======== ========
Purchase of treasury shares as result of Medatech
and Visopt annulment agreement $ - $ 492 $ -
======== ======== ========
The accompanying notes are an integral part of the consolidated financial
statements.
F-8
ATTUNITY LTD. AND ITS SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
- --------------------------------------------------------------------------------
U.S. dollars in thousands
NOTE 1:- GENERAL
a. Attunity Ltd. ("Attunity") and its subsidiaries ("the Company")
develop, market and provide support for computer software
integration tools and application development tools.
The Company's main product is the Attunity Connect. Attunity
Connect is an enterprise information infrastructure product,
which is available on multiple platforms and provides
database-independent access to many databases and file systems.
Attunity Connect standardizes the interaction between data
sources and application programs utilizing various universally
accepted standards. In addition, the Company is currently
developing the Attunity Business Process Integrator ("BPI").
Attunity BPI will provide users with the ability to transform
legacy data and programs into dynamic reusable services.
The Company's principal application development tools are
CorVision, an application generator, and APTuser, a database
retrieval and production report generator. The Company also
markets and supports through its Israeli subsidiary, Attunity
Software Services Ltd. ("ASS") (formerly: "Meyad"), "Mancal
2000", a logistics and financial application software package.
As for geographic markets and major customers, see Note 17.
b. Acquisitions:
1. In February 2000, the Company consummated the acquisition of
all the outstanding shares of Bridges for Islands Ltd.
("BFI"), an Israeli privately held company engaged in the
development of BPI, a business integration solution, in
consideration of $ 18,587, including $ 587 of costs related
to the acquisition, of which $ 4,364 was paid in cash and
the remaining balance by the issuance of 747,650 Ordinary
shares and 127,350 options of Attunity in exchange for the
options held by employees of BFI as of the acquisition date,
aggregating to a value of $ 14,001. The Company entered into
a share price protection guarantee with the shareholders of
BFI pertaining to the shares to be issued to them at $ 16
per share for a one year period from the registration date
with the SEC ("Securities and Exchange Commission") of the
abovementioned shares.
The BFI acquisition has been accounted for according to the
purchase method of accounting, and accordingly, the purchase
price has been allocated to the assets acquired and
liabilities assumed based upon the related fair values on
the date of the acquisition.
F-9
ATTUNITY LTD. AND ITS SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
- --------------------------------------------------------------------------------
U.S. dollars in thousands
NOTE 1:- GENERAL (Cont.)
The purchase price has been allocated as follows:
Working capital deficiency, net $ 83
Property and equipment 73
Long-term liabilities (48)
In process research and development (I) 12,997
Goodwill (II) 4,758
Assembled workforce (III) 724
-------
$18,587
=======
(I) In connection with the BFI acquisition, the Company
recorded a one time expense of approximately $ 12,997
to write-off of in process research and development
acquired from BFI, for which as of the acquisition
date, technological feasibility had not yet been
established and for which no alternative future use
existed.
(II) Goodwill was amortized over its useful life, which is
estimated at 10 years until December 31, 2001 and
thereafter and is being tested for impairment annually
(see also Note 2i).
(III)Assembled workforce was amortized over its useful
life, which was estimated at 3 years.
During 2001, the Company assessed the recoverability of
the carrying amount of assembled workforce based upon the
difference between the carrying amount and fair value of
such asset in accordance with Statement of Financial
Accounting Standard No. 121, "Accounting for the Impairment
of Long-Lived Assets and for Long-Lived Assets to be
Disposed Of" ("SFAS No. 121").
Consequently, the Company wrote-off the assembled
workforce and recorded an impairment charge amounting to $
272, which was included in "Impairment of investment and
other assets" (see also Note 14).
The operations of BFI were included in the consolidated
statements of the Company since February 2000.
In June 2001, the purchase agreement was amended to provide
that, instead of the price protection, the Company issued an
additional 350,000 Ordinary shares (of which 300,000 were
transferred from the shareholders of Medatech Information
Technology Ltd. ("Medatech"), and VisOpt B.V. ("VisOpt")),
at their par value to the former shareholders of BFI.
According to the agreement, in the event of merger,
consolidation or other business combination in which the
Company is not the surviving entity, or in an acquisition of
all or substantially all of the Company's outstanding share
capital or assets, the Company agreed to provide the
shareholders with either cash or additional Ordinary shares
in order to ensure that they will receive $ 11,962 for their
1,097,650 Ordinary shares. An amendment to the price
protection agreement was also signed
F-10
ATTUNITY LTD. AND ITS SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
- --------------------------------------------------------------------------------
U.S. dollars in thousands
NOTE 1:- GENERAL (Cont.)
with certain employees. According to the agreement, certain
former employees were grant 70,632 fully vested options with
an exercise price of $ 0.024 in exchange for their waiving
of the shares of which they were eligible to as result of
the price protection mechanism. In 2002, the Company signed
similar agreement with other former employees, granting
76,659 options under the same terms.
2. In March 2000, the Company acquired 100% of the Ordinary
shares of Medatech Information Technology Ltd. ("Medatech"),
a company which provides software system integration
services and 19.9% of the Ordinary shares of VisOpt B.V.
("VisOpt"), a provider of ERP system integration services in
consideration of $ 7,800, which was paid in the form of the
issuance of 300,000 of the Company's Ordinary shares.
Medatech and VisOpt were owned by the same shareholders.
The Company entered into a share price protection agreement
with the shareholders of Medatech and VisOpt pertaining to
the shares to be issued to them, at $ 26 per share for a one
year period from the registration date with the Securities
and Exchange Commission ("SEC") of the abovementioned
shares.
The acquisition of Medatech was accounted for by the
purchase method of accounting, and the investment in VisOpt
was accounted for under the cost method. The total purchase
price was allocated as follows: $ 1,300 to Medatech and $
6,500 to VisOpt based upon the related fair values on the
date of the acquisition.
Proforma information in accordance with APB 16 "Business
Combinations" has not been provided since the results of
operations of Medatech were discontinued.
On March 19, 2001, in light of the exposure related to price
protection, the Board of Directors decided to reverse the
acquisition of Medatech and VisOpt. On May 28, 2001, the
Company signed an annulment agreement with the former owners
of Medatech and VisOpt, which specifies the terms of the
annulment.
This agreement stated that Attunity would transfer the
Medatech shares to the former shareholders, in exchange for
their waiving to the shares of which they were eligible as
result of the price protection mechanism, and the
shareholders would transfer their Attunity shares to an
escrow agent on behalf of Attunity. The parties also agreed
that all share options granted by Attunity to the
shareholders and to any employees of Medatech pursuant to
the Medatech agreement, would be null and void.
The agreement also states that none of the parties would
have any claims, demands or causes of action with respect to
the Medatech agreement or the annulment thereof, except for
the shares transfer.
F-11
ATTUNITY LTD. AND ITS SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
- --------------------------------------------------------------------------------
U.S. dollars in thousands
NOTE 1:- GENERAL (Cont.)
The Company accounted for the reversal of the acquisition of
Medatech in accordance with Accounting Principles Board
Opinion No. 30 "Reporting the Results of
Operations-Reporting the Effects of Disposal of a Segment of
a Business, and Extraordinary, Unusual and Infrequently
Occurring Events and Transactions" ("APB No. 30") and
Emerging Issues Task Force No. 95-18 "Accounting and
Reporting for Discontinued Business Segment when the
Measurement Date Occurs After the Balance Sheet Date But
Before the Issuance of Financial Statements" ("EITF 95-18)
(see also Note 15).
As a result of the annulment agreement as mentioned above,
the Company recorded gain (loss) from discontinued
operations of $ 220 and $ (2,142) in the years ended
December 31, 2001 and 2000, respectively.
The write-off of the investment in VisOpt, amounted to $
6,090, was recorded as an impairment charge of investment
and was included in "Impairment of Investment and other
assets" in the year ended December 31, 2000 (see also Note
14).
c. Restructuring and non-recurring expenses:
In September 2001, after sustaining substantial losses, due to
recent events and a slow-down in the software industry, the
Company implemented a restructuring plan. The plan consisted of
the involuntary termination of 30 employees (8 research and
development employees, 11 consulting and support employees, 6
sales and marketing employees and 5 other employees).
In accordance with SFAS No. 121, Emerging Issues Task Force No.
94-3, "Liability recognition for Certain Employee Termination
Benefits and Other Costs to Exit an Activity (Including Certain
Costs in a Restructuring)" ("EITF No. 94-3") and Staff Accounting
Bulletin No.100 "Restructuring and Impairment Charges" ("SAB
100"), the Company recorded restructuring charges of $ 1,326.
Since a substantial portion of the Company's employees in its
facilities in the U.S were dismissed, the Company impaired
leasehold improvements that had no useful use as a result of the
dismissal of employees.
The major components of the 2001 restructuring plan charges are
as follows:
Balance as
Utilized of
Original ------------------- December 31,
accruals Cash Non-cash 2002
-------- -------- -------- ------------
Write-off of leasehold improvements $ 389 $ - $ 389 $ -
Termination of employees 385 385 - -
Future rent of unoccupied areas 484 484 - -
Other 68 68 - -
-------- -------- -------- ------------
$1,326 $ 937 $ 389 $ -
======== ======== ======== ============
See also Note 18b.
F-12
ATTUNITY LTD. AND ITS SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
- --------------------------------------------------------------------------------
U.S. dollars in thousands
NOTE 2:- SIGNIFICANT ACCOUNTING POLICIES
The consolidated financial statements have been prepared in accordance with
generally accepted accounting principles in the United States ("U.S.
GAAP").
a. Use of estimates:
The preparation of financial statements in conformity with
generally accepted accounting principles requires management to
make estimates and assumptions that affect the amounts reported
in the financial statements and accompanying notes. Actual
results could differ from those estimates.
b. Financial statements in U.S. dollars ("dollars"):
A majority of the revenues of Attunity and certain of its
subsidiaries is generated in dollars. In addition, a substantial
portion of Attunity and certain subsidiaries' costs is
denominated in dollars. The Company's management believes that
the dollar is the primary currency in the economic environment in
which those companies operate. Thus, the functional and reporting
currency of those companies is the dollar.
Accordingly, monetary accounts maintained in currencies other
than the Dollar are remeasured into dollars in accordance with
Statement of Financial Accounting Standard No. 52 "Foreign
Currency Translation" ("SFAS No. 52"). All transactions gains and
losses of the remeasurement of monetary balance sheet items are
reflected in the statement of operations as financial income or
expenses, as appropriate.
The financial statements of the Israeli and other foreign
subsidiaries whose functional currency is determined to be their
local currency, have been translated into dollars. All balance
sheet accounts have been translated using the exchange rates in
effect at the balance sheet date. Statement of operations amounts
have been translated using the average exchange rate for the
year. The resulting translation adjustments are reported as a
component of shareholders' equity, accumulated other
comprehensive loss.
c. Principles of consolidation:
The consolidated financial statements include the accounts of
Attunity and its wholly-owned subsidiaries. Intercompany balances
and transactions have been eliminated in consolidation.
d. Cash equivalents:
Cash equivalents are short-term highly liquid investments that
are readily convertible to cash, with maturities of three months
or less at the date acquired.
e. Short-term bank deposits:
Short-term bank deposits are deposits with maturities of more
than three months but less than one year. The deposits are in New
Israeli Shekels ("NIS") and bear interest at an average rate of
8.7%. The short-term deposits are presented at their cost,
including accrued interest.
F-13
ATTUNITY LTD. AND ITS SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
- --------------------------------------------------------------------------------
U.S. dollars in thousands
NOTE 2:- SIGNIFICANT ACCOUNTING POLICIES (Cont.)
f. Marketable securities:
The Company accounts for its investments in marketable securities
using Statement of Financial Accounting Standard No. 115,
"Accounting for Certain Investments in Debt and Equity
Securities" ("SFAS No. 115").
Management determines the appropriate classification of its
investments in debt and marketable equity securities at the time
of purchase and reevaluates such determinations at each balance
sheet date. The securities were classified as trading securities
when the Company holds the securities for resale in anticipation
of short-term market movements. The Company's trading securities
carried at their fair value based upon the quoted market price of
those investments. Net realized and unrealized gains and losses
on these securities are included in financial expenses or income,
as appropriate.
g. Property and equipment:
Property and equipment are stated at cost, net of accumulated
depreciation. Depreciation is calculated using the straight-line
method, over the estimated useful lives of the assets, at the
following annual rates:
%
------------------
Computers and peripheral equipment 20 - 33
Office furniture and equipment 10 - 20
Motor vehicles 15
Over the related lease
Leasehold improvements period
See also Note 1c.
h. Impairment of long-lived assets:
The Company's long-lived assets are reviewed for impairment in
accordance with Statement of Financial Accounting Standard No.
144, "Accounting for the Impairment or Disposal of Long-lived
Assets" ("SFAS No. 144"), whenever events or changes in
circumstances indicate that the carrying amount of an asset may
not be recoverable. Recoverability of assets to be held and used
is measured by a comparison of the carrying amount of an asset to
the future undiscounted cash flows expected to be generated by
the assets. If such assets are considered to be impaired, the
impairment to be recognized is measured by the amount by which
the carrying amount of the assets exceeds the fair value of the
assets. In 2002, no impairment losses have been identified.
During 2001, the Company recorded impairment expenses amounting
to $ 272 attributed to assembled workforce, according to SFAS No.
121, which were included in "Impairment of investment and other
assets" (see also Note 1b).
F-14
ATTUNITY LTD. AND ITS SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
- --------------------------------------------------------------------------------
U.S. dollars in thousands
NOTE 2:- SIGNIFICANT ACCOUNTING POLICIES (Cont.)
i. Goodwill:
Goodwill arose from acquisitions prior to July 1, 2001, was
amortized until December 31, 2001, on a straight-line basis over
the estimated useful life, which is 7-10 years.
SFAS No.142 requires goodwill to be tested for impairment on
adoption and at least annually thereafter or between annual tests
in certain circumstances, and written down when impaired, rather
than being amortized as previous accounting standards required.
Goodwill is tested for impairment by comparing the fair value of
the Company's reporting unit with its carrying value. Fair value
was determined using discounted cash flows, market multiples and
comparative analyze. Significant estimates used in the
methodologies included estimates of future cash flows and
estimates of market multiples for the reportable unit.
The Company performed its adoption test at the beginning of the
year and the annual impairment test during the third fiscal
quarter. As of December 31, 2002, no impairment losses have been
identified.
j. Research and development costs:
Research and development costs incurred in the process of
software development before establishment of technological
feasibility are charged to expenses as incurred. Costs of the
production of a product master incurred subsequent to the
establishment of technological feasibility are capitalized
according to the principles set forth in Statement of Financial
Accounting Standards No.86 "Accounting for the Costs of Computer
Software to Be Sold, Leased, or Otherwise Marketed" ("SFAS
No.86").
Based on the Company product development process, technological
feasibility is established upon completion of a detail program
design.
Capitalized software costs are amortized on a product by product
basis commencing with general product release by the amount
computed using the straight-line method over the estimated useful
life of the product (five years), and are included in costs of
revenues.
At each balance sheet date, the Company assesses the
recoverability of this intangible asset by comparing the
unamortized capitalized software costs to the net realizable
value on a product by product basis. Should the amount of the
unamortized capitalized costs of a computer software product
exceeds the net realizable value, these products will be written
down by the excess amount. In the years ended December 31, 2002,
2001 and 2000 the Company recorded $ 0, $ 2,386 and $ 0,
respectively, as impairment of capitalized software costs, which
were included in "Impairment of investment and other assets" (see
also Note 14).
F-15
ATTUNITY LTD. AND ITS SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
- --------------------------------------------------------------------------------
U.S. dollars in thousands
NOTE 2:- SIGNIFICANT ACCOUNTING POLICIES (Cont.)
k. Income taxes:
The Company accounts for income taxes in accordance with
Statement of Financial Accounting Standards No. 109 "Accounting
for Income Taxes", ("SFAS No. 109"). This Statement prescribes
the use of the liability method whereby deferred tax asset and
liability account balances are determined based on differences
between financial reporting and tax bases of assets and
liabilities and are measured using the enacted tax rates and laws
that will be in effect when the differences are expected to
reverse. The Company provides a valuation allowance, if
necessary, to reduce deferred tax assets to their estimated
realizable value.
l. Advertising expenses:
Advertising expenses are carried to the statement of operations,
as incurred. Advertising expenses for the years ended December
31, 2002, 2001 and 2000 amounted to $ 55, $ 648 and $ 572,
respectively.
m. Revenue recognition:
The Company generates revenues mainly from license fees and
sub-license fees for the right to use its software products,
maintenance, support, consulting and training services. The
Company sells its products primarily through its direct sales
force to customers and indirectly through distributors and value
added resellers ("VARs"). Both the customers and the distributors
or resellers are considered end users. The Company is also
entitled to royalties from some distributors and VARs upon the
sublicensing of the software to end users.
The Company accounts for software sales in accordance with
Statement of Position No. 97-2, "Software Revenue Recognition",
as amended ("SOP No. 97-2"). SOP No. 97-2, generally requires
revenue earned on software arrangements involving multiple
elements to be allocated to each element based on the relative
fair value of the elements. The Company has also adopted
Statement of Position No. 98-9, "Modification of SOP No. 97-2,
Software Revenue Recognition with Respect to Certain
Transactions" ("SOP No. 98-9"). SOP No. 98-9 requires that
revenue be recognized under the "residual method" when vendor
specific objective evidence ("VSOE") of fair value exists for all
undelivered elements and no VSOE exists for the delivered
elements and all other four criteria of SOP No. 97-2 are met.
Under the residual method any discount in the arrangement is
allocated to the delivered element.
Revenue from license fees is recognized when persuasive evidence
of an agreement exists, delivery of the product has occurred, no
significant obligations with regard to implementation remain, the
fee is fixed or determinable and collectibility is probable. The
Company generally does not grant a right of return to its
customers. The Company considers all arrangements with payment
terms extending beyond one year not to be fixed or determinable.
If the fee is not fixed or determinable, revenue is recognized as
payments become due from the customer provided that all other
revenue recognition criteria have been met.
F-16
ATTUNITY LTD. AND ITS SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
- --------------------------------------------------------------------------------
U.S. dollars in thousands
NOTE 2:- SIGNIFICANT ACCOUNTING POLICIES (Cont.)
Revenues from royalties are recognized according to quarterly
royalties reports, as received from customers which embed the
Company's products in their own products and the Company is
entitled to a percentage of the customer revenue from the
combined product.
Maintenance and support revenue included in multiple element
arrangement is deferred and recognized on a straight-line basis
over the term of the maintenance and support agreement.
Arrangements that include consulting and training services are
evaluated to determine whether those services are essential to
the functionality of other elements of the arrangement. To date,
the Company had determined that the services are not considered
essential to the functionality of other elements of the
arrangement, therefore, these revenues are recognized as the
services are performed.
Deferred revenues includes unearned amounts received under
maintenance and support contracts and amounts received from
customers but not recognized as revenues.
In agreements for which an acceptance provision in the contract
is required by the customer, the Company defers revenues until
receiving the acceptance confirmation.
n. Concentrations of credit risks:
Financial instruments that potentially subject the Company to
concentrations of credit risk consist principally of cash and
cash equivalents, short-term bank deposits and trade receivables.
Cash and cash equivalents and short-term bank deposits are
invested in major banks in Israel, Europe and the United States.
Such deposits in the United States may be in excess of insured
limits and are not insured in other jurisdictions. Management
believes that the financial institutions that hold the Company's
investments are financially sound and, accordingly, minimal
credit risk exists.
The Company's trade receivables are mainly derived from sales to
customers located primarily in the United States, Israel, Europe,
Far East and South America. The Company performs ongoing credit
evaluations of its customers and to date has not experienced any
material losses. An allowance for doubtful accounts is determined
with respect to those amounts that the Company has determined to
be doubtful of collection.
The Company has no significant off-balance-sheet concentration of
credit risk such as foreign exchange contracts, option contracts
or other foreign hedging arrangements.
F-17
ATTUNITY LTD. AND ITS SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
- --------------------------------------------------------------------------------
U.S. dollars in thousands
NOTE 2:- SIGNIFICANT ACCOUNTING POLICIES (Cont.)
o. Accounting for stock-based compensation:
The Company has elected to follow Accounting Principles Board
Statement No. 25 "Accounting for Stock Issued to Employees" ("APB
No. 25") and FASB Interpretation No. 44 "Accounting for Certain
Transactions Involving Stock Compensation" ("FIN No. 44") in
accounting for its employee stock option plans. Under APB No. 25,
when the exercise price of an employee stock option is equivalent
to or above the market price of the underlying shares on the date
of grant, compensation expense is recognized.
In December 2002, the FASB issued Statement of Financial
Accounting Standard No. 148, "Accounting for Stock Based
Compensation Transmission and Disclosure - an amendment of FASB
Statement No. 123" ("SFAS No. 148"). SFAS No. 148 permits two
additional transition methods for entities that adopt the fair
value based method of accounting for stock-based employee
compensation. The transition guidance and annual disclosure
provisions of SFAS No. 148 are effective for fiscal years ending
after December 15, 2002, with earlier application permitted in
certain circumstances. The interim disclosure provisions are
effective for financial reports containing financial statements
for interim periods beginning after December 15, 2002. As at the
balance sheet date, the Company continues to apply APB No. 25
(see also Note 12).
Pro forma information regarding the Company's net income (loss)
and net earnings (loss) per share is required by Statement of
Financial Accounting Standard No. 123 "Accounting for Stock-Based
Compensation" and has been determined as if the Company had
accounted for its employee stock options under the fair value
method prescribed by SFAS No. 123.
The fair value for options granted in 2000, 2001 and 2002 is
amortized over their vesting period and estimated at the date of
grant using a Black-Scholes options pricing model with the
following weighted average assumptions:
2002 2001 2000
-------- -------- --------
Dividend yield 0% 0% 0%
Expected volatility 79.5% 130% 91%
Risk-free interest 1.5% 3% 4.5%
Expected life of up to 6 years 6 years 6 years
F-18
ATTUNITY LTD. AND ITS SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
- --------------------------------------------------------------------------------
U.S. dollars in thousands
NOTE 2:- SIGNIFICANT ACCOUNTING POLICIES (Cont.)
Proforma information under SFAS No. 123, is as follows:
Year ended December 31,
---------------------------------------
2002 2001 2000
----------- ----------- ----------
Net income (loss) from continued operations $ 504 $(15,851) $(29,159)
Net income (loss) from discontinued
operations, net of income tax - 220 (2,142)
----------- ----------- ----------
Net income (loss) $ 504 $(15,631) $(31,301)
=========== =========== ==========
Deduct stock-based employee compensation
fair value $ (994) $ (1,508) $ (3,652)
=========== =========== ==========
Proforma:
Net loss from continued operations $ (490) $(17,359) $(32,811)
Net income (loss) from discontinued
operations, net of income tax - 220 (2,142)
----------- ----------- ----------
Net loss $ (490) $(17,139) $(34,953)
=========== =========== ==========
Net earnings (loss) per share:
Basic and diluted net earnings (loss)
per share from continued operations as
reported $ 0.03 $ (1.36) $ (2.96)
=========== =========== ==========
Basic and diluted net earnings (loss)
per share from discontinued
operations, net of income tax $ - $ 0.02 $ (0.22)
=========== =========== ==========
Basic and diluted net earnings (loss)
per share $ 0.03 $ (1.34) $ (3.18)
=========== =========== ==========
Proforma basic and diluted net loss per
share from continued operations as
reported $ (0.03) $ (1.49) $ (3.33)
=========== =========== ==========
Proforma basic and diluted net earnings
(loss) per share from discontinued
operations , net of income tax $ - $ 0.02 $ (0.22)
=========== =========== ==========
Proforma basic and diluted net loss per
share $ (0.03) $ (1.47) $ (3.55)
=========== =========== ==========
The Company applies SFAS No. 123 and Emerging Issues Task Force
No. 96-18 "Accounting for Equity Instruments that are Issued to
Other than Employees for Acquiring, or in Conjunction with
Selling, Goods or Services" ("EITF 96-18"), with respect to
options and warrants issued to non-employees. SFAS No. 123
requires the use of option valuation model to measure the fair
value of the warrants at the date of grant.
F-19
ATTUNITY LTD. AND ITS SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
- --------------------------------------------------------------------------------
U.S. dollars in thousands
NOTE 2:- SIGNIFICANT ACCOUNTING POLICIES (Cont.)
p. Basic and diluted net earnings (loss) per share:
Basic net earnings (loss) per share are computed based on the
weighted average number of Ordinary shares outstanding during
each year. Diluted net earnings per share are computed based on
the weighted average number of Ordinary shares outstanding during
each year, plus dilutive potential Ordinary shares considered
outstanding during the year, in accordance with Statement of
Financial Accounting Standard No. 128. "Earnings Per Share"
("SFAS No. 128").
Certain outstanding stock options and warrants have been excluded
from the calculation of the diluted net earnings (loss) per
Ordinary share because the securities are antidilutive for all
periods presented. The total weighted average number of shares
related to the outstanding stock options and warrants excluded
from the calculations of diluted net earnings (loss) per share
were 6,367,656, 6,950,161 and 1,383,713 for the years ended
December 31, 2002, 2001 and 2000, respectively.
q. Severance pay:
The Company's liability for severance pay is calculated pursuant
to Israeli severance pay law based on the most recent salary of
the employees multiplied by the number of years of employment, as
of the balance sheet date for all employees in Israel. Employees
are entitled to one month's salary for each year of employment or
a portion thereof. The Company's liability for all of its
employees is fully provided by monthly deposits with severance
pay fund, insurance policies and by an accrual. The value of
these policies is recorded as an asset in the Company's balance
sheet.
The deposited funds include profits accumulated up to the balance
sheet date. The deposited funds may be withdrawn only upon the
fulfillment of the obligation pursuant to Israeli severance pay
law or labor agreements. The value of these policies is recorded
as an asset in the Company's balance sheet.
Severance pay expenses for the years ended December 31, 2002,
2001 and 2000 were $ 576, $ 1,375 and $ 554, respectively.
r. Fair value of financial instruments:
The estimated fair value of financial instruments has been
determined by the Company using available market information and
valuation methodologies. Considerable judgment is required in
estimating fair values. Accordingly, the estimates may not be
indicative of the amounts the Company could realize in a current
market exchange.
F-20
ATTUNITY LTD. AND ITS SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
- --------------------------------------------------------------------------------
U.S. dollars in thousands
NOTE 2:- SIGNIFICANT ACCOUNTING POLICIES (Cont.)
The carrying amounts of cash and cash equivalents, short-term
bank deposits, trade receivables, short-term bank credits and
trade payables approximate their fair values due to the
short-term maturity of these instruments.
The fair value of long-term liabilities was estimated by
discounting the future cash flow using rate currently available
for long-term liabilities of similar terms and maturity. The
carrying amount of the Company's long-term liabilities
approximates their fair value.
s. Impact of recently issued accounting standards:
In November 2002, the FASB issued FASB Interpretation No. 45,
"Guarantor's Accounting and Disclosure Requirements for
Guarantees, Including Indirect Guarantees of Indebtedness of
Others, an interpretation of FASB Statements No. 5, 57, and 107
and Rescission of FASB Interpretation No. 34" ("FIN No. 45"). FIN
No. 45 elaborates on the disclosures to be made by a guarantor in
its interim and annual financial statements about its obligations
under certain guarantees that it has issued. It also clarifies
that a guarantor is required to recognize, at the inception of a
guarantee, a liability for the fair value of the obligation
undertaken in issuing the guarantee. FIN No. 45 does not
prescribe a specific approach for subsequently measuring the
guarantor's recognized liability over the term of the related
guarantee. It also incorporates, without change, the guidance in
FASB Interpretation No. 34, "Disclosure of Indirect Guarantees of
Indebtedness of Others," which is being superseded. The
disclosure provisions of FIN No. 45 are effective for financial
statements of interim or annual periods that end after December
15, 2002, and the provisions for initial recognition and
measurement are effective on a prospective basis for guarantees
that are issued or modified after December 31, 2002, irrespective
of a guarantor's year-end. The Company does not expect the
adoption of FIN No. 45 will have a material impact on its results
of operations or financial position.
t. Reclassification:
Certain amounts from prior years referring to revenues and
balances of restricted cash, goodwill, share capital and
additional paid in capital have been reclassified to conform with
current year presentation. The reclassification had no effect on
previously reported net loss, shareholders' equity or cash flows.
NOTE 3:- OTHER ACCOUNTS RECEIVABLE AND PREPAID EXPENSES
December 31,
-----------------------------
2002 2001
-------------- ------------
Prepaid expenses $ 460 $ 548
Government authorities 370 309
Employees 166 172
Other 237 53
-------------- ------------
$1,233 $1,082
============== ============
F-21
ATTUNITY LTD. AND ITS SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
- --------------------------------------------------------------------------------
U.S. dollars in thousands
NOTE 4:- PROPERTY AND EQUIPMENT, NET
December 31,
------------------------------
2002 2001
-------------- -------------
Cost:
Computers and peripheral equipment $ 4,937 $ 4,811
Office furniture and equipment 827 806
Motor vehicles 572 688
Leasehold improvements 1,110 1,025
----- -----
7,446 7,330
----- -----
Accumulated depreciation:
Computers and peripheral equipment 4,513 2,775
Office furniture and equipment 581 1,831
Motor vehicles 316 344
Leasehold improvements 891 710
--- ---
6,301 5,660
----- -----
Depreciated cost $ 1,145 $ 1,670
======= =======
Depreciation expenses for the years ended December 31, 2002, 2001 and
2000 are $ 679, $ 806 and $ 728, respectively.
During 2001, as part of the restructuring plan, the Company recorded
impairment charges amounting to $ 389 attributed to leasehold
improvements (see Note 1c).
For charges on the Company's property and equipment, see Note 10.
NOTE 5:- SOFTWARE DEVELOPMENT COSTS, NET
a. Original amounts:
December 31,
------------------------------
2002 2001
------------- --------------
Software development costs $15,297 $13,702
Less - accumulated amortization 9,222 7,632
----- -----
Amortized cost $ 6,075 $ 6,070
======= =======
b. Amortization expenses amounted to $ 1,590, $ 2,378 and $ 2,064
for the years ended December 31, 2002, 2001 and 2000,
respectively.
During 2001, the Company recorded impairment expenses amounting
to $ 2,386 attributed to capitalized software costs, which were
included in "Impairment of investment and other assets".
F-22
ATTUNITY LTD. AND ITS SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
- --------------------------------------------------------------------------------
U.S. dollars in thousands
NOTE 5:- SOFTWARE DEVELOPMENT COSTS, NET (Cont.)
c. Estimated amortization expenses for the years ended:
December 31,
------------
2003 $1,874
2004 1,874
2005 1,077
2006 756
2007 494
NOTE 6:- GOODWILL
The changes in the carrying amount of goodwill for the year ended
December 31, 2002, are as follows:
Balance as of January 1, 2002 $5,399
Foreign currency translation adjustments 285
------
Balance as of December 31, 2002 $5,684
======
The results of operations presented below for the three years ended
December 31, 2002, 2001 and 2000, reflect the operations had the
Company adopted the non-amortization provisions of SFAS No. 142
effective January 1, 2000:
Year ended December 31,
---------------------------------------
2002 2001 2000
----------- ----------- -----------
Reported net income (loss) $ 504 $(15,631) $(31,301)
Goodwill amortization - 733 737
----------- ----------- -----------
Adjusted net income (loss) $ 504 $(14,898) $(30,564)
=========== =========== ===========
Basic and diluted net earnings
(loss) per share:
Reported net income (loss) $ 0.03 $ (1.34) $ (3.18)
Goodwill amortization - 0.06 0.08
----------- ----------- -----------
Adjusted net income (loss) $ 0.03 $ (1.28) $ (3.10)
=========== =========== ===========
F-23
ATTUNITY LTD. AND ITS SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
- --------------------------------------------------------------------------------
U.S. dollars in thousands
NOTE 7:- SHORT-TERM BANK CREDIT
December 31,
---------------------------------------------------
Interest rate Amount
------------------------ ------------------------
2002 2001 2002 2001
------------------------ ----------- ----------
%
------------------------
Short-term bank loans:
In NIS 11.75 - $ 149 $ -
Short-term bank credit:
In NIS 13.4 6.3-7.3 26 174
----------- ----------
$ 175 $ 174
=========== ==========
(1) Total authorized credit lines approximate $ 662
===========
(2) Unutilized credit lines approximate $ 513
===========
(3) Weighted average interest rates at the end of the 12.2% 6.8%
year =========== ==========
NOTE 8:- ACCRUED EXPENSES AND OTHER LIABILITIES
December 31,
---------------------------
2002 2001
------------- ------------
Government authorities $ 421 $ 361
Lawsuit accrual (see also Note 18b) 810 -
Accrued expenses 687 367
Termination of lease accrual (see also Note 18b) 290 -
Royalties to Government authorities 270 386
Others 180 42
----------- -----------
$ 2,658 $ 1,156
=========== ===========
F-24
ATTUNITY LTD. AND ITS SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
- --------------------------------------------------------------------------------
U.S. dollars in thousands
NOTE 9:- LONG-TERM DEBTS
December 31,
--------------------------
2002 2001
------------ -----------
Capital lease obligations, linked to the U.S.
dollar and bears interest of 6.7% $ 174 $ 337
Other loans, linked to the Israeli Consumer
Price Index and bears interest of 5% to 7.8% 86 105
------------ -----------
260 442
Less - current maturities:
Capital lease obligations 135 168
Other loans 70 63
------------ -----------
$ 55 $ 211
============ ===========
As of December 31, 2002, the aggregate
annual maturities of
long-term debts are as follows:
First year (current maturities) $ 205 $ 231
Second year 41 167
Third year 14 39
Fourth year - 5
------------ -----------
$ 260 $ 442
============ ===========
See also Note 10.
NOTE 10:- CHARGES (ASSETS PLEDGED)
As collateral for certain liabilities of the Company to banks and others,
fixed charges have been recorded on certain property and equipment of the
Company.
NOTE 11:- COMMITMENTS AND CONTINGENT LIABILITIES
a. Lease commitments:
The Company leases its operating facilities under non-cancelable
operating lease agreements which expire in various dates. Future
minimum commitments under these leases as of December 31, 2002,
are as follows:
Operating
Year ending December 31, leases
------------------------------ ------------
2003 $1,169
2004 1,250
2005 and thereafter 1,121
------------
$3,540
============
Rent expenses under operating leases for the years ended December
31, 2002, 2001 and 2000 were $704, $1,298 and $850, respectively.
F-25
ATTUNITY LTD. AND ITS SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
- --------------------------------------------------------------------------------
U.S. dollars in thousands
NOTE 11:- COMMITMENTS AND CONTINGENT LIABILITIES (Cont.)
b. Royalties:
The Company participates in programs sponsored by the Israeli
Government for the support of research and development
activities. Through December 31, 2002, the Company had obtained
grants from the Office of the Chief Scientist of the Israeli
Ministry of Industry and Trade ("the OCS") in the aggregate
amount of $ 2,418 for certain of the Company's research and
development projects. The Company is obligated to pay royalties
to the OCS, amounting to 2%-5% of the sales of the products and
other related revenues generated from such projects, up to
100%-150% of the grants received, linked to the U.S. dollar.
The obligation to pay these royalties is contingent on actual
sales of the products and in the absence of such sales no payment
is required.
Through December 31, 2002, the Company has paid or accrued
royalties to the OCS in the amount of $ 1,128. As of December 31,
2002, the aggregate contingent liability to the OCS amounted to $
1,472.
c. Litigation:
In November 2002, the four Special Situations Funds ("SSF") that
invested in the Company's October 2001 private placement filed a
complaint against the Company alleging that the Company had
breached the Registration Rights Agreement related to their
investment in the Company.
As such, SSF sought to collect liquidation damages of
approximately $603 plus unspecified actual damages allegedly due
as a result of delay in having Registration Statement covering
the shares purchased by SSF declared effective. Subsequent to the
balance sheet date a ruling was given, refer to Note 19.
NOTE 12:- SHAREHOLDERS' EQUITY
a. The Ordinary shares of the Company are quoted on Nasdaq stock
market. The Ordinary shares confer upon the holders the right to
receive notice to participate and vote in general meetings of the
Company, and the right to receive dividends, if declared.
In March 2000, the Company issued 850,000 Ordinary shares to
private investors in consideration of approximately $ 13,000 (see
also Note 12d).
b. In October 2001, the Company issued 3,846,156 Ordinary shares to
private investors in consideration of approximately $ 4,666. In
addition, the Company granted the investors and agents warrants
to purchase 4,150,387 of the Company's Ordinary shares at an
exercise price of $1.75 -$ 2.25. The agreement states that in the
event that the share price reaches $ 3 and $ 4, the Company may
force the investors to exercise the warrants, otherwise they
would be forfeited. These warrants will expire in October 2005.
F-26
ATTUNITY LTD. AND ITS SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
- --------------------------------------------------------------------------------
U.S. dollars in thousands
NOTE 12:- SHAREHOLDERS' EQUITY (Cont.)
c. Stock Option Plans:
Under the Company's 1992, 1994, 1998 and 2001 Stock Option Plans
(the "Plans"), the Company has granted options to purchase
Ordinary Shares to key employees, directors and officers as an
incentive to attract and retain qualified personnel. The exercise
price of options granted under the Plans may not be less than
100% (110% in the case of a 10% shareholder) of the fair market
value of the Company's Ordinary shares on the date of grant for
ISO options and 75% of the fair market for non-qualified. Under
the terms of these four plans, options generally become
exercisable ratably over a three to five - year of employment
commencing with the date of grant. The options generally expire
no later than 10 years from the date of the grant, and are
non-transferable, except under the laws of succession.
Under the Plans 3,500,000 Ordinary shares of the Company were
reserved for issuance. Any options which are canceled or
forfeited before expiration become available for future grants.
As of December 31, 2002, under the plans there are 1,575,980
options available for future grants.
Below is a summary of the Company's stock option activity, and
related information:
Year ended December 31
------------------------------------------------------------
2002 2001 2000
------------------- ------------------- -------------------
Weighted Weighted Weighted
average average average
exercise exercise exercise
Amount price Amount price Amount price
--------- --------- --------- --------- --------- ---------
In In In
thousands thousands thousands
--------- --------- ---------
Outstanding at the
beginning of the
year 2,238 $ 3.87 1,226 $ 8.61 1,068 $ 8.02
Granted 143 $ 1.09 1,710 $ 1.26 539 $ 8.81
Exercised (187) $ 0.02 (20) $ 0.02 (189) $ 5.54
Forfeited and
cancelled (590) $ 4.85 (678) $ 5.57 (192) $ 8.33
--------- --------- ---------
Outstanding at the 1,604 $ 3.71 2,238 $ 3.87 1,226 $ 8.61
end of the year ========= ======= ========= ======= ========= =======
Exercisable at 990 $ 5.18 1,218 $ 5.74 387 $ 7.44
December 31, ========= ======= ========= ======= ========= =======
F-27
ATTUNITY LTD. AND ITS SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
- --------------------------------------------------------------------------------
U.S. dollars in thousands
NOTE 12:- SHAREHOLDERS' EQUITY (Cont.)
The options outstanding as of December 31, 2002, have been separated
into ranges of exercise prices as follows:
Weighted
Outstanding average Weighted Exercisable Weighted
Ranges of at remaining average at average
exercise December 31, contractual exercise December 31, exercise
prices 2002 life price 2002 price
-------------- -------------- ------------ ----------- -------------- -----------
$ In thousands Years $ In thousands $
-------------- -------------- ------------ ----------- -------------- -----------
0.02 6 3 0.02 4 0.02
0.08 40 5.76 0.82 - -
1.05 - 1.4 879 4.38 1.2 369 1.20
1.5 - 1.94 79 3.31 1.72 51 1.72
2.9 - 3 26 3.21 2.94 20 2.94
4.5 - 6.5 66 3.33 5.5 57 5.50
6.88 - 9.75 423 2.86 8.24 406 8.24
10 - 13.25 72 2.12 11.06 72 11.06
16 13 3 16 11 16
-------------- --------------
1,604 3.71 990 5.18
============== =========== ============== ===========
Weighted average fair values and weighted average exercise
prices of options whose exercise prices is equal to, lower
than or exceeds market price of the shares at date of grant
are as follows:
Year ended December 31,
-----------------------------------------------------------------------
2002 2001 2000
-----------------------------------------------------------------------
Weighted Weighted Weighted Weighted Weighted Weighted
average average average average average average
fair exercise fair exercise fair exercise
value price value price value price
---------- --------- --------- --------- -------- -----------
Equals market
price at
date of grant $ 0.84 $ 1.22 $ 0.98 $ 1.32 $ 7.08 $ 7.83
========== ========= ========= ========= ======== ========
Exceeds market
price at
date of grant $ - $ - $ 1.30 $ 1.83 $ 11.11 $ 21.88
========== ========= ========= ========= ======== =========
Lower than
market price
at date of
grant $ 1.29 $ 0.02 $ 1.77 $ 0.02 $ 7.89 $ 1.78
========== ========= ========= ========= ======== =========
F-28
ATTUNITY LTD. AND ITS SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
- --------------------------------------------------------------------------------
U.S. dollars in thousands
NOTE 12:- SHAREHOLDERS' EQUITY (Cont.)
d. Stock warrants:
The Company has issued warrants, as follows:
Outstanding Exercisable
as of as of
December 31, Exercise December 31, Exercisable
Issuance date 2002 price 2002 through
------------- ------------ ----------- ------------ -----------------
June 2000 (1) 425,000 $20-$25.50 425,000 March 31, 2005
October 2000(2) 72,000 $ 12 72,000 October 31, 2005
June 2001 (3) 180,000 $ 2.5 180,000 December 31, 2004
October 2001(4) 4,150,387 $1.75-$2.25 4,150,387 October 16, 2005
--------- ---------
4,827,387 4,827,387
========= =========
(1) Issued to investors and underwriters of 2000 private
placement. These warrants will expire on March 31, 2005.
(2) Issued to consultants and underwriters of 2000 private
placement. These warrants will expire on October 31, 2005.
(3) Issued to a consultant for public relationship services.
These warrants will expire on December 31, 2004.
(4) Issued to investors and underwriters of the October 2001
private placement. These warrants will expire on October 16,
2005.
The Company had accounted for its warrants to consultants under
the fair value method of SFAS No. 123 and EITF No. 96-18. The
fair value for these warrants was estimated using Black-Scholes
option-pricing model with the following weighted-average
assumptions for 2002 and 2001: risk-free interest rates of 2.5%
for 2002, and 3% for 2001, dividend yields of 0% for each year,
volatility factors of the expected market price of the Company's
Ordinary shares of 0.795 and 1.3, respectively and a
weighted-average contractual life of approximately 2 years for
each year.
In 2002, the Company has recorded $ 50 as compensation expenses
in the financial statements, as a result of warrants granted to a
consultant for public relationship services, which has been
vested through 2002.
e. During 2000, the Company granted a senior employee a fully
recourse loan in the amount of $ 121 to satisfy tax payment in
respect of options exercised.
During 2001, as a result of delay in the employee repayment of
the debt, the Company wrote the loan off. In addition, the
Company imposed restrictions on the employee's ownership on the
shares, until settlement will be achieved. As a result of the
uncertainty of the loan repayment, the Company recorded $ 90 as a
loan write-off charge and the remaining $ 31, which represents
the fair value of the shares, was accounted as treasury shares.
F-29
ATTUNITY LTD. AND ITS SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
- --------------------------------------------------------------------------------
U.S. dollars in thousands
NOTE 12:- SHAREHOLDERS' EQUITY (Cont.)
During 2002, the Company collected the employee debt and
therefore released he restrictions on the employee's ownership.
f. During 2001, the Company issued to the former shareholders and
employees of Bridges for Islands 350,000 Ordinary shares at their
par value and 133,094 options with an exercise price of $ 0.024
as result of the price protection mechanism described in Note
1b1.
g. Dividends:
In the event that cash dividends are declared in the future, such
dividends will be paid in New Israeli Shekels ("NIS"). The
Company does not intend to pay cash dividends in the foreseeable
future.
NOTE 13:- TAXES ON INCOME
a. Tax benefits under the Law for the Encouragement of Capital
Investments, 1959 ("the Law"):
The production facilities of Attunity and its subsidiary Attunity
Software Services Ltd. ("ASS") have been granted "Approved
Enterprise" status under the Investment Law.
In June 2000, Attunity Ltd. filed an application for a fourth
investment program which has not been approved, yet the other
three investment programs, which were approved in February 1998,
April 1998 and November 2001, will expire in April 2006, November
2008 and December 2011, respectively.
As of December 31, 2002, the investments under June 2000
investment program remain in progress and has not been completed.
According to the provisions of the Law, Attunity Ltd. has elected
to enjoy "alternative benefits" - waiver of grants in return for
tax exemption - and, accordingly, income derived from the
"Approved Enterprise" will be tax-exempt for a period of two
years commencing with the year it first earns taxable income, and
will be taxed at 10% to 25%, based upon the percentage of foreign
investment in Attunity for an additional period of five-eight
years. The period of tax benefits, detailed above, is subject to
limits of the earlier of 12 years from the commencement of
production, or 14 years from the date of approval.
ASS has been granted status as an "Approved Enterprise" for two
separate investment programs from 1991 and 1993 whereby it has
elected to receive Government grants and to enjoy the benefit of
a reduced tax rate of 25% during a period of seven years
commencing with the year it first earns taxable income. The
period of tax benefits, detailed above, is subject to limits of
the earlier of 12 years from the commencement of production, or
14 years from the date of approval. In 1993, ASS received
approval for an expansion of the aforementioned programs whereby
it has elected to enjoy "alternative benefits" - waiver of grants
in return for tax exemption - and, accordingly, its income from
the "Approved Enterprise" will be tax-exempt for a period of ten
years commencing with the year it first earns taxable income.
F-30
ATTUNITY LTD. AND ITS SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
- --------------------------------------------------------------------------------
U.S. dollars in thousands
NOTE 13:- TAXES ON INCOME (Cont.)
As of December 2002, ASS has not yet received final approvals for
such programs.
If these retained tax-exempt profits are distributed in a manner
other than in the complete liquidation of the Company they would
be taxed at the corporate tax rate applicable to such profits as
if the Company had not elected the alternative system of
benefits, currently between 15%-20% for an "Approved Enterprise".
As of December 31, 2002, the accumulated deficit of the Company
does not include tax-exempt profits earned by the Company's
"Approved Enterprise".
The Company's decision is not to distribute dividends, other than
upon the liquidation of the Company.
As Attunity currently has no taxable income, the benefits have
not yet commenced for all programs.
The entitlement to the above benefits is conditional upon the
Company's fulfilling the conditions stipulated by the above law,
regulations published thereunder and the instruments of approval
for the specific investments in "approved enterprises". In the
event of failure to comply with these conditions, the benefits
may be canceled and the Company may be required to refund the
amount of the benefits, in whole or in part, including interest.
Should Attunity or ASS derive income from sources other than the
"Approved Enterprise" during the periods of benefits, such income
shall be taxable at the regular corporate tax rate of 36%.
b. Measurement of taxable income under the Income Tax (Inflationary
Adjustments) Law, 1985:
Results of Attunity and its Israeli subsidiaries for tax purposes
are measured and reflected in real terms of earnings in NIS after
certain adjustments for increases in the Customer Price Index. As
explained in Note 2b, the financial statements are presented in
U.S. dollars. The difference between the annual change in the
Israeli Customer Price Index and in the NIS/dollar exchange rate
causes a difference between taxable income or loss and the income
or loss before taxes shown in the financial statements. In
accordance with paragraph 9(f) of SFAS No. 109, the Company has
not provided deferred income taxes on this difference between the
reporting currency and the tax bases of assets and liabilities.
c. Tax benefits under the Law for the Encouragement of Industry
(Taxation),1969:
Attunity and ASS are "industrial companies" under the above law
and as such are entitled to certain tax benefits, mainly
accelerated depreciation of machinery and equipment. It may also
be entitled to deduct over three year period expenses incurred in
connection with a public share offering and to authorize know-how
acquired from third party.
F-31
ATTUNITY LTD. AND ITS SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
- --------------------------------------------------------------------------------
U.S. dollars in thousands
NOTE 13:- TAXES ON INCOME (Cont.)
d. On July 24, 2002, Amendment 132 to the Israeli Income Tax
Ordinance ("the Amendment") was approved by the Israeli
parliament and came into effect on January 1, 2003. The principal
objectives of the Amendment were to broaden the categories of
taxable income and to reduce the tax rates imposed on employees
income.
The material consequences of the Amendment applicable to the
Company include, among other things, imposing tax upon all income
of Israel residents, individuals and corporations, regardless of
the territorial source of income and certain modifications in the
qualified taxation tracks of employee stock options.
e. Tax loss carryforwards:
Net operating loss carryforwards as of December 31, 2002 are as
follows:
Israel $ 27,533
United States *) 9,098
UK 2,240
Hong Kong 1,463
France 702
-----------
$ 41,036
===========
Net operating losses in Israel, UK and Hong Kong may be carried
forward indefinitely. Net operating losses in the U.S. are
available through 2021 and in France through 2006.
*) Utilization of U.S. net operating losses may be subject to
substantial annual limitation due to the "change in
ownership" provisions of the Internal Revenue Code of 1986
and similar state provisions. The annual limitation may
result in the expiration of net operating losses before
utilization.
f. Deferred taxes:
Deferred income taxes reflect the net tax effects of temporary
differences between the carrying amounts of assets and
liabilities for financial reporting purposes and the amounts used
for income tax purposes. Significant components of the Company's
deferred tax liabilities and assets are as follows:
December 31,
---------------------------
2002 2001
------------ -------------
Net operating loss carryforwards $ 10,255 $ 10,069
Other 1,211 1,220
------------ -----------
Total deferred tax asset before valuation
allowance 11,466 11,289
Less - valuation allowance (11,466) (11,289)
------------ -----------
Net deferred tax assets $ - $ -
============ ===========
F-32
ATTUNITY LTD. AND ITS SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
- --------------------------------------------------------------------------------
U.S. dollars in thousands
NOTE 13:- TAXES ON INCOME (Cont.)
The Company has provided valuation allowances in respect of
deferred tax assets resulting from tax loss carryforwards and
other temporary differences. Management currently believes that
since the Company has a history of losses it is more likely than
not that the deferred tax regarding the loss carryforwards and
other temporary differences will not be realized in the
foreseeable future.
During fiscal year 2002, the Company increased the valuation
allowance by $ 177 to $ 11,466.
g. Reconciliation:
A reconciliation of the theoretical tax expense, assuming all
income is taxed at the statutory rate applicable to the income of
the Company and the actual tax expense, is as follows:
Year ended December 31,
--------------------------------------
2002 2001 2000
---------- ---------- -----------
Income (loss) from continued operations
before income taxes, as reported in the
consolidated statements of operations $ 768 $(15,449) $(29,359)
========== ========== ===========
Theoretical tax expense (income tax benefit)
computed at the rate applicable to the
Company (1) $ 276 $ (5,562) $(10,569)
Tax adjustments in respect of inflation in
Israel and effect of different tax rates
for foreign subsidiaries (471) (13) (90)
Losses for which valuation allowance was
provided - 3,965 7,099
Utilization of operating carryforward tax
losses (227) - -
Nondeductible expenses including goodwill
amortization, investment impairment and
others 422 1,626 3,360
Tax withholding 264 386 -
---------- ---------- -----------
Taxes on income (tax benefit) $ 264 $ 402 $ (200)
========== ========== ===========
(1)Statutory rate applicable to the Company 36% 36% 36%
========== ========== ===========
h. Pre-tax income (loss):
Domestic $ (1,753) $(13,548) $(29,062)
Foreign 2,521 (1,901) (297)
---------- ---------- -----------
$ 768 $(15,449) $(29,359)
========== ========== ===========
NOTE 14:- IMPAIRMENT OF INVESTMENT AND OTHER ASSETS
Year ended December 31,
--------------------------------------
2002 2001 2000
----------- ---------- ----------
Impairment of capitalized software costs (see
Note 5) $ - $ 2,386 $ -
Impairment of assembled workforce - 272 -
Impairment of investment (see Note 1b2) - - 6,090
----------- ---------- ----------
$ - $ 2,658 $ 6,090
=========== ========== ==========
F-33
ATTUNITY LTD. AND ITS SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
- --------------------------------------------------------------------------------
U.S. dollars in thousands
NOTE 15:- DISCONTINUED OPERATIONS
In March 2001, the Board of Directors decided to reverse the
acquisition of Medatech and VisOpt (see Note 1b(2)). As of December
31, 2000, the annulment of the acquisition of Medatech was accounted
for as discontinued operations in accordance with APB No. 30
"Reporting the Results of Operations-Reporting the Effects of Disposal
of a Segment of a Business, and Extraordinary, Unusual and
Infrequently Occurring Events and Transactions" and EITF 95-18
"Accounting and Reporting for a Discontinued Business Segment When the
Measurement Date Occurs After the Balance Sheet Date But Before the
Issuance of Financial Statements"
The Company recognized the loss from the discontinued operations in
2000, in accordance with EITF 95-18 which stated that if a loss is
expected from the planned disposal of a segment, the estimated loss,
as determined in accordance with APB No. 30, should be recognized in
the not yet issued financial statements for the period prior to the
measurement date and the segment's operating results should be
presented as discontinued operations.
As a result of the annulment of the Medatech agreement as mentioned
above, the results of operations of Medatech were reported separately
as discontinued operations in the statements of operations for the
year ended December 31, 2000, and are summarized as follows:
For the period
from March 2,
2000 (date of
acquisition)
through
December 31,
2000
---------------
Earnings from discontinued operations of a segment:
Revenues $(3,871)
Cost of revenues 2,715
Research and development expenses 300
Selling, general and administrative expenses 657
Financial income, net (21)
Income tax 74
Goodwill amortization 64
---------------
(82)
---------------
Loss on disposal of segment:
Impairment of goodwill 474
Loss from annulment of agreement 1,272
Predicted expenses in connection with the annulment agreement 560
Fair value of the shares which will be returned to the Company (82)
---------------
2,224
---------------
$ 2,142
===============
During 2001, the Company recorded income totaling $ 220, which
resulted from the difference between the provision made in 2000 and
the actual results.
F-34
ATTUNITY LTD. AND ITS SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
- --------------------------------------------------------------------------------
U.S. dollars in thousands
NOTE 16:- EARNINGS (LOSS) PER SHARE
The following table sets forth the computation of basic and
diluted net earnings (loss) per share:
a. Numerator:
Year ended December 31,
--------------------------------------
2002 2001 2000
---------- ---------- -----------
Net income (loss) from continued operations $ 504 $(15,851) $ (29,159)
---------- ---------- -----------
Net income (loss) from discontinued
operations, net of income tax - 220 (2,142)
---------- ---------- -----------
Net income (loss) $ 504 $(15,631) $ (31,301)
========== ========== ===========
Numerator for basic and diluted net
earnings (loss) per share
from continued operations - income
available to shareholders of
Ordinary shares $ 504 $(15,851) $ (29,159)
========== ========== ===========
Numerator for basic and diluted net
earnings (loss) per share
from discontinued operations -
income available to
shareholders of Ordinary shares $ - $ 220 $ (2,142)
========== ========== ===========
Numerator for basic and diluted net earnings
(loss) per share - income available to
shareholders of Ordinary shares $ 504 $(15,631) $ (31,301)
========== ========== ===========
b. Denominator:
Denominator for basic net earnings (loss) per
share - weighted average number of Ordinary
shares 14,697 11,666 9,844
---------- ---------- -----------
Effect of dilutive securities:
Employee stock options 28 *) - *) -
---------- ---------- -----------
Denominator for diluted net earnings
(loss) per share - adjusted weighted
average number of Ordinary shares, assumed
exercise of options 14,725 11,666 9,844
========== ========== ===========
*) The effect of the inclusion of the options and warrants in
2001 and 2000 would have been antidilutive
F-35
ATTUNITY LTD. AND ITS SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
- --------------------------------------------------------------------------------
U.S. dollars in thousands
NOTE 17:- GEOGRAPHIC AND MAJOR CUSTOMERS INFORMATION
The Company manages its business on a basis of one reportable segment:
computer software integration tools and application development tools
(See Note 1a for a brief description of the Company's business). Total
revenues are attributed to geographic areas based on the location of
the end customers. This data is presented in accordance with Statement
of Financial Accounting Standard No. 131, "Disclosures about Segments
of an Enterprise and Related Information" ("SFAS No. 131").
Year ended December 31,
--------------------------------------
2002 2001 2000
----------- ---------- ----------
Revenues from sales to unaffiliated customers:
Israel $ 2,576 $ 2,761 $ 3,231
United States 7,025 7,589 9,037
Europe 4,950 4,012 5,001
Far East 1,064 1,212 889
South America 1,500 1,066 -
Other 340 229 513
----------- ---------- ----------
$ 17,455 $ 16,869 $ 18,671
=========== ========== ==========
The Company's long-lived assets are as follows:
December 31,
------------------------------
2002 2001
------------- -------------
Israel $ 12,467 $ 12,478
United States 274 470
Other 163 191
------------- -------------
$ 12,904 $ 13,139
============= =============
Major customer's data as percentage of total sales:
Year ended December 31,
--------------------------------------
2002 2001 2000
----------- ---------- ----------
%
--------------------------------------
Customer A 10.3 - -
=========== ========== ==========
F-36
ATTUNITY LTD. AND ITS SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
- --------------------------------------------------------------------------------
U.S. dollars in thousands
NOTE 18:- SELECTED STATEMENTS OF OPERATIONS DATA
a. Research and development costs, net:
Year ended December 31,
-----------------------------------------
2002 2001 2000
------------ ---------- ------------
Total costs $ 3,618 $ 5,771 $ 5,554
Less - capitalized software
development costs (1,595) (1,789) (1,995)
------------ ---------- ------------
$ 2,023 $ 3,982 $ 3,559
============ ========== ============
b. Restructuring and other non-recurring charges:
Restructuring charges (1) $ - $ 1,326 $ -
Outcome of lawsuit (2) 810 - -
Termination of lease (3) 290 - -
Employment termination benefits (4) 467 - -
Others 141 - -
------------ ---------- ------------
$ 1,708 $ 1,326 $ -
============ ========== ============
(1) See also Note 1c.
(2) See also Note 19.
(3) During 2002, the Company's subsidiary in the United States
ceased the use of its former lease facilities before the end
of the agreement term, which will expire in September 2005.
The Company early adopted Statement of Financial Accounting
Standard No. 146, "Accounting for Costs Associated with Exit
Disposal Activities" ("SFAS No. 146"), which addresses the
recognition, measurement, and reporting of costs associated
with exit and disposal activities, including restructuring
activities.
According to SFAS No. 146, the Company recognized a one time
charge in a total amount of $290 related to the costs that
will continue to be incurred under the agreement for its
remaining time, without economic benefit to the Company.
The one-time charge was measured at its fair value at the
cease of use date based on the future remaining lease
payments, reduced by estimated sublease rentals that could
be reasonably obtained for those facilities.
(4) One time charge related to employment termination of Chief
Executive Officer of the Company and few other employees
during 2002.
F-37
ATTUNITY LTD. AND ITS SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
- --------------------------------------------------------------------------------
U.S. dollars in thousands
NOTE 18:- SELECTED STATEMENTS OF OPERATIONS DATA (Cont.)
c. Financial income, net:
Year ended December 31,
-----------------------------------------
2002 2001 2000
------------ ---------- ------------
Financial income:
Gain on trading marketable securities $ - $ - $ 40
Interest and other income 69 142 411
Foreign currency translation
differences 141 515 237
----------- ----------- ------------
210 657 688
----------- ----------- ------------
Financial expenses:
Interest (69) (304) (57)
Foreign currency translation
differences - (305) (215)
----------- ----------- ------------
(69) (609) (272)
----------- ----------- ------------
$ 141 $ 48 $ 416
=========== =========== ============
NOTE 19:- SUBSEQUENT EVENTS
On March 28, 2003 the court ruled against the Company in favor of SSF.
The Judge awarded SSF liquidation damages in the amount of $ 603 plus
interest from the date the complaint was filed, see also Note 11c.
The Company has appealed the decision.
At December 31, 2002, the Company recorded a one time charge in the
amount of $ 810, related to the outcome of the lawsuit and its related
expenses. The charge was included in restructuring and other
non-recurring charges in the statement of operations.
- - - - - - - - - - - -
F-38
S I G N A T U R E S
-------------------
THE REGISTRANT HEREBY CERTIFIES THAT IT MEETS ALL OF THE REQUIREMENTS FOR
FILING ON FORM 20-F AND THAT IT HAS DULY CAUSED AND AUTHORIZED THE UNDERSIGNED
TO SIGN THIS ANNUAL REPORT ON ITS BEHALF.
ATTUNITY LTD
(REGISTRANT)
BY: /s/Arie Gonen
-------------
Arie Gonen, Chairman of the Board and
Acting Chief Executive Officer
BY: /s/ Ofer Segev
--------------
Ofer Segev, Chief Financial Officer and
Chief Operating Officer
Dated: June 30, 2003
67
EXHIBIT INDEX
Exhibit No. Description of Exhibit
----------- ----------------------
3.1 Memorandum of Association of the Registrant (1)
3.2 Articles of Association of the Registrant, as Amended (2)
4.1 Specimen of Ordinary Share Certificate (3)
8 List of Subsidiaries of the Registrant
10.1 Share Purchase Agreement among the Registrant, VisOpt B.V., Moyo
B.V. and Natram B.V. dated as of July 21, 2000 (4)
10.2 Share Purchase Agreement between the Registrant and Bridges for
Islands Ltd. dated March 27, 2000 (5)
10.3 Share Purchase Agreement among the Registrant, MedaTech Information
Technology Ltd., Natram Management Ltd., Moyo Management Ltd. and
Alan Harel, dated as of July 14, 2000 (6)
10.4 Annulment Agreement among the Registrant, VisOpt B.V., Moyo B.V. and
Natram B.V. dated as of May 28, 2001 (2)
10.5 Annulment Agreement among the Registrant, MedaTech Information
Technology Ltd., Natram Management Ltd., Moyo Management Ltd. and
Alan Harel, dated as of May 28, 2001 (2)
10.6 Amendment to Share Purchase Agreement among the Registrant, Bridges
for Islands Ltd., Dov Biran, Dr. Dov Biran Holdings Ltd. and Poalim
Capital Markets and Investments Ltd., dated as of June 20, 2001 (2)
10.7 1992 Employee Stock Option Plan (1)
10.8 1994 Employee Stock Option Plan
10.9 1998 Employee Stock Option Plan
10.10 Employment and Services Agreement among the Registrant and Mr. Gonen
21 List of Subsidiaries of the Registrant
23.1 Consent of Kost, Forer & Gabbay, Certified Public Accountants
(Israel)
99.1 Certification by Chief Executive Officer Pursuant to Section 302 of
the Sarbanes-Oxley Act of 2002.
99.2 Certification by Chief Financial Officer Pursuant to Section 302 of
the Sarbanes-Oxley Act of 2002.
99.3 Certification by Chief Executive Officer Pursuant to 18 U.S.C.
Section 1350, As Adopted Pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002.
99.4 Certification by Chief Financial Officer Pursuant to 18 U.S.C.
Section 1350, As Adopted Pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002.
- -------------------
(1) Filed as an exhibit to the Registrant's Registration Statement on Form
F-1, registration number 33-54020, and incorporated herein by reference.
(2) Filed as an exhibit to the registrant's annual report on Form 20-F for
the year ended December 31, 2000.
(3) Filed as Exhibit 4.1 to the Registrant's Registration Statement on Form
F-1 registration number 33-54020, and incorporated herein by reference.
(4) Filed as Exhibit 10.4 to the Registrant's Registration Statement on Form
F-3 registration number 333-12450, and incorporated herein by reference.
(5) Filed as Exhibit 10.5 to the Registrant's Registration Statement on Form
F-3 registration number 333-11972, and incorporated herein by reference.
(6) Filed as Exhibit 10.5 to the Registrant's Registration Statement on Form
F-3 registration number 333-12450, and incorporated herein by reference.